CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: succimer
Accession: CHEBI:63623
browse the term
Definition: A sulfur-containing carboxylic acid that is succinic acid bearing two mercapto substituents at positions 2 and 3. A lead chelator used as an antedote to lead poisoning.
Synonyms: exact_synonym: (2R,3S)-2,3-disulfanylsuccinic acid
related_synonym: (R*,S*)-2,3-Dimercaptobutanedioic acid; DMSA; Dimercaptosuccinic acid; Formula=C4H6O4S2; InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+; InChIKey=ACTRVOBWPAIOHC-XIXRPRMCSA-N; SMILES=OC(=O)[C@@H](S)[C@@H](S)C(O)=O; meso-2,3-Dimercaptobernsteinsaeure; meso-2,3-Dimercaptosuccinic acid; meso-Dimercaptosuccinic acid; succimero; succimerum
alt_id: CHEBI:9303
xref: Beilstein:1725150; CAS:304-55-2; DrugBank:DB00566; Drug_Central:2486; KEGG:C07598; KEGG:D00572; LINCS:LSM-4749
xref_mesh: MESH:D004113
xref: PMID:19123743; PMID:21112928; PMID:22234625; Reaxys:1725150; Wikipedia:Succimer
G
AASDHPPT
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AASDHPPT mRNA
CTD
PMID:26378955
NCBI chr11:106,077,662...106,098,695
Ensembl chr11:106,075,501...106,098,699
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCB1 mRNA
CTD
PMID:26378955
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions increases transport
ISO EXP
ABCC2 protein affects the reaction [Succimer binds to and results in increased secretion of [Mercuric Chloride binds to Cysteine]]; ABCC2 protein binds to and results in increased secretion of [Succimer binds to [Mercuric Chloride binds to Cysteine]] ABCC2 protein results in increased transport of Succimer metabolite ABCC2 results in increased transport of Succimer metabolite
CTD
PMID:17940195 PMID:18511429 PMID:19063911
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCE1
ATP binding cassette subfamily E member 1
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCE1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCE1 mRNA
CTD
PMID:26378955
NCBI chr 4:145,098,311...145,129,524
Ensembl chr 4:145,098,288...145,129,524
G
ABCG1
ATP binding cassette subfamily G member 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCG1 mRNA
CTD
PMID:26378955
NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
G
ABLIM1
actin binding LIM protein 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABLIM1 mRNA
CTD
PMID:26378955
NCBI chr10:114,431,110...114,801,373
Ensembl chr10:114,431,112...114,768,061
G
ABTB2
ankyrin repeat and BTB domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ABTB2 mRNA
CTD
PMID:21641980
NCBI chr11:34,150,987...34,358,010
Ensembl chr11:34,150,987...34,358,010
G
ACAP1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACAP1 mRNA
CTD
PMID:21641980
NCBI chr17:7,336,529...7,351,477
Ensembl chr17:7,336,529...7,351,477
G
ACOD1
aconitate decarboxylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACOD1 mRNA
CTD
PMID:21641980
NCBI chr13:76,948,511...76,958,638
Ensembl chr13:76,948,511...76,958,638
G
ACP5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
G
ACSL4
acyl-CoA synthetase long chain family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACSL4 mRNA
CTD
PMID:21641980
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
G
ACTC1
actin alpha cardiac muscle 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACTC1 mRNA
CTD
PMID:26378955
NCBI chr15:34,790,230...34,795,549
Ensembl chr15:34,790,107...34,795,589
G
ACTG2
actin gamma 2, smooth muscle
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACTG2 mRNA
CTD
PMID:26378955
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
G
ACY1
aminoacylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACY1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACY1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:51,983,535...51,989,197
Ensembl chr 3:51,983,340...51,989,197
G
ACY3
aminoacylase 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACY3 mRNA
CTD
PMID:26378955
NCBI chr11:67,642,555...67,650,730
Ensembl chr11:67,642,555...67,650,730
G
ADAM28
ADAM metallopeptidase domain 28
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAM28 mRNA
CTD
PMID:26378955
NCBI chr 8:24,294,069...24,359,014
Ensembl chr 8:24,294,069...24,359,014
G
ADAM8
ADAM metallopeptidase domain 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAM8 mRNA
CTD
PMID:26378955
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAMTS1 mRNA
CTD
PMID:26378955
NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
G
ADAMTS10
ADAM metallopeptidase with thrombospondin type 1 motif 10
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS10 mRNA
CTD
PMID:26378955
NCBI chr19:8,580,240...8,610,715
Ensembl chr19:8,580,240...8,610,735
G
ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif 5
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS5 mRNA
CTD
PMID:26378955
NCBI chr21:26,917,922...26,967,088
Ensembl chr21:26,917,922...26,967,088
G
ADAT1
adenosine deaminase tRNA specific 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAT1 mRNA
CTD
PMID:26378955
NCBI chr16:75,596,868...75,623,281
Ensembl chr16:75,596,868...75,623,300
G
ADD3
adducin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ADD3 mRNA
CTD
PMID:21641980
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
G
ADM
adrenomedullin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADM mRNA
CTD
PMID:21641980
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
ADORA2B
adenosine A2b receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADORA2B mRNA
CTD
PMID:21641980
NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
G
AEBP2
AE binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AEBP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AEBP2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:19,404,072...19,522,227
Ensembl chr12:19,404,045...19,720,801
G
AFP
alpha fetoprotein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AFP mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AFP mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
G
AGAP1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGAP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGAP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:235,494,043...236,131,793
Ensembl chr 2:235,494,043...236,131,793
G
AGFG2
ArfGAP with FG repeats 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGFG2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGFG2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:100,539,203...100,568,220
Ensembl chr 7:100,539,203...100,568,220
G
AGMO
alkylglycerol monooxygenase
multiple interactions decreases expression
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGMO mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGMO mRNA Succimer results in decreased expression of AGMO mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:15,117,223...15,562,015
Ensembl chr 7:15,200,317...15,562,015
G
AGT
angiotensinogen
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGT mRNA
CTD
PMID:26378955
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AHNAK
AHNAK nucleoprotein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AHNAK mRNA
CTD
PMID:21641980
NCBI chr11:62,433,544...62,546,806
Ensembl chr11:62,433,542...62,556,235
G
AHNAK2
AHNAK nucleoprotein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AHNAK2 mRNA
CTD
PMID:21641980
NCBI chr14:104,937,253...104,978,374
Ensembl chr14:104,937,244...104,978,374
G
AIF1L
allograft inflammatory factor 1 like
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AIF1L mRNA
CTD
PMID:26378955
NCBI chr 9:131,096,531...131,123,144
Ensembl chr 9:131,096,476...131,123,152
G
AIRN
antisense of IGF2R non-protein coding RNA
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AIRN mRNA
CTD
PMID:21641980
NCBI chr 6:160,003,291...160,007,664
Ensembl chr 6:160,003,291...160,007,664
G
AKAP9
A-kinase anchoring protein 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AKAP9 mRNA
CTD
PMID:21641980
NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
ISO
Succimer inhibits the reaction [sodium arsenite results in decreased expression of AKT1 protein]
CTD
PMID:31163222
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
AKTIP
AKT interacting protein
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AKTIP mRNA
CTD
PMID:26378955
NCBI chr16:53,491,040...53,504,412
Ensembl chr16:53,491,040...53,504,411
G
ALAD
aminolevulinate dehydratase
multiple interactions increases activity
ISO
[diphenyldiselenide co-treated with Succimer] inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein]; Succimer inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein] Succimer results in increased activity of ALAD protein Succimer inhibits the reaction [arsenite results in decreased activity of ALAD protein]; Succimer inhibits the reaction [sodium arsenite results in decreased activity of ALAD protein]
CTD
PMID:9559101 PMID:15202869 PMID:15331134 PMID:17188940
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
ALCAM
activated leukocyte cell adhesion molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALCAM mRNA
CTD
PMID:21641980
NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,909...105,576,900
G
ALDH1L1
aldehyde dehydrogenase 1 family member L1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ALDH1L1 mRNA
CTD
PMID:21641980
NCBI chr 3:126,103,570...126,197,945
Ensembl chr 3:126,103,562...126,197,994
G
ALG6
ALG6 alpha-1,3-glucosyltransferase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALG6 mRNA
CTD
PMID:21641980
NCBI chr 1:63,367,627...63,438,553
Ensembl chr 1:63,367,575...63,438,553
G
ALKBH8
alkB homolog 8, tRNA methyltransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ALKBH8 mRNA
CTD
PMID:26378955
NCBI chr11:107,502,727...107,565,735
Ensembl chr11:107,502,727...107,565,742
G
ALPG
alkaline phosphatase, germ cell
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ALPG mRNA
CTD
PMID:26378955
NCBI chr 2:232,406,844...232,410,714
Ensembl chr 2:232,406,844...232,410,714
G
AMPD3
adenosine monophosphate deaminase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AMPD3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AMPD3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
G
AMZ1
archaelysin family metallopeptidase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AMZ1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AMZ1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:2,679,522...2,765,138
Ensembl chr 7:2,679,522...2,775,500
G
ANAPC1
anaphase promoting complex subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANAPC1 mRNA
CTD
PMID:21641980
NCBI chr 2:111,766,231...111,884,193
Ensembl chr 2:111,611,639...111,884,690
G
ANGPT2
angiopoietin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANGPT2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ANGPT2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
G
ANGPTL2
angiopoietin like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ANGPTL2 mRNA
CTD
PMID:21641980
NCBI chr 9:127,087,348...127,122,635
Ensembl chr 9:127,087,348...127,122,635
G
ANK3
ankyrin 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANK3 mRNA
CTD
PMID:26378955
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
ANKMY1
ankyrin repeat and MYND domain containing 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANKMY1 mRNA
CTD
PMID:26378955
NCBI chr 2:240,468,632...240,561,064
Ensembl chr 2:240,479,422...240,569,209
G
ANKRD12
ankyrin repeat domain 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD12 mRNA
CTD
PMID:21641980
NCBI chr18:9,136,781...9,285,985
Ensembl chr18:9,136,228...9,285,985
G
ANKRD26
ankyrin repeat domain containing 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD26 mRNA
CTD
PMID:21641980
NCBI chr10:26,947,582...27,100,494
Ensembl chr10:26,973,793...27,100,494
G
ANKRD37
ankyrin repeat domain 37
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD37 mRNA
CTD
PMID:21641980
NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
G
ANKRD44
ankyrin repeat domain 44
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD44 mRNA
CTD
PMID:21641980
NCBI chr 2:196,967,014...197,310,780
Ensembl chr 2:196,967,017...197,311,173
G
ANPEP
alanyl aminopeptidase, membrane
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANPEP mRNA
CTD
PMID:26378955
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
G
AOX1
aldehyde oxidase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AOX1 mRNA
CTD
PMID:26378955
NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064
G
APOBEC1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of APOBEC1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of APOBEC1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:7,649,400...7,670,599
Ensembl chr12:7,649,400...7,665,908
G
APOC2
apolipoprotein C2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of APOC2 mRNA
CTD
PMID:26378955
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
APOH
apolipoprotein H
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of APOH mRNA
CTD
PMID:21641980
NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
G
APOL4
apolipoprotein L4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of APOL9A mRNA
CTD
PMID:21641980
NCBI chr22:36,189,128...36,204,833
Ensembl chr22:36,189,124...36,204,840
G
AQP11
aquaporin 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AQP11 mRNA
CTD
PMID:21641980
NCBI chr11:77,589,953...77,610,356
Ensembl chr11:77,589,391...77,610,356
G
ARAP3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARAP3 mRNA
CTD
PMID:26378955
NCBI chr 5:141,653,402...141,682,230
Ensembl chr 5:141,653,401...141,682,230
G
ARFGEF3
ARFGEF family member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARFGEF3 mRNA
CTD
PMID:21641980
NCBI chr 6:138,161,939...138,344,663
Ensembl chr 6:138,161,939...138,344,663
G
ARG2
arginase 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ARG2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARG2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ARG2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGAP18
Rho GTPase activating protein 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGAP18 mRNA
CTD
PMID:21641980
NCBI chr 6:129,576,132...129,710,177
Ensembl chr 6:129,576,132...129,710,177
G
ARHGEF6
Rac/Cdc42 guanine nucleotide exchange factor 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGEF6 mRNA
CTD
PMID:21641980
NCBI chr X:136,665,550...136,780,932
Ensembl chr X:136,665,547...136,780,932
G
ARL17B
ADP ribosylation factor like GTPase 17B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARF2 mRNA
CTD
PMID:21641980
NCBI chr17:46,274,184...46,361,787
Ensembl chr17:46,274,784...46,361,766 Ensembl chr17:46,274,784...46,361,766
G
ARPC2
actin related protein 2/3 complex subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPC2 mRNA
CTD
PMID:21641980
NCBI chr 2:218,217,189...218,254,348
Ensembl chr 2:218,217,141...218,254,356
G
ARPP19
cAMP regulated phosphoprotein 19
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPP19 mRNA
CTD
PMID:21641980
NCBI chr15:52,547,045...52,569,446
Ensembl chr15:52,547,045...52,569,883
G
ARRDC4
arrestin domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ARRDC4 mRNA
CTD
PMID:21641980
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
G
ASH1L
ASH1 like histone lysine methyltransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ASH1L mRNA
CTD
PMID:26378955
NCBI chr 1:155,335,268...155,563,202
Ensembl chr 1:155,335,268...155,563,162
G
ASPH
aspartate beta-hydroxylase
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ASPH mRNA
CTD
PMID:26378955
NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
G
ATAD2
ATPase family AAA domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA
CTD
PMID:21641980
NCBI chr 8:123,319,850...123,416,350
Ensembl chr 8:123,319,850...123,416,350
G
ATAD5
ATPase family AAA domain containing 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD5 mRNA
CTD
PMID:21641980
NCBI chr17:30,831,966...30,895,869
Ensembl chr17:30,831,966...30,895,869
G
ATF2
activating transcription factor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATF2 mRNA
CTD
PMID:26378955
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
G
ATP11C
ATPase phospholipid transporting 11C
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP11C mRNA
CTD
PMID:26378955
NCBI chr X:139,726,348...139,936,903
Ensembl chr X:139,726,346...139,945,276
G
ATP13A3
ATPase 13A3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP13A3 mRNA
CTD
PMID:26378955
NCBI chr 3:194,402,677...194,494,334
Ensembl chr 3:194,402,672...194,498,364
G
ATP1B1
ATPase Na+/K+ transporting subunit beta 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP1B1 mRNA
CTD
PMID:26378955
NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP2B1 mRNA
CTD
PMID:21641980
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
G
ATP6V0D2
ATPase H+ transporting V0 subunit d2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP6V0D2 mRNA
CTD
PMID:21641980
NCBI chr 8:86,098,910...86,154,225
Ensembl chr 8:85,987,323...86,154,225
G
ATP7A
ATPase copper transporting alpha
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP7A mRNA
CTD
PMID:26378955
NCBI chr X:77,910,693...78,050,395
Ensembl chr X:77,910,690...78,050,395
G
ATP8A1
ATPase phospholipid transporting 8A1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATP8A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP8A1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:42,408,373...42,657,105
Ensembl chr 4:42,408,373...42,657,121
G
ATRX
ATRX chromatin remodeler
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATRX mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ATRX mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATRX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:77,504,880...77,786,216
Ensembl chr X:77,504,880...77,786,233
G
ATXN1
ataxin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATXN1 mRNA
CTD
PMID:21641980
NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491
G
ATXN3
ataxin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATXN3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATXN3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:92,044,775...92,106,582
Ensembl chr14:92,044,496...92,106,621
G
B3GALT4
beta-1,3-galactosyltransferase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of B3GALT4 mRNA
CTD
PMID:21641980
NCBI chr 6:33,277,123...33,278,825
Ensembl chr 6:33,277,123...33,284,832
G
B4GALT5
beta-1,4-galactosyltransferase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of B4GALT5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of B4GALT5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,878
G
BAK1
BCL2 antagonist/killer 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAK1 mRNA
CTD
PMID:26378955
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA]
CTD
PMID:31163222 PMID:32402895
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BAZ1A
bromodomain adjacent to zinc finger domain 1A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ1A mRNA
CTD
PMID:26378955
NCBI chr14:34,752,731...34,875,360
Ensembl chr14:34,752,731...34,875,647
G
BAZ2B
bromodomain adjacent to zinc finger domain 2B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ2B mRNA
CTD
PMID:26378955
NCBI chr 2:159,315,312...159,712,442
Ensembl chr 2:159,318,979...159,616,569
G
BBOX1
gamma-butyrobetaine hydroxylase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BBOX1 mRNA
CTD
PMID:26378955
NCBI chr11:27,040,815...27,127,809
Ensembl chr11:27,040,725...27,127,809
G
BBS9
Bardet-Biedl syndrome 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BBS9 mRNA
CTD
PMID:21641980
NCBI chr 7:33,129,285...33,635,767
Ensembl chr 7:33,109,557...33,877,180
G
BCL2
BCL2 apoptosis regulator
multiple interactions
ISO
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA]
CTD
PMID:32402895
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL2L11
BCL2 like 11
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L11 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L11 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2L11 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BCL6B
BCL6B transcription repressor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL6B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL6B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:7,023,050...7,029,644
Ensembl chr17:7,023,050...7,030,290
G
BCL7A
BAF chromatin remodeling complex subunit BCL7A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCL7A mRNA
CTD
PMID:21641980
NCBI chr12:122,021,884...122,062,044
Ensembl chr12:122,019,422...122,062,044
G
BCLAF1
BCL2 associated transcription factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCLAF1 mRNA
CTD
PMID:21641980
NCBI chr 6:136,256,627...136,289,846
Ensembl chr 6:136,256,627...136,289,851
G
BCO2
beta-carotene oxygenase 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCO2 mRNA
CTD
PMID:26378955
NCBI chr11:112,175,512...112,218,946
Ensembl chr11:112,175,510...112,224,699
G
BIRC3
baculoviral IAP repeat containing 3
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC3 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BIRC3 mRNA
CTD
PMID:26378955
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
G
BLM
BLM RecQ like helicase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BLM mRNA
CTD
PMID:21641980
NCBI chr15:90,717,346...90,816,166
Ensembl chr15:90,717,346...90,816,166
G
BLVRB
biliverdin reductase B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BLVRB mRNA
CTD
PMID:21641980
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
G
BPNT2
3'(2'), 5'-bisphosphate nucleotidase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BPNT2 mRNA
CTD
PMID:26378955
NCBI chr 8:56,957,931...56,993,867
Ensembl chr 8:56,957,931...56,993,867
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRAF mRNA
CTD
PMID:26378955
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
G
BRCA1
BRCA1 DNA repair associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRCA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRCA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
BRCA2
BRCA2 DNA repair associated
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BRCA2 mRNA
CTD
PMID:26378955
NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
G
BRD8
bromodomain containing 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRD8 mRNA
CTD
PMID:21641980
NCBI chr 5:138,139,770...138,178,630
Ensembl chr 5:138,139,770...138,178,953
G
BRWD1
bromodomain and WD repeat domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRWD1 mRNA
CTD
PMID:21641980
NCBI chr21:39,184,176...39,321,212
Ensembl chr21:39,184,176...39,321,559
G
BTG1
BTG anti-proliferation factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BTG1 mRNA
CTD
PMID:21641980
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
G
BTG2
BTG anti-proliferation factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG2 mRNA
CTD
PMID:21641980
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
BTG3
BTG anti-proliferation factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG3 mRNA
CTD
PMID:21641980
NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945
G
C12orf57
chromosome 12 open reading frame 57
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GRCC10 mRNA
CTD
PMID:21641980
NCBI chr12:6,943,433...6,946,003
Ensembl chr12:6,942,978...6,946,003
G
C1GALT1
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of C1GALT1 mRNA
CTD
PMID:26378955
NCBI chr 7:7,157,377...7,248,616
Ensembl chr 7:7,156,934...7,248,616
G
C3
complement C3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of C3 mRNA
CTD
PMID:26378955
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CA13
carbonic anhydrase 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAR13 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CAR13 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:85,245,458...85,284,073
Ensembl chr 8:85,220,587...85,284,073
G
CACNA1A
calcium voltage-gated channel subunit alpha1 A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CACNA1A mRNA
CTD
PMID:26378955
NCBI chr19:13,206,442...13,506,479
Ensembl chr19:13,206,442...13,624,489
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CACNA1B mRNA
CTD
PMID:26378955
NCBI chr 9:137,877,782...138,124,619
Ensembl chr 9:137,877,782...138,124,624
G
CADPS
calcium dependent secretion activator
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CADPS mRNA
CTD
PMID:26378955
NCBI chr 3:62,398,348...62,875,416
Ensembl chr 3:62,398,346...62,875,416
G
CAMK1D
calcium/calmodulin dependent protein kinase ID
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAMK1D mRNA
CTD
PMID:21641980
NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545
G
CAMK2D
calcium/calmodulin dependent protein kinase II delta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAMK2D mRNA
CTD
PMID:21641980
NCBI chr 4:113,451,032...113,761,738
Ensembl chr 4:113,418,054...113,761,927
G
CAND1
cullin associated and neddylation dissociated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAND1 mRNA
CTD
PMID:21641980
NCBI chr12:67,269,358...67,319,953
Ensembl chr12:67,269,358...67,319,953
G
CANX
calnexin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CANX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CANX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
G
CAPN3
calpain 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN3 mRNA
CTD
PMID:26378955
NCBI chr15:42,359,501...42,412,317
Ensembl chr15:42,359,498...42,412,949
G
CAPN7
calpain 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAPN7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:15,206,246...15,252,916
Ensembl chr 3:15,206,152...15,252,916
G
CASK
calcium/calmodulin dependent serine protein kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASK mRNA
CTD
PMID:21641980
NCBI chr X:41,514,934...41,923,554
Ensembl chr X:41,514,934...41,923,554
G
CASP1
caspase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP1 mRNA
CTD
PMID:26378955
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CASP12
caspase 12 (gene/pseudogene)
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CASP12 mRNA
CTD
PMID:26378955
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
multiple interactions
ISO
Succimer inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein]
CTD
PMID:31163222
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP4
caspase 4
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CASP4 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP4 mRNA
CTD
PMID:26378955
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
G
CASP8AP2
caspase 8 associated protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:89,829,880...89,874,436
Ensembl chr 6:89,829,894...89,874,436
G
CAST
calpastatin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAST mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAST mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,525,267...96,779,595 Ensembl chr 5:96,525,267...96,779,595
G
CAT
catalase
multiple interactions
ISO
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; Succimer inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Succimer promotes the reaction [Thioctic Acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]]; Thioctic Acid promotes the reaction [Succimer inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]]
CTD
PMID:15998567 PMID:31163222 PMID:32402895
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CBFA2T2
CBFA2/RUNX1 partner transcriptional co-repressor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CBFA2T2 mRNA
CTD
PMID:26378955
NCBI chr20:33,490,096...33,650,030
Ensembl chr20:33,490,075...33,650,036
G
CBLB
Cbl proto-oncogene B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of CBLB mRNA
CTD
PMID:26378955
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
CCDC117
coiled-coil domain containing 117
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC117 mRNA
CTD
PMID:21641980
NCBI chr22:28,772,695...28,789,301
Ensembl chr22:28,772,674...28,789,301
G
CCDC88A
coiled-coil domain containing 88A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC88A mRNA
CTD
PMID:21641980
NCBI chr 2:55,287,842...55,419,856
Ensembl chr 2:55,287,842...55,419,895
G
CCL15
C-C motif chemokine ligand 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL22
C-C motif chemokine ligand 22
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL22 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL22 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL3
C-C motif chemokine ligand 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL4
C-C motif chemokine ligand 4
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL4 mRNA [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL5
C-C motif chemokine ligand 5
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL7
C-C motif chemokine ligand 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCN1
cellular communication network factor 1
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCN1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CCN1 mRNA
CTD
PMID:26378955
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCN2
cellular communication network factor 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CCN2 mRNA
CTD
PMID:26378955
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNG2
cyclin G2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNG2 mRNA
CTD
PMID:21641980
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
G
CCNT2
cyclin T2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNT2 mRNA
CTD
PMID:21641980
NCBI chr 2:134,918,822...134,959,342
Ensembl chr 2:134,918,235...134,959,342
G
CCNY
cyclin Y
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNY mRNA
CTD
PMID:21641980
NCBI chr10:35,247,025...35,572,667
Ensembl chr10:35,247,025...35,572,669
G
CCR1
C-C motif chemokine receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCR1 mRNA
CTD
PMID:21641980
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCRL2
C-C motif chemokine receptor like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCRL2 mRNA
CTD
PMID:21641980
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
G
CD109
CD109 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD109 mRNA
CTD
PMID:21641980
NCBI chr 6:73,679,192...73,828,313
Ensembl chr 6:73,695,785...73,828,316
G
CD200R1L
CD200 receptor 1 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD200R4 mRNA
CTD
PMID:21641980
NCBI chr 3:112,815,711...112,846,864
Ensembl chr 3:112,815,709...112,846,864
G
CD209
CD209 molecule
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD209 mRNA
CTD
PMID:26378955
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
G
CD24
CD24 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD24A mRNA
CTD
PMID:21641980
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD274
CD274 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD274 mRNA
CTD
PMID:21641980
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CD276
CD276 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD276 mRNA
CTD
PMID:21641980
NCBI chr15:73,683,944...73,714,514
Ensembl chr15:73,683,966...73,714,514
G
CD36
CD36 molecule (CD36 blood group)
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD36 mRNA
CTD
PMID:26378955
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD40
CD40 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD40 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD40 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD44
CD44 molecule (IN blood group)
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD5L
CD5 molecule like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD5L mRNA
CTD
PMID:21641980
NCBI chr 1:157,827,068...157,841,808
Ensembl chr 1:157,830,911...157,898,256
G
CD74
CD74 molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CD74 mRNA
CTD
PMID:26378955
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
G
CD80
CD80 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD80 mRNA
CTD
PMID:21641980
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CD83
CD83 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD83 mRNA
CTD
PMID:21641980
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
G
CD86
CD86 molecule
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD86 mRNA
CTD
PMID:26378955
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CD93
CD93 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD93 mRNA
CTD
PMID:21641980
NCBI chr20:23,079,360...23,086,324
Ensembl chr20:23,079,360...23,086,324
G
CDA
cytidine deaminase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDA mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDA mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903
G
CDADC1
cytidine and dCMP deaminase domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDADC1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDADC1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:49,247,925...49,293,485
Ensembl chr13:49,247,925...49,293,485
G
CDC42BPA
CDC42 binding protein kinase alpha
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDC42BPA mRNA
CTD
PMID:26378955
NCBI chr 1:226,989,858...227,318,492
Ensembl chr 1:226,989,865...227,318,492
G
CDC42EP2
CDC42 effector protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDC42EP2 mRNA
CTD
PMID:21641980
NCBI chr11:65,314,866...65,322,417
Ensembl chr11:65,314,866...65,322,417
G
CDC6
cell division cycle 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDC6 mRNA
CTD
PMID:21641980
NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
G
CDC7
cell division cycle 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDC7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDC7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:91,500,851...91,525,764
Ensembl chr 1:91,500,851...91,525,764
G
CDH10
cadherin 10
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDH10 mRNA
CTD
PMID:26378955
NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
G
CDK12
cyclin dependent kinase 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDK12 mRNA
CTD
PMID:21641980
NCBI chr17:39,461,486...39,567,559
Ensembl chr17:39,461,486...39,567,559
G
CDKN1A
cyclin dependent kinase inhibitor 1A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDKN1A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDKN1A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDO1
cysteine dioxygenase type 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDO1 mRNA
CTD
PMID:26378955
NCBI chr 5:115,804,733...115,816,659
Ensembl chr 5:115,804,733...115,816,659
G
CDS2
CDP-diacylglycerol synthase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDS2 mRNA
CTD
PMID:21641980
NCBI chr20:5,127,008...5,197,887
Ensembl chr20:5,126,879...5,197,887
G
CEBPD
CCAAT enhancer binding protein delta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CEBPD mRNA
CTD
PMID:21641980
NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
G
CELF2
CUGBP Elav-like family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CELF2 mRNA
CTD
PMID:21641980
NCBI chr10:10,462,550...11,336,675
Ensembl chr10:10,798,397...11,336,675
G
CENPE
centromere protein E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CENPE mRNA
CTD
PMID:21641980
NCBI chr 4:103,105,811...103,198,343
Ensembl chr 4:103,105,349...103,198,445
G
CENPJ
centromere protein J
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CENPJ mRNA
CTD
PMID:21641980
NCBI chr13:24,882,279...24,934,000
Ensembl chr13:24,882,279...24,922,889
G
CEP170
centrosomal protein 170
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CEP170 mRNA
CTD
PMID:21641980
NCBI chr 1:243,124,428...243,255,785
Ensembl chr 1:243,124,428...243,255,793
G
CEPT1
choline/ethanolamine phosphotransferase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CEPT1 mRNA
CTD
PMID:26378955
NCBI chr 1:111,139,499...111,185,104
Ensembl chr 1:111,139,479...111,185,104
G
CERK
ceramide kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CERK mRNA
CTD
PMID:21641980
NCBI chr22:46,684,410...46,738,252
Ensembl chr22:46,684,410...46,738,252
G
CERS4
ceramide synthase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CERS4 mRNA
CTD
PMID:21641980
NCBI chr19:8,209,370...8,262,421
Ensembl chr19:8,206,736...8,262,421
G
CFLAR
CASP8 and FADD like apoptosis regulator
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
CHD4
chromodomain helicase DNA binding protein 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CHD4 mRNA
CTD
PMID:26378955
NCBI chr12:6,570,082...6,607,379
Ensembl chr12:6,570,082...6,614,524
G
CHD9
chromodomain helicase DNA binding protein 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHD9 mRNA
CTD
PMID:21641980
NCBI chr16:53,054,991...53,327,497
Ensembl chr16:53,054,991...53,329,150
G
CHEK1
checkpoint kinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHEK1 mRNA
CTD
PMID:21641980
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
G
CHIT1
chitinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CHIT1 mRNA
CTD
PMID:21641980
NCBI chr 1:203,216,079...203,230,099
Ensembl chr 1:203,212,827...203,273,641
G
CHKA
choline kinase alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHKA mRNA
CTD
PMID:21641980
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
G
CHN1
chimerin 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CHN1 mRNA
CTD
PMID:26378955
NCBI chr 2:174,798,809...175,005,381
Ensembl chr 2:174,798,809...175,005,381
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHUK mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CHUK mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
G
CLDN12
claudin 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLDN12 mRNA
CTD
PMID:21641980
NCBI chr 7:90,403,461...90,415,954
Ensembl chr 7:90,383,721...90,513,402
G
CLEC10A
C-type lectin domain containing 10A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC10A mRNA
CTD
PMID:21641980
NCBI chr17:7,074,537...7,080,251
Ensembl chr17:7,074,537...7,080,307
G
CLEC2D
C-type lectin domain family 2 member D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC2D mRNA
CTD
PMID:21641980
NCBI chr12:9,669,713...9,699,553
Ensembl chr12:9,664,969...9,699,553
G
CLEC4A
C-type lectin domain family 4 member A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLEC4A3 mRNA
CTD
PMID:21641980
NCBI chr12:8,102,907...8,138,607
Ensembl chr12:8,123,617...8,138,607
G
CLEC4E
C-type lectin domain family 4 member E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4E mRNA
CTD
PMID:21641980
NCBI chr12:8,533,275...8,540,905
Ensembl chr12:8,533,305...8,540,905
G
CLEC6A
C-type lectin domain containing 6A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4N mRNA
CTD
PMID:21641980
NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330
G
CLEC7A
C-type lectin domain containing 7A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CLEC7A mRNA
CTD
PMID:26378955
NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
G
CLK1
CDC like kinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLK1 mRNA
CTD
PMID:21641980
NCBI chr 2:200,853,009...200,864,658
Ensembl chr 2:200,853,009...200,864,691
G
CLMN
calmin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLMN mRNA
CTD
PMID:21641980
NCBI chr14:95,181,940...95,319,908
Ensembl chr14:95,181,940...95,319,908
G
CLPX
caseinolytic mitochondrial matrix peptidase chaperone subunit X
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLPX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CLPX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:65,148,219...65,185,342
Ensembl chr15:65,148,219...65,185,342
G
CLSPN
claspin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLSPN mRNA
CTD
PMID:21641980
NCBI chr 1:35,720,213...35,769,978
Ensembl chr 1:35,720,218...35,769,978
G
CLTA
clathrin light chain A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLTA mRNA
CTD
PMID:21641980
NCBI chr 9:36,190,874...36,212,059
Ensembl chr 9:36,190,856...36,304,781
G
CLTC
clathrin heavy chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLTC mRNA
CTD
PMID:21641980
NCBI chr17:59,619,895...59,696,956
Ensembl chr17:59,619,680...59,696,956
G
CLU
clusterin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLU mRNA
CTD
PMID:21641980
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CMPK2
cytidine/uridine monophosphate kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CMPK2 mRNA
CTD
PMID:21641980
NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
G
CNNM3
cyclin and CBS domain divalent metal cation transport mediator 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNNM3 mRNA
CTD
PMID:21641980
NCBI chr 2:96,816,268...96,837,466
Ensembl chr 2:96,816,245...96,835,382
G
CNOT4
CCR4-NOT transcription complex subunit 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNOT4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CNOT4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:135,361,795...135,510,102
Ensembl chr 7:135,361,795...135,510,145
G
CNOT7
CCR4-NOT transcription complex subunit 7
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CNOT7 mRNA
CTD
PMID:26378955
NCBI chr 8:17,224,966...17,246,857
Ensembl chr 8:17,224,966...17,246,878
G
COL14A1
collagen type XIV alpha 1 chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL14A1 mRNA
CTD
PMID:21641980
NCBI chr 8:120,124,454...120,373,573
Ensembl chr 8:120,059,780...120,373,573
G
COL18A1
collagen type XVIII alpha 1 chain
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COL18A1 mRNA
CTD
PMID:26378955
NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720
G
COL3A1
collagen type III alpha 1 chain
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of COL3A1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COL3A1 mRNA
CTD
PMID:26378955
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
COL5A1
collagen type V alpha 1 chain
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of COL5A1 mRNA
CTD
PMID:26378955
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
G
COL7A1
collagen type VII alpha 1 chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL7A1 mRNA
CTD
PMID:21641980
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
G
COL8A1
collagen type VIII alpha 1 chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL8A1 mRNA
CTD
PMID:21641980
NCBI chr 3:99,638,594...99,799,217
Ensembl chr 3:99,638,475...99,799,226
G
COLEC12
collectin subfamily member 12
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COLEC12 mRNA
CTD
PMID:26378955
NCBI chr18:316,737...500,701
Ensembl chr18:316,737...500,722
G
COX5B
cytochrome c oxidase subunit 5B
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COX5B mRNA
CTD
PMID:26378955
NCBI chr 2:97,646,062...97,648,383
Ensembl chr 2:97,646,062...97,648,383
G
CP
ceruloplasmin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CP mRNA
CTD
PMID:26378955
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CPA4
carboxypeptidase A4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CPA4 mRNA
CTD
PMID:26378955
NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180
G
CPD
carboxypeptidase D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPD mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPD mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,927...30,469,989
G
CPN1
carboxypeptidase N subunit 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPN1 mRNA
CTD
PMID:26378955
NCBI chr10:100,042,193...100,081,869
Ensembl chr10:100,042,193...100,081,869
G
CPNE2
copine 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPNE2 mRNA
CTD
PMID:21641980
NCBI chr16:57,092,583...57,148,369
Ensembl chr16:57,092,583...57,148,369
G
CREBBP
CREB binding protein
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CREBBP mRNA
CTD
PMID:26378955
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
G
CRIM1
cysteine rich transmembrane BMP regulator 1
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CRIM1 mRNA
CTD
PMID:26378955
NCBI chr 2:36,355,778...36,551,135
Ensembl chr 2:36,355,778...36,551,135
G
CSAD
cysteine sulfinic acid decarboxylase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSAD mRNA
CTD
PMID:26378955
NCBI chr12:53,157,663...53,181,351
Ensembl chr12:53,157,663...53,180,925
G
CSF1
colony stimulating factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CSF1 mRNA
CTD
PMID:26378955
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
G
CSF3
colony stimulating factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSF3 mRNA
CTD
PMID:21641980
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CSGALNACT1
chondroitin sulfate N-acetylgalactosaminyltransferase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT1 mRNA
CTD
PMID:26378955
NCBI chr 8:19,404,161...19,757,908
Ensembl chr 8:19,404,161...19,758,029
G
CSGALNACT2
chondroitin sulfate N-acetylgalactosaminyltransferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSGALNACT2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:43,138,445...43,185,308
Ensembl chr10:43,138,445...43,185,302
G
CSN3
casein kappa
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSN3 mRNA
CTD
PMID:21641980
NCBI chr 4:70,238,381...70,251,432
Ensembl chr 4:70,238,382...70,251,474
G
CSRP2
cysteine and glycine rich protein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSRP2 mRNA
CTD
PMID:26378955
NCBI chr12:76,858,709...76,879,019
Ensembl chr12:76,858,709...76,879,023
G
CST3
cystatin C
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CST3 mRNA
CTD
PMID:26378955
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CST7
cystatin F
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CST7 mRNA
CTD
PMID:26378955
NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928
G
CSTF3
cleavage stimulation factor subunit 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSTF3 mRNA
CTD
PMID:21641980
NCBI chr11:33,084,584...33,161,480
Ensembl chr11:33,077,188...33,162,371
G
CTCF
CCCTC-binding factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTCF mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CTCF mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:67,562,526...67,639,185
Ensembl chr16:67,562,467...67,639,177
G
CTDSPL2
CTD small phosphatase like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTDSPL2 mRNA
CTD
PMID:21641980
NCBI chr15:44,427,629...44,529,038
Ensembl chr15:44,427,622...44,529,038
G
CTH
cystathionine gamma-lyase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CTH mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTH mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
G
CTSB
cathepsin B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSB mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CTSB mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSF
cathepsin F
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CTSF mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:66,563,464...66,568,606
Ensembl chr11:66,563,464...66,568,879
G
CTSH
cathepsin H
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSH mRNA
CTD
PMID:26378955
NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574
G
CTSK
cathepsin K
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSK mRNA
CTD
PMID:26378955
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
G
CTSS
cathepsin S
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSS mRNA
CTD
PMID:26378955
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
CTTNBP2NL
CTTNBP2 N-terminal like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTTNBP2NL mRNA
CTD
PMID:21641980
NCBI chr 1:112,391,087...112,461,164
Ensembl chr 1:112,396,214...112,463,456
G
CUL3
cullin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CUL3 mRNA
CTD
PMID:21641980
NCBI chr 2:224,470,150...224,585,363
Ensembl chr 2:224,470,150...224,585,397
G
CUX1
cut like homeobox 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CUX1 mRNA
CTD
PMID:21641980
NCBI chr 7:101,816,007...102,283,958
Ensembl chr 7:101,815,904...102,283,958
G
CWC22
CWC22 spliceosome associated protein homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CWC22 mRNA
CTD
PMID:21641980
NCBI chr 2:179,944,876...180,007,297
Ensembl chr 2:179,944,876...180,007,297
G
CX3CR1
C-X3-C motif chemokine receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CX3CR1 mRNA
CTD
PMID:21641980
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CXCL1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL1 mRNA
CTD
PMID:26378955
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL11
C-X-C motif chemokine ligand 11
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL11 mRNA
CTD
PMID:26378955
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
G
CXCL13
C-X-C motif chemokine ligand 13
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL13 mRNA
CTD
PMID:26378955
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
G
CXCL16
C-X-C motif chemokine ligand 16
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CXCL16 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CXCL16 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:4,733,533...4,739,928
Ensembl chr17:4,733,533...4,739,928
G
CXCL2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CXCL15 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL5 mRNA
CTD
PMID:26378955
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYB5R4
cytochrome b5 reductase 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYB5R4 mRNA
CTD
PMID:26378955
NCBI chr 6:83,859,689...83,967,423
Ensembl chr 6:83,859,656...83,967,423
G
CYBB
cytochrome b-245 beta chain
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYBB mRNA
CTD
PMID:26378955
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP1A1 mRNA
CTD
PMID:26378955
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
decreases activity
EXP
Succimer results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP20A1
cytochrome P450 family 20 subfamily A member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP20A1 mRNA
CTD
PMID:26378955
NCBI chr 2:203,239,018...203,306,026
Ensembl chr 2:203,238,977...203,306,026
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2B10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2B10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2S1
cytochrome P450 family 2 subfamily S member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2S1 mRNA
CTD
PMID:26378955
NCBI chr19:41,193,219...41,207,539
Ensembl chr19:41,193,210...41,207,539
G
CYP4B1
cytochrome P450 family 4 subfamily B member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4B1 mRNA
CTD
PMID:26378955
NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413
G
CYP4F22
cytochrome P450 family 4 subfamily F member 22
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP4F39 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4F39 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:15,508,525...15,552,317
Ensembl chr19:15,508,525...15,552,317
G
CYP4V2
cytochrome P450 family 4 subfamily V member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4V3 mRNA
CTD
PMID:26378955
NCBI chr 4:186,191,567...186,213,463
Ensembl chr 4:186,191,567...186,213,463
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
G
CYP7B1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP7B1 mRNA
CTD
PMID:26378955
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
G
CYRIB
CYFIP related Rac1 interactor B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYRIB mRNA
CTD
PMID:21641980
NCBI chr 8:129,839,593...130,017,129
Ensembl chr 8:129,839,593...130,017,504
G
DAAM1
dishevelled associated activator of morphogenesis 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DAAM1 mRNA
CTD
PMID:21641980
NCBI chr14:59,188,667...59,371,405
Ensembl chr14:59,188,646...59,371,405
G
DAB2
DAB adaptor protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DAB2 mRNA
CTD
PMID:21641980
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
G
DCBLD2
discoidin, CUB and LCCL domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DCBLD2 mRNA
CTD
PMID:21641980
NCBI chr 3:98,795,941...98,901,695
Ensembl chr 3:98,795,941...98,901,695
G
DCSTAMP
dendrocyte expressed seven transmembrane protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DCSTAMP mRNA
CTD
PMID:21641980
NCBI chr 8:104,339,796...104,356,689
Ensembl chr 8:104,339,087...104,356,689
G
DDHD1
DDHD domain containing 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DDHD1 mRNA
CTD
PMID:26378955
NCBI chr14:53,036,755...53,153,323
Ensembl chr14:53,036,745...53,153,323
G
DDIT3
DNA damage inducible transcript 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDIT3 mRNA
CTD
PMID:21641980
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DDX46
DEAD-box helicase 46
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDX46 mRNA
CTD
PMID:21641980
NCBI chr 5:134,758,779...134,831,121
Ensembl chr 5:134,758,771...134,855,133
G
DDX50
DExD-box helicase 50
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDX50 mRNA
CTD
PMID:21641980
NCBI chr10:68,901,315...68,946,847
Ensembl chr10:68,901,286...68,946,847
G
DEPTOR
DEP domain containing MTOR interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DEPTOR mRNA
CTD
PMID:21641980
NCBI chr 8:119,873,722...120,050,918
Ensembl chr 8:119,873,717...120,050,918
G
DHCR24
24-dehydrocholesterol reductase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DHCR24 mRNA
CTD
PMID:26378955
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
G
DHX58
DExH-box helicase 58
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DHX58 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DHX58 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:42,101,411...42,112,714
Ensembl chr17:42,101,404...42,112,714
G
DHX9
DExH-box helicase 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DHX9 mRNA
CTD
PMID:21641980
NCBI chr 1:182,839,347...182,887,982
Ensembl chr 1:182,839,347...182,887,982
G
DKC1
dyskerin pseudouridine synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DKC1 mRNA
CTD
PMID:21641980
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
G
DLAT
dihydrolipoamide S-acetyltransferase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DLAT mRNA
CTD
PMID:21641980
NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404
G
DMPK
DM1 protein kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DMPK mRNA
CTD
PMID:26378955
NCBI chr19:45,769,709...45,782,490
Ensembl chr19:45,769,709...45,782,552
G
DNAJA1
DnaJ heat shock protein family (Hsp40) member A1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
G
DNAJC2
DnaJ heat shock protein family (Hsp40) member C2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJC2 mRNA
CTD
PMID:21641980
NCBI chr 7:103,312,289...103,344,767
Ensembl chr 7:103,312,289...103,344,830
G
DNAJC21
DnaJ heat shock protein family (Hsp40) member C21
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJC21 mRNA
CTD
PMID:26378955
NCBI chr 5:34,929,559...34,958,964
Ensembl chr 5:34,929,559...34,958,964
G
DNAJC3
DnaJ heat shock protein family (Hsp40) member C3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJC3 mRNA
CTD
PMID:21641980
NCBI chr13:95,677,139...95,794,988
Ensembl chr13:95,677,139...95,794,988
G
DNAJC5
DnaJ heat shock protein family (Hsp40) member C5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNAJC5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNAJC5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:63,895,126...63,936,011
Ensembl chr20:63,895,126...63,936,031
G
DNAJC5B
DnaJ heat shock protein family (Hsp40) member C5 beta
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJC5B mRNA
CTD
PMID:26378955
NCBI chr 8:66,014,978...66,101,245
Ensembl chr 8:66,021,553...66,101,245
G
DNMT3L
DNA methyltransferase 3 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNMT3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNMT3L mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr21:44,246,339...44,261,897
Ensembl chr21:44,246,339...44,262,216
G
DOCK10
dedicator of cytokinesis 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DOCK10 mRNA
CTD
PMID:21641980
NCBI chr 2:224,765,090...225,042,468
Ensembl chr 2:224,765,090...225,042,468
G
DPH3
diphthamide biosynthesis 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DPH3 mRNA
CTD
PMID:26378955
NCBI chr 3:16,257,061...16,264,943
Ensembl chr 3:16,257,061...16,264,969
G
DPH5
diphthamide biosynthesis 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DPH5 mRNA
CTD
PMID:21641980
NCBI chr 1:100,989,623...101,025,784
Ensembl chr 1:100,989,623...101,026,088
G
DPYD
dihydropyrimidine dehydrogenase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DPYD mRNA
CTD
PMID:26378955
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
G
DPYS
dihydropyrimidinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DPYS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DPYS mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:104,379,431...104,467,055
Ensembl chr 8:104,330,324...104,467,055
G
DSC2
desmocollin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DSC2 mRNA
CTD
PMID:26378955
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
G
DSCC1
DNA replication and sister chromatid cohesion 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DSCC1 mRNA
CTD
PMID:21641980
NCBI chr 8:119,833,976...119,855,894
Ensembl chr 8:119,833,976...119,855,894
G
DSG2
desmoglein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DSG2 mRNA
CTD
PMID:26378955
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,497,624...31,551,351
G
DTL
denticleless E3 ubiquitin protein ligase homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DTL mRNA
CTD
PMID:21641980
NCBI chr 1:212,035,748...212,105,013
Ensembl chr 1:212,035,553...212,107,400
G
DTX1
deltex E3 ubiquitin ligase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DTX1 mRNA
CTD
PMID:26378955
NCBI chr12:113,056,730...113,098,025
Ensembl chr12:113,056,730...113,098,028
G
DTX4
deltex E3 ubiquitin ligase 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DTX4 mRNA
CTD
PMID:26378955
NCBI chr11:59,171,430...59,208,588
Ensembl chr11:59,171,430...59,208,588
G
DUSP1
dual specificity phosphatase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP1 mRNA
CTD
PMID:21641980
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP14
dual specificity phosphatase 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP14 mRNA
CTD
PMID:21641980
NCBI chr17:37,488,566...37,513,498
Ensembl chr17:37,489,891...37,513,501
G
DUSP6
dual specificity phosphatase 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP6 mRNA
CTD
PMID:21641980
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DZIP3
DAZ interacting zinc finger protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DZIP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DZIP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:108,589,510...108,694,840
Ensembl chr 3:108,589,705...108,694,840
G
E2F2
E2F transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F2 mRNA
CTD
PMID:21641980
NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233
G
E2F7
E2F transcription factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F7 mRNA
CTD
PMID:21641980
NCBI chr12:77,021,251...77,065,569
Ensembl chr12:77,021,248...77,065,569
G
E2F8
E2F transcription factor 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F8 mRNA
CTD
PMID:21641980
NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
G
ECT2
epithelial cell transforming 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ECT2 mRNA
CTD
PMID:21641980
NCBI chr 3:172,750,726...172,829,265
Ensembl chr 3:172,750,682...172,821,474
G
EDIL3
EGF like repeats and discoidin domains 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EDIL3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EDIL3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:83,940,554...84,384,880
Ensembl chr 5:83,940,554...84,384,880
G
EEF1D
eukaryotic translation elongation factor 1 delta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EEF1D mRNA
CTD
PMID:21641980
NCBI chr 8:143,579,728...143,597,415
Ensembl chr 8:143,579,697...143,599,541
G
EEIG2
EEIG family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EEIG2 mRNA
CTD
PMID:21641980
NCBI chr 1:108,560,100...108,639,322
Ensembl chr 1:108,560,089...108,644,900
G
EFCAB7
EF-hand calcium binding domain 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EFCAB7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EFCAB7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:63,523,525...63,585,370
Ensembl chr 1:63,523,372...63,572,693
G
EGFR
epidermal growth factor receptor
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGFR mRNA
CTD
PMID:26378955
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGLN3
egl-9 family hypoxia inducible factor 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGLN3 mRNA
CTD
PMID:26378955
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
G
EGR1
early growth response 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of EGR1 mRNA
CTD
PMID:26378955
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EGR2
early growth response 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EGR2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EGR2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EGR2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
G
EGR3
early growth response 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGR3 mRNA
CTD
PMID:26378955
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
G
EHD1
EH domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EHD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EHD1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:64,851,642...64,879,693
Ensembl chr11:64,851,642...64,888,296
G
EHD2
EH domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EHD2 mRNA
CTD
PMID:26378955
NCBI chr19:47,713,422...47,743,134
Ensembl chr19:47,713,422...47,743,134
G
EIF2AK2
eukaryotic translation initiation factor 2 alpha kinase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EIF2AK2 mRNA
CTD
PMID:26378955
NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF2S1 mRNA
CTD
PMID:21641980
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
EIF2S3B
eukaryotic translation initiation factor 2 subunit gamma B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF2S3Y mRNA
CTD
PMID:21641980
NCBI chr12:10,505,890...10,523,135
Ensembl chr12:10,505,602...10,523,135
G
EIF3A
eukaryotic translation initiation factor 3 subunit A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF3A mRNA
CTD
PMID:21641980
NCBI chr10:119,033,670...119,080,817
Ensembl chr10:119,033,670...119,080,817
G
ELL2
elongation factor for RNA polymerase II 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ELL2 mRNA
CTD
PMID:21641980
NCBI chr 5:95,885,098...95,961,851
Ensembl chr 5:95,885,098...95,961,851
G
ELOC
elongin C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOC mRNA
CTD
PMID:21641980
NCBI chr 8:73,945,119...73,972,287
Ensembl chr 8:73,939,169...73,972,307
G
ELOVL6
ELOVL fatty acid elongase 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOVL6 mRNA
CTD
PMID:21641980
NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199
G
ENDOD1
endonuclease domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ENDOD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ENDOD1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:95,089,846...95,132,645
Ensembl chr11:95,089,846...95,132,645
G
ENO2
enolase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ENO2 mRNA
CTD
PMID:26378955
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ENPP2 mRNA
CTD
PMID:26378955
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
G
EPB41L2
erythrocyte membrane protein band 4.1 like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EPB41L2 mRNA
CTD
PMID:21641980
NCBI chr 6:130,839,347...131,063,245
Ensembl chr 6:130,839,347...131,063,322
G
EPHA8
EPH receptor A8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EPHA8 mRNA
CTD
PMID:21641980
NCBI chr 1:22,563,489...22,603,595
Ensembl chr 1:22,563,489...22,603,595
G
EPS15
epidermal growth factor receptor pathway substrate 15
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EPS15 mRNA
CTD
PMID:26378955
NCBI chr 1:51,354,263...51,519,266
Ensembl chr 1:51,354,263...51,519,328
G
EPSTI1
epithelial stromal interaction 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EPSTI1 mRNA
CTD
PMID:21641980
NCBI chr13:42,886,388...42,992,241
Ensembl chr13:42,886,388...42,992,271
G
ERAP1
endoplasmic reticulum aminopeptidase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERAP1 mRNA
CTD
PMID:26378955
NCBI chr 5:96,760,813...96,935,854
Ensembl chr 5:96,760,810...96,808,100
G
ERBB4
erb-b2 receptor tyrosine kinase 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERBB4 mRNA
CTD
PMID:26378955
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
G
ERN1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ERN1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ERN1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
ERO1A
endoplasmic reticulum oxidoreductase 1 alpha
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERO1A mRNA
CTD
PMID:26378955
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
G
ESCO2
establishment of sister chromatid cohesion N-acetyltransferase 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ESCO2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ESCO2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ESCO2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640
G
ESD
esterase D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ESD mRNA
CTD
PMID:21641980
NCBI chr13:46,771,256...46,797,700
Ensembl chr13:46,771,256...46,797,420
G
ESR1
estrogen receptor 1
multiple interactions
ISO
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ESR1 protein]; Succimer inhibits the reaction [sodium arsenite results in decreased expression of ESR1 protein]
CTD
PMID:31163222 PMID:32402895
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ETS2
ETS proto-oncogene 2, transcription factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ETS2 mRNA
CTD
PMID:21641980
NCBI chr21:38,805,183...38,824,955
Ensembl chr21:38,805,183...38,824,955
G
EVA1B
eva-1 homolog B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EVA1B mRNA
CTD
PMID:21641980
NCBI chr 1:36,322,030...36,324,154
Ensembl chr 1:36,322,030...36,324,154
G
EVI5
ecotropic viral integration site 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EVI5 mRNA
CTD
PMID:21641980
NCBI chr 1:92,508,696...92,792,410
Ensembl chr 1:92,508,696...92,792,404
G
EXO1
exonuclease 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXO1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EXO1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
G
EXOSC1
exosome component 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXOSC1 mRNA
CTD
PMID:21641980
NCBI chr10:97,435,909...97,446,006
Ensembl chr10:97,435,909...97,446,017
G
EYA4
EYA transcriptional coactivator and phosphatase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EYA4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EYA4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:133,240,593...133,532,128
Ensembl chr 6:133,240,514...133,532,128
G
F13A1
coagulation factor XIII A chain
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of F13A1 mRNA
CTD
PMID:26378955
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
F3
coagulation factor III, tissue factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of F3 mRNA
CTD
PMID:26378955
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
FABP4
fatty acid binding protein 4
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FABP4 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FABP4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
G
FAHD2A
fumarylacetoacetate hydrolase domain containing 2A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAHD2A mRNA
CTD
PMID:26378955
NCBI chr 2:95,402,708...95,421,656
Ensembl chr 2:95,402,708...95,416,616
G
FAM13B
family with sequence similarity 13 member B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM13B mRNA
CTD
PMID:21641980
NCBI chr 5:137,937,960...138,052,178
Ensembl chr 5:137,937,960...138,051,961
G
FAM13C
family with sequence similarity 13 member C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM13C mRNA
CTD
PMID:21641980
NCBI chr10:59,246,129...59,363,181
Ensembl chr10:59,246,130...59,363,181
G
FAM156A
family with sequence similarity 156 member A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VCF2 mRNA
CTD
PMID:21641980
NCBI chr X:52,947,254...52,995,472
Ensembl chr X:52,926,402...52,995,472 Ensembl chr X:52,926,402...52,995,472
G
FAM162A
family with sequence similarity 162 member A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAM162A mRNA
CTD
PMID:26378955
NCBI chr 3:122,384,182...122,412,334
Ensembl chr 3:122,384,161...122,412,334
G
FAM199X
family with sequence similarity 199, X-linked
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM199X mRNA
CTD
PMID:21641980
NCBI chr X:104,157,066...104,195,902
Ensembl chr X:104,166,453...104,195,902
G
FAM20C
FAM20C golgi associated secretory pathway kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FAM20C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FAM20C mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:192,571...260,772
Ensembl chr 7:192,571...260,772
G
FAM76B
family with sequence similarity 76 member B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM76B mRNA
CTD
PMID:21641980
NCBI chr11:95,768,953...95,789,782
Ensembl chr11:95,768,953...95,790,409
G
FANCB
FA complementation group B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FANCB mRNA
CTD
PMID:21641980
NCBI chr X:14,689,524...14,873,069
Ensembl chr X:14,690,388...14,873,255
G
FAR1
fatty acyl-CoA reductase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAR1 mRNA
CTD
PMID:21641980
NCBI chr11:13,668,668...13,732,346
Ensembl chr11:13,668,659...13,732,346
G
FAS
Fas cell surface death receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FAS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FAS mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FBP1
fructose-bisphosphatase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FBP1 mRNA
CTD
PMID:26378955
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
G
FBXO15
F-box protein 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FBXO15 mRNA
CTD
PMID:21641980
NCBI chr18:74,073,368...74,147,834
Ensembl chr18:74,073,353...74,147,843
G
FCGR3A
Fc gamma receptor IIIa
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FCGR4 mRNA
CTD
PMID:21641980
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
FEZ1
fasciculation and elongation protein zeta 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FEZ1 mRNA
CTD
PMID:26378955
NCBI chr11:125,442,881...125,496,265
Ensembl chr11:125,442,881...125,592,568
G
FGD2
FYVE, RhoGEF and PH domain containing 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FGD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGD2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FGD2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:37,005,655...37,029,069
Ensembl chr 6:37,005,646...37,029,069
G
FGD3
FYVE, RhoGEF and PH domain containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FGD3 mRNA
CTD
PMID:26378955
NCBI chr 9:92,947,523...93,036,233
Ensembl chr 9:92,947,523...93,036,236
G
FGD4
FYVE, RhoGEF and PH domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FGD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGD4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:32,399,558...32,646,050
Ensembl chr12:32,399,558...32,646,050
G
FGF1
fibroblast growth factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGF1 mRNA
CTD
PMID:26378955
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
G
FHIT
fragile histidine triad diadenosine triphosphatase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FHIT mRNA
CTD
PMID:26378955
NCBI chr 3:59,747,277...61,251,452
Ensembl chr 3:59,747,277...61,251,459
G
FIP1L1
factor interacting with PAPOLA and CPSF1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FIP1L1 mRNA
CTD
PMID:21641980
NCBI chr 4:53,377,641...53,460,862
Ensembl chr 4:53,377,569...53,464,382
G
FLI1
Fli-1 proto-oncogene, ETS transcription factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FLI1 mRNA
CTD
PMID:21641980
NCBI chr11:128,685,351...128,813,267
Ensembl chr11:128,686,535...128,813,267
G
FMN1
formin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FMN1 mRNA
CTD
PMID:21641980
NCBI chr15:32,765,544...33,194,714
Ensembl chr15:32,765,544...33,194,714
G
FN1
fibronectin 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FN1 mRNA
CTD
PMID:26378955
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL1 mRNA
CTD
PMID:21641980
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL2 mRNA
CTD
PMID:21641980
NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317
G
FOXP1
forkhead box P1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FOXP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FOXP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:70,954,708...71,583,978
Ensembl chr 3:70,954,693...71,583,978
G
FRMD4B
FERM domain containing 4B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FRMD4B mRNA
CTD
PMID:21641980
NCBI chr 3:69,168,782...69,542,586
Ensembl chr 3:69,168,782...69,542,583
G
FSCN1
fascin actin-bundling protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FSCN1 mRNA
CTD
PMID:21641980
NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655
G
FSHB
follicle stimulating hormone subunit beta
multiple interactions
ISO
Succimer inhibits the reaction [sodium arsenite results in decreased expression of FSHB protein]
CTD
PMID:31163222
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
G
FTH1
ferritin heavy chain 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FTH1 mRNA
CTD
PMID:26378955
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FUBP1
far upstream element binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUBP1 mRNA
CTD
PMID:21641980
NCBI chr 1:77,944,055...77,979,501
Ensembl chr 1:77,944,055...77,979,110
G
FUS
FUS RNA binding protein
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FUS mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:31,180,110...31,194,871
Ensembl chr16:31,180,138...31,196,963
G
FUT11
fucosyltransferase 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUT11 mRNA
CTD
PMID:21641980
NCBI chr10:73,772,276...73,780,254
Ensembl chr10:73,772,276...73,780,251
G
FXYD2
FXYD domain containing ion transport regulator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FXYD2 mRNA
CTD
PMID:21641980
NCBI chr11:117,820,057...117,828,089
Ensembl chr11:117,800,844...117,828,698
G
FYCO1
FYVE and coiled-coil domain autophagy adaptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FYCO1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FYCO1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:45,917,903...45,995,824
Ensembl chr 3:45,917,903...45,995,824
G
FYN
FYN proto-oncogene, Src family tyrosine kinase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FYN mRNA
CTD
PMID:26378955
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
G
FZD10
frizzled class receptor 10
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD10 mRNA
CTD
PMID:26378955
NCBI chr12:130,162,464...130,165,740
Ensembl chr12:130,162,459...130,165,740
G
FZD7
frizzled class receptor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FZD7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441
G
G2E3
G2/M-phase specific E3 ubiquitin protein ligase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of G2E3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of G2E3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:30,559,158...30,620,064
Ensembl chr14:30,559,158...30,620,064
G
GABPB1
GA binding protein transcription factor subunit beta 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GABPB1 mRNA
CTD
PMID:21641980
NCBI chr15:50,275,389...50,355,198
Ensembl chr15:50,275,389...50,355,408
G
GADD45A
growth arrest and DNA damage inducible alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GADD45A mRNA
CTD
PMID:21641980
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GADD45B
growth arrest and DNA damage inducible beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GADD45B mRNA
CTD
PMID:21641980
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GALNT1
polypeptide N-acetylgalactosaminyltransferase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of GALNT1 mRNA
CTD
PMID:26378955
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
G
GALNT7
polypeptide N-acetylgalactosaminyltransferase 7
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GALNT7 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GALNT7 mRNA
CTD
PMID:26378955
NCBI chr 4:173,168,811...173,323,967
Ensembl chr 4:173,168,811...173,323,967
G
GARIN5A
golgi associated RAB2 interactor 5A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GARIN5A mRNA
CTD
PMID:21641980
NCBI chr19:50,466,788...50,476,848
Ensembl chr19:50,466,785...50,476,848
G
GAS5
growth arrest specific 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GAS5 mRNA
CTD
PMID:21641980
NCBI chr 1:173,863,901...173,869,045
Ensembl chr 1:173,858,559...173,868,882
G
GAS6
growth arrest specific 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GAS6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GAS6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:113,820,549...113,864,076
Ensembl chr13:113,820,549...113,864,076
G
GASK1B
golgi associated kinase 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GASK1B mRNA
CTD
PMID:21641980
NCBI chr 4:158,124,474...158,173,025
Ensembl chr 4:158,124,474...158,173,318
G
GBP1
guanylate binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP1 mRNA
CTD
PMID:21641980
NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
G
GBP6
guanylate binding protein family member 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP6 mRNA
CTD
PMID:21641980
NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160
G
GCA
grancalcin
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCA mRNA
CTD
PMID:26378955
NCBI chr 2:162,318,763...162,375,396
Ensembl chr 2:162,318,840...162,371,595
G
GCH1
GTP cyclohydrolase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCH1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,902,826
G
GCLC
glutamate-cysteine ligase catalytic subunit
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLC mRNA
CTD
PMID:26378955
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCLM mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLM mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GDA
guanine deaminase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GDA mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GDA mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193
G
GFOD1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GFOD1 mRNA
CTD
PMID:21641980
NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662
G
GGT1
gamma-glutamyltransferase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GGT1 mRNA
CTD
PMID:26378955
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GIGYF2
GRB10 interacting GYF protein 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GIGYF2 mRNA
CTD
PMID:26378955
NCBI chr 2:232,697,331...232,860,605
Ensembl chr 2:232,697,299...232,860,605
G
GJA1
gap junction protein alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GJA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GJA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GLG1
golgi glycoprotein 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLG1 mRNA
CTD
PMID:26378955
NCBI chr16:74,447,440...74,607,114
Ensembl chr16:74,447,427...74,607,144
G
GLI3
GLI family zinc finger 3
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GLI3 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLI3 mRNA
CTD
PMID:26378955
NCBI chr 7:41,960,949...42,264,268
Ensembl chr 7:41,960,949...42,264,100
G
GLIPR1
GLI pathogenesis related 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLIPR1 mRNA
CTD
PMID:26378955
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
G
GLRX
glutaredoxin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GLRX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLRX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GMNN
geminin DNA replication inhibitor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GMNN mRNA
CTD
PMID:21641980
NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,931...24,786,099
G
GMPS
guanine monophosphate synthase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GMPS mRNA
CTD
PMID:21641980
NCBI chr 3:155,869,430...155,944,020
Ensembl chr 3:155,870,650...155,944,020
G
GNA13
G protein subunit alpha 13
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNA13 mRNA
CTD
PMID:26378955
NCBI chr17:65,009,289...65,056,740
Ensembl chr17:65,009,289...65,056,740
G
GNAI2
G protein subunit alpha i2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNAI2 mRNA
CTD
PMID:26378955
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
GNAQ
G protein subunit alpha q
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNAQ mRNA
CTD
PMID:26378955
NCBI chr 9:77,716,097...78,031,811
Ensembl chr 9:77,716,097...78,031,811
G
GNG4
G protein subunit gamma 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GNG4 mRNA
CTD
PMID:21641980
NCBI chr 1:235,547,685...235,650,608
Ensembl chr 1:235,547,685...235,650,754
G
GOLGA4
golgin A4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GOLGA4 mRNA
CTD
PMID:21641980
NCBI chr 3:37,243,271...37,366,879
Ensembl chr 3:37,243,191...37,366,879
G
GPATCH4
G-patch domain containing 4 (gene/pseudogene)
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPATCH4 mRNA
CTD
PMID:21641980
NCBI chr 1:156,594,301...156,601,479
Ensembl chr 1:156,594,301...156,601,496
G
GPBP1
GC-rich promoter binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPBP1 mRNA
CTD
PMID:21641980
NCBI chr 5:57,174,059...57,264,679
Ensembl chr 5:57,173,948...57,264,679
G
GPD2
glycerol-3-phosphate dehydrogenase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GPD2 mRNA
CTD
PMID:26378955
NCBI chr 2:156,400,281...156,586,403
Ensembl chr 2:156,435,290...156,613,735
G
GPR150
G protein-coupled receptor 150
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR150 mRNA
CTD
PMID:21641980
NCBI chr 5:95,620,087...95,622,142
Ensembl chr 5:95,620,087...95,622,142
G
GPR155
G protein-coupled receptor 155
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPR155 mRNA
CTD
PMID:21641980
NCBI chr 2:174,431,571...174,487,029
Ensembl chr 2:174,431,571...174,487,094
G
GPR84
G protein-coupled receptor 84
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR84 mRNA
CTD
PMID:21641980
NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487
G
GPR85
G protein-coupled receptor 85
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR85 mRNA
CTD
PMID:21641980
NCBI chr 7:113,082,285...113,087,724
Ensembl chr 7:113,078,331...113,087,778
G
GPT
glutamic--pyruvic transaminase
multiple interactions
ISO
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of GPT protein]
CTD
PMID:32402895
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GRAMD1B
GRAM domain containing 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAMD1B mRNA
CTD
PMID:21641980
NCBI chr11:123,358,422...123,627,767
Ensembl chr11:123,358,428...123,627,774
G
GRAP
GRB2 related adaptor protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAP mRNA
CTD
PMID:21641980
NCBI chr17:19,020,656...19,051,373
Ensembl chr17:19,020,656...19,047,011
G
GSAP
gamma-secretase activating protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSAP mRNA
CTD
PMID:21641980
NCBI chr 7:77,310,751...77,416,630
Ensembl chr 7:77,310,751...77,416,349
G
GSG1
germ cell associated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSG1 mRNA
CTD
PMID:21641980
NCBI chr12:13,083,532...13,103,667
Ensembl chr12:13,083,532...13,103,683
G
GSK3B
glycogen synthase kinase 3 beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GSK3B mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GSK3B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GSN mRNA
CTD
PMID:26378955
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSTA3
glutathione S-transferase alpha 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSTA1 mRNA
CTD
PMID:21641980
NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698
G
GTF3C2
general transcription factor IIIC subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GTF3C2 mRNA
CTD
PMID:21641980
NCBI chr 2:27,325,854...27,356,764
Ensembl chr 2:27,325,849...27,356,999
G
GUCY1B1
guanylate cyclase 1 soluble subunit beta 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GUCY1B1 mRNA
CTD
PMID:26378955
NCBI chr 4:155,759,021...155,807,811
Ensembl chr 4:155,758,992...155,807,811
G
H1-2
H1.2 linker histone, cluster member
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H1F2 mRNA
CTD
PMID:21641980
NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
G
H2AC7
H2A clustered histone 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2AC7 mRNA
CTD
PMID:21641980
NCBI chr 6:26,198,784...26,199,293
Ensembl chr 6:26,198,784...26,199,293
G
H2BC4
H2B clustered histone 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2BC4 mRNA
CTD
PMID:21641980
NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926
G
H3-3B
H3.3 histone B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of H3F3B mRNA
CTD
PMID:21641980
NCBI chr17:75,776,434...75,779,779
Ensembl chr17:75,776,434...75,785,893
G
H3C15
H3 clustered histone 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H3C15 mRNA
CTD
PMID:21641980
NCBI chr 1:149,852,608...149,853,125
Ensembl chr 1:149,852,608...149,853,125
G
H4C1
H4 clustered histone 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H4C1 mRNA
CTD
PMID:21641980
NCBI chr 6:26,021,649...26,022,050
Ensembl chr 6:26,021,649...26,022,050
G
HAGHL
hydroxyacylglutathione hydrolase like
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HAGHL mRNA
CTD
PMID:26378955
NCBI chr16:727,106...729,715
Ensembl chr16:726,936...735,525
G
HAO1
hydroxyacid oxidase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HAO1 mRNA
CTD
PMID:21641980
NCBI chr20:7,882,985...7,940,458
Ensembl chr20:7,882,985...7,940,458
G
HAUS6
HAUS augmin like complex subunit 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAUS6 mRNA
CTD
PMID:21641980
NCBI chr 9:19,053,141...19,102,904
Ensembl chr 9:19,053,141...19,102,904
G
HAVCR2
hepatitis A virus cellular receptor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAVCR2 mRNA
CTD
PMID:21641980
NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869
G
HBE1
hemoglobin subunit epsilon 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HBB-Y mRNA
CTD
PMID:26378955
NCBI chr11:5,268,345...5,269,945
Ensembl chr11:5,268,345...5,505,652
G
HBEGF
heparin binding EGF like growth factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HBEGF mRNA
CTD
PMID:21641980
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
G
HCAR3
hydroxycarboxylic acid receptor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HCAR2 mRNA
CTD
PMID:21641980
NCBI chr12:122,714,756...122,716,811
Ensembl chr12:122,714,756...122,716,811
G
HDAC9
histone deacetylase 9
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HDAC9 mRNA
CTD
PMID:26378955
NCBI chr 7:18,086,825...19,002,416
Ensembl chr 7:18,086,949...19,002,416
G
HDC
histidine decarboxylase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HDC mRNA
CTD
PMID:21641980
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
G
HECTD1
HECT domain E3 ubiquitin protein ligase 1
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HECTD1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HECTD1 mRNA
CTD
PMID:26378955
NCBI chr14:31,100,117...31,207,793
Ensembl chr14:31,100,117...31,207,804
G
HELLS
helicase, lymphoid specific
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HELLS mRNA
CTD
PMID:21641980
NCBI chr10:94,545,788...94,613,905
Ensembl chr10:94,545,329...94,613,905
G
HELZ
helicase with zinc finger
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HELZ mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HELZ mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:67,070,444...67,245,989
Ensembl chr17:67,070,444...67,245,989
G
HERPUD1
homocysteine inducible ER protein with ubiquitin like domain 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HERPUD1 mRNA
CTD
PMID:26378955
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
G
HFE
homeostatic iron regulator
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HFE mRNA
CTD
PMID:26378955
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
G
HIP1
huntingtin interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HIP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HIP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:75,533,298...75,738,941
Ensembl chr 7:75,533,298...75,738,962
G
HIVEP1
HIVEP zinc finger 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HIVEP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HIVEP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:12,007,693...12,212,048
Ensembl chr 6:12,008,762...12,164,999
G
HIVEP3
HIVEP zinc finger 3
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HIVEP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HIVEP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:41,506,365...42,035,934
Ensembl chr 1:41,506,365...42,035,925
G
HK3
hexokinase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HK3 mRNA
CTD
PMID:21641980
NCBI chr 5:176,880,869...176,899,346
Ensembl chr 5:176,880,869...176,899,346
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-EB1 mRNA
CTD
PMID:21641980
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HLA-E
major histocompatibility complex, class I, E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-T23 mRNA
CTD
PMID:21641980
NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194
G
HMGB2
high mobility group box 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGB2 mRNA
CTD
PMID:21641980
NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGCS1 mRNA
CTD
PMID:21641980
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HMMR
hyaluronan mediated motility receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMMR mRNA
CTD
PMID:21641980
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
G
HMOX1
heme oxygenase 1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMOX1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HMOX1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HMX2
H6 family homeobox 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMX2 mRNA
CTD
PMID:21641980
NCBI chr10:123,148,136...123,150,672
Ensembl chr10:123,148,136...123,150,672
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:21641980
NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
G
HNRNPA3
heterogeneous nuclear ribonucleoprotein A3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA3 mRNA
CTD
PMID:21641980
NCBI chr 2:177,212,794...177,223,959
Ensembl chr 2:177,212,694...177,223,959
G
HNRNPDL
heterogeneous nuclear ribonucleoprotein D like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPDL mRNA
CTD
PMID:21641980
NCBI chr 4:82,422,564...82,430,462
Ensembl chr 4:82,422,565...82,430,462
G
HNRNPH1
heterogeneous nuclear ribonucleoprotein H1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HNRNPH1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:179,614,178...179,634,784
Ensembl chr 5:179,614,178...179,634,784
G
HNRNPH3
heterogeneous nuclear ribonucleoprotein H3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH3 mRNA
CTD
PMID:21641980
NCBI chr10:68,331,693...68,343,196
Ensembl chr10:68,331,174...68,343,193
G
HPD
4-hydroxyphenylpyruvate dioxygenase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HPD mRNA
CTD
PMID:26378955
NCBI chr12:121,839,527...121,888,611
Ensembl chr12:121,839,527...121,863,596
G
HPGDS
hematopoietic prostaglandin D synthase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HPGDS mRNA
CTD
PMID:21641980
NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876
G
HSP90B1
heat shock protein 90 beta family member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSP90B1 mRNA
CTD
PMID:21641980
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA1B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HSPA1B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
HSPA4
heat shock protein family A (Hsp70) member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA4 mRNA
CTD
PMID:21641980
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HUNK
hormonally up-regulated Neu-associated kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HUNK mRNA
CTD
PMID:21641980
NCBI chr21:31,873,020...32,004,064
Ensembl chr21:31,873,020...32,044,633
G
HYCC1
hyccin PI4KA lipid kinase complex subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HYCC1 mRNA
CTD
PMID:21641980
NCBI chr 7:22,895,843...23,014,130
Ensembl chr 7:22,889,371...23,014,130
G
HYCC2
hyccin PI4KA lipid kinase complex subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HYCC2 mRNA
CTD
PMID:21641980
NCBI chr 2:200,973,718...201,071,671
Ensembl chr 2:200,973,718...201,071,671
G
ICAM1
intercellular adhesion molecule 1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ICAM1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ICAM1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ID1
inhibitor of DNA binding 1
multiple interactions
EXP ISO
[Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of ID1 mRNA [Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID1 mRNA
CTD
PMID:25522732
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
ID2
inhibitor of DNA binding 2
multiple interactions
EXP ISO
[Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID2 mRNA
CTD
PMID:25522732
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
ID3
inhibitor of DNA binding 3
multiple interactions
ISO EXP
[Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of ID3 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ID3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ID3 mRNA
CTD
PMID:21641980 PMID:25522732 PMID:26378955
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
G
ID4
inhibitor of DNA binding 4
multiple interactions
EXP ISO
[Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID4 mRNA
CTD
PMID:25522732
NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197
G
IDE
insulin degrading enzyme
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IDE mRNA
CTD
PMID:26378955
NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096
G
IDI1
isopentenyl-diphosphate delta isomerase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IDI1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IDI1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IER3
immediate early response 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IER3 mRNA
CTD
PMID:21641980
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IFI16
interferon gamma inducible protein 16
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFI16 mRNA
CTD
PMID:26378955
NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155
G
IFI27
interferon alpha inducible protein 27
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFI27 mRNA
CTD
PMID:26378955
NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695
G
IFI27L2
interferon alpha inducible protein 27 like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI27L2A mRNA
CTD
PMID:21641980
NCBI chr14:94,127,781...94,129,604
Ensembl chr14:94,127,779...94,130,253
G
IFI35
interferon induced protein 35
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI35 mRNA
CTD
PMID:21641980
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
G
IFI44
interferon induced protein 44
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI44 mRNA
CTD
PMID:21641980
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
G
IFI44L
interferon induced protein 44 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI44L mRNA
CTD
PMID:21641980
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
G
IFI6
interferon alpha inducible protein 6
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFI6 mRNA
CTD
PMID:26378955
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
G
IFIH1
interferon induced with helicase C domain 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFIH1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT1 mRNA
CTD
PMID:21641980
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IFIT3
interferon induced protein with tetratricopeptide repeats 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT3 mRNA
CTD
PMID:21641980
NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473
G
IFNAR2
interferon alpha and beta receptor subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFNAR2 mRNA
CTD
PMID:21641980
NCBI chr21:33,229,938...33,265,664
Ensembl chr21:33,205,282...33,265,675
G
IFT57
intraflagellar transport 57
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IFT57 mRNA
CTD
PMID:26378955
NCBI chr 3:108,160,812...108,222,424
Ensembl chr 3:108,160,812...108,222,435
G
IFT74
intraflagellar transport 74
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFT74 mRNA
CTD
PMID:21641980
NCBI chr 9:26,947,110...27,066,134
Ensembl chr 9:26,947,039...27,066,134
G
IFT80
intraflagellar transport 80
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFT80 mRNA
CTD
PMID:21641980
NCBI chr 3:160,256,986...160,399,225
Ensembl chr 3:160,256,986...160,399,880
G
IGF1
insulin like growth factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF1R mRNA
CTD
PMID:26378955
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IGF2BP1
insulin like growth factor 2 mRNA binding protein 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF2BP1 mRNA
CTD
PMID:26378955
NCBI chr17:48,996,558...49,056,145
Ensembl chr17:48,997,385...49,056,145
G
IGF2BP2
insulin like growth factor 2 mRNA binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGF2BP2 mRNA
CTD
PMID:21641980
NCBI chr 3:185,643,130...185,825,042
Ensembl chr 3:185,643,130...185,825,042
G
IGFBP1
insulin like growth factor binding protein 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP1 mRNA
CTD
PMID:26378955
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
G
IGFBP3
insulin like growth factor binding protein 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP3 mRNA
CTD
PMID:26378955
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IGFBP4
insulin like growth factor binding protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGFBP4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGFBP5
insulin like growth factor binding protein 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP5 mRNA
CTD
PMID:26378955
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IGFBP6
insulin like growth factor binding protein 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP6 mRNA
CTD
PMID:26378955
NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345
G
IGLC2
immunoglobulin lambda constant 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGLC2 mRNA
CTD
PMID:21641980
NCBI chr22:22,900,976...22,901,295
Ensembl chr22:22,900,976...22,901,437
G
IGSF3
immunoglobulin superfamily member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGSF3 mRNA
CTD
PMID:21641980
NCBI chr 1:116,574,398...116,667,755
Ensembl chr 1:116,574,399...116,667,755
G
IGSF6
immunoglobulin superfamily member 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGSF6 mRNA
CTD
PMID:21641980
NCBI chr16:21,639,550...21,652,608
Ensembl chr16:21,639,550...21,652,608
G
IHH
Indian hedgehog signaling molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IHH mRNA
CTD
PMID:26378955
NCBI chr 2:219,054,424...219,060,921
Ensembl chr 2:219,054,424...219,060,921
G
IKBKE
inhibitor of nuclear factor kappa B kinase subunit epsilon
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IKBKE mRNA
CTD
PMID:21641980
NCBI chr 1:206,470,476...206,496,889
Ensembl chr 1:206,470,476...206,496,889
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IKBKG mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IKBKG mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
G
IKZF1
IKAROS family zinc finger 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IKZF1 mRNA
CTD
PMID:26378955
NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
G
IKZF5
IKAROS family zinc finger 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IKZF5 mRNA
CTD
PMID:26378955
NCBI chr10:122,990,806...123,008,795
Ensembl chr10:122,990,807...123,008,812
G
IL13RA1
interleukin 13 receptor subunit alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL13RA1 mRNA
CTD
PMID:21641980
NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535
G
IL13RA2
interleukin 13 receptor subunit alpha 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL13RA2 mRNA
CTD
PMID:21641980
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL18RAP
interleukin 18 receptor accessory protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL18RAP mRNA
CTD
PMID:21641980
NCBI chr 2:102,418,621...102,452,565
Ensembl chr 2:102,418,689...102,452,565
G
IL1B
interleukin 1 beta
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1B mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IL1B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1RL1 mRNA
CTD
PMID:21641980
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1RN mRNA
CTD
PMID:21641980
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL4I1
interleukin 4 induced 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL4I1 mRNA
CTD
PMID:21641980
NCBI chr19:49,889,654...49,929,504
Ensembl chr19:49,889,654...49,929,539
G
IL6
interleukin 6
multiple interactions
ISO
Succimer inhibits the reaction [sodium arsenite results in increased secretion of IL6 protein]
CTD
PMID:31163222
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL6RA mRNA
CTD
PMID:21641980
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
IL6ST
interleukin 6 cytokine family signal transducer
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL6ST mRNA
CTD
PMID:21641980
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
INPP5D
inositol polyphosphate-5-phosphatase D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INPP5D mRNA
CTD
PMID:21641980
NCBI chr 2:233,060,342...233,207,903
Ensembl chr 2:233,059,967...233,207,903
G
INSIG1
insulin induced gene 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INSIG1 mRNA
CTD
PMID:21641980
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
IRAK2
interleukin 1 receptor associated kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRAK2 mRNA
CTD
PMID:21641980
NCBI chr 3:10,164,919...10,243,745
Ensembl chr 3:10,164,919...10,243,745
G
IRF4
interferon regulatory factor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF4 mRNA
CTD
PMID:21641980
NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443
G
IRF7
interferon regulatory factor 7
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF7 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IRF7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
IRF9
interferon regulatory factor 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF9 mRNA
CTD
PMID:21641980
NCBI chr14:24,161,265...24,166,565
Ensembl chr14:24,161,234...24,168,043
G
IRGM
immunity related GTPase M
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRGM1 mRNA
CTD
PMID:21641980
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
G
ISG15
ISG15 ubiquitin like modifier
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG15 mRNA
CTD
PMID:21641980
NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540
G
ISG20
interferon stimulated exonuclease gene 20
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ISG20 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:88,635,632...88,656,483
Ensembl chr15:88,635,670...88,656,483
G
ITGA4
integrin subunit alpha 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGA4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGA4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:181,457,205...181,538,940
Ensembl chr 2:181,457,202...181,538,940
G
ITGAM
integrin subunit alpha M
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAM mRNA
CTD
PMID:26378955
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITGAV
integrin subunit alpha V
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAV mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAV mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
G
ITGAX
integrin subunit alpha X
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
G
ITGB5
integrin subunit beta 5
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGB5 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGB5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:124,761,948...124,901,418
Ensembl chr 3:124,761,948...124,901,418
G
ITGB7
integrin subunit beta 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGB7 mRNA
CTD
PMID:21641980
NCBI chr12:53,191,323...53,207,251
Ensembl chr12:53,191,323...53,207,282
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITPR1 mRNA
CTD
PMID:26378955
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
ITPR2
inositol 1,4,5-trisphosphate receptor type 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITPR2 mRNA
CTD
PMID:26378955
NCBI chr12:26,335,352...26,833,194
Ensembl chr12:26,335,352...26,833,194
G
ITSN2
intersectin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITSN2 mRNA
CTD
PMID:26378955
NCBI chr 2:24,202,864...24,361,368
Ensembl chr 2:24,202,864...24,360,536
G
JADE1
jade family PHD finger 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of JADE1 mRNA
CTD
PMID:21641980
NCBI chr 4:128,809,700...128,875,224
Ensembl chr 4:128,809,700...128,875,224
G
JADE2
jade family PHD finger 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of JADE2 mRNA
CTD
PMID:21641980
NCBI chr 5:134,523,952...134,583,227
Ensembl chr 5:134,524,312...134,583,230
G
JAG1
jagged canonical Notch ligand 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of JAG1 mRNA
CTD
PMID:26378955
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
G
JAK2
Janus kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of JAK2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of JAK2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
JAZF1
JAZF zinc finger 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of JAZF1 mRNA
CTD
PMID:26378955
NCBI chr 7:27,830,577...28,180,795
Ensembl chr 7:27,830,573...28,180,795
G
JDP2
Jun dimerization protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of JDP2 mRNA
CTD
PMID:21641980
NCBI chr14:75,426,943...75,474,107
Ensembl chr14:75,427,716...75,474,111
G
JMJD1C
jumonji domain containing 1C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of JMJD1C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of JMJD1C mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:63,167,225...63,521,890
Ensembl chr10:63,167,221...63,521,850
G
KANK2
KN motif and ankyrin repeat domains 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KANK2 mRNA
CTD
PMID:21641980
NCBI chr19:11,164,270...11,197,865
Ensembl chr19:11,164,270...11,197,791
G
KAT14
lysine acetyltransferase 14
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KAT14 mRNA
CTD
PMID:26378955
NCBI chr20:18,137,153...18,188,372
Ensembl chr20:18,137,228...18,188,387
G
KAT7
lysine acetyltransferase 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KAT7 mRNA
CTD
PMID:21641980
NCBI chr17:49,788,681...49,835,026
Ensembl chr17:49,788,624...49,835,026
G
KBTBD11
kelch repeat and BTB domain containing 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD11 mRNA
CTD
PMID:21641980
NCBI chr 8:1,973,677...2,006,936
Ensembl chr 8:1,973,677...2,006,936
G
KBTBD7
kelch repeat and BTB domain containing 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD7 mRNA
CTD
PMID:21641980
NCBI chr13:41,189,834...41,194,569
Ensembl chr13:41,189,834...41,194,569
G
KCNQ1OT1
KCNQ1 opposite strand/antisense transcript 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KCNQ1OT1 mRNA
CTD
PMID:21641980
NCBI chr11:2,608,328...2,699,994
Ensembl chr11:2,597,308...2,700,003
G
KCTD12
potassium channel tetramerization domain containing 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of KCTD12 mRNA
CTD
PMID:21641980
NCBI chr13:76,880,175...76,886,405
Ensembl chr13:76,880,175...76,886,405
G
KDM4C
lysine demethylase 4C
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KDM4C mRNA
CTD
PMID:26378955
NCBI chr 9:6,720,863...7,175,648
Ensembl chr 9:6,720,863...7,175,648
G
KDM5A
lysine demethylase 5A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of KDM5A mRNA
CTD
PMID:26378955
NCBI chr12:280,057...389,320
Ensembl chr12:280,057...389,320
G
KDM7A
lysine demethylase 7A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KDM7A mRNA
CTD
PMID:21641980
NCBI chr 7:140,084,746...140,176,983
Ensembl chr 7:140,084,746...140,176,983
G
KIF11
kinesin family member 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF11 mRNA
CTD
PMID:21641980
NCBI chr10:92,593,130...92,655,395
Ensembl chr10:92,574,105...92,655,395
G
KIF20B
kinesin family member 20B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF20B mRNA
CTD
PMID:21641980
NCBI chr10:89,701,590...89,774,934
Ensembl chr10:89,701,590...89,774,939
G
KIF21B
kinesin family member 21B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF21B mRNA
CTD
PMID:21641980
NCBI chr 1:200,969,390...201,023,714
Ensembl chr 1:200,969,390...201,023,714
G
KIF3C
kinesin family member 3C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of KIF3C mRNA
CTD
PMID:21641980
NCBI chr 2:25,926,598...25,982,497
Ensembl chr 2:25,926,598...25,982,749
G
KIF5B
kinesin family member 5B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF5B mRNA
CTD
PMID:21641980
NCBI chr10:32,009,015...32,056,425
Ensembl chr10:32,009,015...32,056,425
G
KIFC3
kinesin family member C3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIFC3 mRNA
CTD
PMID:21641980
NCBI chr16:57,758,217...57,862,858
Ensembl chr16:57,758,217...57,863,053
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KIT mRNA
CTD
PMID:26378955
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
G
KLF4
KLF transcription factor 4
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KLF4 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KLF4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
G
KLF6
KLF transcription factor 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF6 mRNA
CTD
PMID:26378955
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
G
KLF7
KLF transcription factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:207,074,137...207,173,851
Ensembl chr 2:207,074,137...207,173,856
G
KMT2E
lysine methyltransferase 2E (inactive)
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KMT2E mRNA
CTD
PMID:21641980
NCBI chr 7:105,014,205...105,115,019
Ensembl chr 7:104,940,943...105,115,019
G
KRR1
KRR1 small subunit processome component homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KRR1 mRNA
CTD
PMID:21641980
NCBI chr12:75,490,863...75,511,609
Ensembl chr12:75,490,863...75,511,636
G
LAYN
layilin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LAYN mRNA
CTD
PMID:21641980
NCBI chr11:111,540,280...111,561,745
Ensembl chr11:111,540,280...111,561,745
G
LCK
LCK proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LCK mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LCK mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:32,251,265...32,286,165
Ensembl chr 1:32,251,244...32,286,165
G
LCN2
lipocalin 2
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] results in increased expression of LCN2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LCN2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LCN2 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:25522732 PMID:26378955
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LDLRAD3
low density lipoprotein receptor class A domain containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LDLRAD3 mRNA
CTD
PMID:26378955
NCBI chr11:35,944,062...36,232,136
Ensembl chr11:35,943,981...36,232,136
G
LEMD3
LEM domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LEMD3 mRNA
CTD
PMID:21641980
NCBI chr12:65,169,583...65,248,355
Ensembl chr12:65,169,583...65,248,355
G
LFNG
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LFNG mRNA
CTD
PMID:26378955
NCBI chr 7:2,512,529...2,529,177
Ensembl chr 7:2,512,529...2,529,177
G
LGALS9
galectin 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LGALS9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LGALS9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:27,631,188...27,649,560
Ensembl chr17:27,629,798...27,649,560
G
LHB
luteinizing hormone subunit beta
multiple interactions
ISO
Succimer inhibits the reaction [sodium arsenite results in decreased expression of LHB protein]
CTD
PMID:31163222
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
LHX2
LIM homeobox 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LHX2 mRNA
CTD
PMID:26378955
NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
G
LIF
LIF interleukin 6 family cytokine
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIF mRNA
CTD
PMID:21641980
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
G
LIG4
DNA ligase 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIG4 mRNA
CTD
PMID:26378955
NCBI chr13:108,207,442...108,218,349
Ensembl chr13:108,207,439...108,218,368
G
LILRA6
leukocyte immunoglobulin like receptor A6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIRA2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIRA2 mRNA
CTD
PMID:21641980
NCBI chr19:54,236,590...54,242,790
Ensembl chr19:54,236,590...54,242,790
G
LIMS1
LIM zinc finger domain containing 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LIMS1 mRNA
CTD
PMID:26378955
NCBI chr 2:108,533,671...108,687,246
Ensembl chr 2:108,533,671...108,687,246
G
LIMS2
LIM zinc finger domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIMS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:127,638,426...127,681,786
Ensembl chr 2:127,638,381...127,681,786
G
LINC-PINT
long intergenic non-protein coding RNA, p53 induced transcript
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LNCPINT mRNA
CTD
PMID:21641980
NCBI chr 7:130,877,562...131,109,925
Ensembl chr 7:130,791,264...131,110,176
G
LMCD1
LIM and cysteine rich domains 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMCD1 mRNA
CTD
PMID:26378955
NCBI chr 3:8,501,823...8,574,668
Ensembl chr 3:8,501,807...8,574,668
G
LMLN
leishmanolysin like peptidase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMLN mRNA
CTD
PMID:26378955
NCBI chr 3:197,960,217...198,043,720
Ensembl chr 3:197,960,200...198,043,720
G
LNPEP
leucyl and cystinyl aminopeptidase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LNPEP mRNA
CTD
PMID:26378955
NCBI chr 5:96,936,080...97,037,513
Ensembl chr 5:96,935,394...97,037,513
G
LPAR1
lysophosphatidic acid receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LPAR1 mRNA
CTD
PMID:21641980
NCBI chr 9:110,873,263...111,038,998
Ensembl chr 9:110,873,263...111,038,470
G
LRP1
LDL receptor related protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LRP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LRP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LRRC8C mRNA
CTD
PMID:21641980
NCBI chr 1:89,615,824...89,719,533
Ensembl chr 1:89,633,072...89,769,903
G
LSM1
LSM1 homolog, mRNA degradation associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM1 mRNA
CTD
PMID:21641980
NCBI chr 8:38,163,321...38,176,730
Ensembl chr 8:38,163,335...38,176,730
G
LSM8
LSM8 homolog, U6 small nuclear RNA associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM8 mRNA
CTD
PMID:21641980
NCBI chr 7:118,184,164...118,204,035
Ensembl chr 7:118,184,144...118,204,035
G
LSP1
lymphocyte specific protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSP1 mRNA
CTD
PMID:21641980
NCBI chr11:1,853,084...1,892,263
Ensembl chr11:1,850,904...1,892,267
G
LSS
lanosterol synthase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSS mRNA
CTD
PMID:21641980
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
LTB
lymphotoxin beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LTB mRNA
CTD
PMID:21641980
NCBI chr 6:31,580,558...31,582,425
Ensembl chr 6:31,580,525...31,582,522
G
LUC7L2
LUC7 like 2, pre-mRNA splicing factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LUC7L2 mRNA
CTD
PMID:21641980
NCBI chr 7:139,340,472...139,423,454
Ensembl chr 7:139,340,359...139,423,457
G
LUC7L3
LUC7 like 3 pre-mRNA splicing factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LUC7L3 mRNA
CTD
PMID:21641980
NCBI chr17:50,719,603...50,756,219
Ensembl chr17:50,719,565...50,756,219
G
LY96
lymphocyte antigen 96
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LY96 mRNA
CTD
PMID:26378955
NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079
G
MAFB
MAF bZIP transcription factor B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAFB mRNA
CTD
PMID:21641980
NCBI chr20:40,685,848...40,689,236
Ensembl chr20:40,685,848...40,689,236
G
MAGI2
membrane associated guanylate kinase, WW and PDZ domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MAGI2 mRNA
CTD
PMID:21641980
NCBI chr 7:78,017,055...79,453,667
Ensembl chr 7:78,017,055...79,453,667
G
MALAT1
metastasis associated lung adenocarcinoma transcript 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MALAT1 mRNA
CTD
PMID:21641980
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073
G
MALT1
MALT1 paracaspase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MALT1 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MALT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MALT1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:58,671,465...58,754,477
Ensembl chr18:58,671,465...58,754,477
G
MAP3K2
mitogen-activated protein kinase kinase kinase 2
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MAP3K2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K2 mRNA
CTD
PMID:26378955
NCBI chr 2:127,298,668...127,388,465
Ensembl chr 2:127,298,668...127,388,465
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAPK1IP1L
mitogen-activated protein kinase 1 interacting protein 1 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPK1IP1L mRNA
CTD
PMID:21641980
NCBI chr14:55,051,647...55,070,194
Ensembl chr14:55,051,647...55,070,194
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPK8 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAPK8 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MAPRE2
microtubule associated protein RP/EB family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPRE2 mRNA
CTD
PMID:21641980
NCBI chr18:34,977,027...35,143,470
Ensembl chr18:34,976,928...35,143,470
G
MARCKS
myristoylated alanine rich protein kinase C substrate
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKS mRNA
CTD
PMID:21641980
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MARCKSL1
MARCKS like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKSL1 mRNA
CTD
PMID:21641980
NCBI chr 1:32,333,839...32,336,233
Ensembl chr 1:32,333,839...32,336,233
G
MARVELD1
MARVEL domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MARVELD1 mRNA
CTD
PMID:21641980
NCBI chr10:97,713,730...97,718,150
Ensembl chr10:97,713,173...97,718,150
G
MATR3
matrin 3
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MATR3 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MATR3 mRNA
CTD
PMID:26378955
NCBI chr 5:139,274,101...139,331,677
Ensembl chr 5:139,273,752...139,331,671 Ensembl chr 5:139,273,752...139,331,671
G
MBNL2
muscleblind like splicing regulator 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MBNL2 mRNA
CTD
PMID:26378955
NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,120
G
MBNL3
muscleblind like splicing regulator 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MBNL3 mRNA
CTD
PMID:26378955
NCBI chr X:132,369,320...132,490,035
Ensembl chr X:132,369,320...132,489,968
G
MBTD1
mbt domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MBTD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MBTD1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:51,177,425...51,260,958
Ensembl chr17:51,177,425...51,260,163
G
MCHR1
melanin concentrating hormone receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCHR1 mRNA
CTD
PMID:21641980
NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,679,273...40,682,812
G
MCOLN2
mucolipin TRP cation channel 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCOLN2 mRNA
CTD
PMID:21641980
NCBI chr 1:84,925,583...84,997,113
Ensembl chr 1:84,925,583...84,997,113
G
MDM2
MDM2 proto-oncogene
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MDM2 mRNA
CTD
PMID:26378955
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
MECOM
MDS1 and EVI1 complex locus
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MECOM mRNA
CTD
PMID:26378955
NCBI chr 3:169,083,507...169,663,712
Ensembl chr 3:169,083,499...169,663,775
G
MECP2
methyl-CpG binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MECP2 mRNA
CTD
PMID:21641980
NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103
G
MED13
mediator complex subunit 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MED13 mRNA
CTD
PMID:21641980
NCBI chr17:61,942,605...62,065,278
Ensembl chr17:61,942,605...62,065,278
G
MEF2A
myocyte enhancer factor 2A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2A mRNA
CTD
PMID:21641980
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
MEF2C
myocyte enhancer factor 2C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2C mRNA
CTD
PMID:21641980
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
G
MESP2
mesoderm posterior bHLH transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MESP2 mRNA
CTD
PMID:21641980
NCBI chr15:89,776,332...89,778,754
Ensembl chr15:89,760,591...89,778,754
G
MFAP3L
microfibril associated protein 3 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFAP3L mRNA
CTD
PMID:21641980
NCBI chr 4:169,986,602...170,027,277
Ensembl chr 4:169,986,597...170,033,031
G
MFSD11
major facilitator superfamily domain containing 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MFSD11 mRNA
CTD
PMID:21641980
NCBI chr17:76,736,634...76,803,805
Ensembl chr17:76,735,865...76,781,449
G
MFSD2A
MFSD2 lysolipid transporter A, lysophospholipid
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFSD2 mRNA
CTD
PMID:21641980
NCBI chr 1:39,955,145...39,969,956
Ensembl chr 1:39,955,112...39,969,968
G
MGA
MAX dimerization protein MGA
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MGA mRNA
CTD
PMID:21641980
NCBI chr15:41,621,224...41,769,940
Ensembl chr15:41,621,134...41,773,081
G
MGAT4A
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT4A mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MGAT4A mRNA
CTD
PMID:26378955
NCBI chr 2:98,619,106...98,731,132
Ensembl chr 2:98,619,106...98,731,132
G
MGAT5B
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA
CTD
PMID:26378955
NCBI chr17:76,868,404...76,950,393
Ensembl chr17:76,868,404...76,950,393
G
MGST2
microsomal glutathione S-transferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MGST2 mRNA
CTD
PMID:21641980
NCBI chr 4:139,665,819...139,754,618
Ensembl chr 4:139,665,768...139,740,745
G
MIA3
MIA SH3 domain ER export factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIA3 mRNA
CTD
PMID:21641980
NCBI chr 1:222,618,097...222,668,007
Ensembl chr 1:222,618,097...222,668,007
G
MICAL2
microtubule associated monooxygenase, calponin and LIM domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MICAL2 mRNA
CTD
PMID:26378955
NCBI chr11:12,110,590...12,362,140
Ensembl chr11:12,094,008...12,359,144
G
MICALL2
MICAL like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MICALL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MICALL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:1,434,359...1,459,470
Ensembl chr 7:1,428,465...1,459,470
G
MID1
midline 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MID1 mRNA
CTD
PMID:26378955
NCBI chr X:10,445,310...10,833,683
Ensembl chr X:10,445,310...10,833,654
G
MINDY2
MINDY lysine 48 deubiquitinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MINDY2 mRNA
CTD
PMID:21641980
NCBI chr15:58,771,302...58,861,900
Ensembl chr15:58,771,192...58,861,900
G
MIR17HG
miR-17-92a-1 cluster host gene
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIR17HG mRNA
CTD
PMID:21641980
NCBI chr13:91,347,820...91,354,575
Ensembl chr13:91,347,686...91,397,592
G
MIX23
mitochondrial matrix import factor 23
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIX23 mRNA
CTD
PMID:21641980
NCBI chr 3:122,359,591...122,383,231
Ensembl chr 3:122,359,591...122,383,231
G
MKI67
marker of proliferation Ki-67
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA
CTD
PMID:21641980
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MLLT10
MLLT10 histone lysine methyltransferase DOT1L cofactor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MLLT10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MLLT10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:21,533,756...21,743,630
Ensembl chr10:21,524,646...21,743,630
G
MMP10
matrix metallopeptidase 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
G
MMP11
matrix metallopeptidase 11
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP11 mRNA
CTD
PMID:26378955
NCBI chr22:23,772,849...23,784,316
Ensembl chr22:23,768,226...23,784,316
G
MMP12
matrix metallopeptidase 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP12 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP12 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP9
matrix metallopeptidase 9
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MNDA
myeloid cell nuclear differentiation antigen
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MNDA mRNA
CTD
PMID:21641980
NCBI chr 1:158,831,351...158,849,502
Ensembl chr 1:158,831,351...158,849,506
G
MOCOS
molybdenum cofactor sulfurase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOCOS mRNA
CTD
PMID:21641980
NCBI chr18:36,187,497...36,272,157
Ensembl chr18:36,187,497...36,272,157
G
MOSPD2
motile sperm domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MOSPD2 mRNA
CTD
PMID:21641980
NCBI chr X:14,873,421...14,922,327
Ensembl chr X:14,873,421...14,922,327
G
MOV10
Mov10 RNA helicase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOV10 mRNA
CTD
PMID:21641980
NCBI chr 1:112,674,439...112,700,739
Ensembl chr 1:112,673,141...112,700,756
G
MRPL50
mitochondrial ribosomal protein L50
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPL50 mRNA
CTD
PMID:21641980
NCBI chr 9:101,387,633...101,398,618
Ensembl chr 9:101,387,633...101,398,618
G
MRPS6
mitochondrial ribosomal protein S6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPS6 mRNA
CTD
PMID:21641980
NCBI chr21:34,073,578...34,143,030
Ensembl chr21:34,073,224...34,143,034
G
MSGN1
mesogenin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSGN1 mRNA
CTD
PMID:21641980
NCBI chr 2:17,816,460...17,817,798
Ensembl chr 2:17,816,460...17,817,798
G
MSH2
mutS homolog 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MSH2 mRNA
CTD
PMID:21641980
NCBI chr 2:47,403,067...47,709,830
Ensembl chr 2:47,403,067...47,663,146
G
MSH5
mutS homolog 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSH5 mRNA
CTD
PMID:21641980
NCBI chr 6:31,740,005...31,762,676
Ensembl chr 6:31,739,677...31,762,676
G
MT1X
metallothionein 1X
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
MT2A
metallothionein 2A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT2A mRNA
CTD
PMID:26378955
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MTF1
metal regulatory transcription factor 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MTF1 mRNA
CTD
PMID:26378955
NCBI chr 1:37,809,574...37,859,592
Ensembl chr 1:37,809,574...37,859,592
G
MTF2
metal response element binding transcription factor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MTF2 mRNA
CTD
PMID:26378955
NCBI chr 1:93,079,283...93,139,076
Ensembl chr 1:93,079,235...93,139,079
G
MTREX
Mtr4 exosome RNA helicase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTREX mRNA
CTD
PMID:21641980
NCBI chr 5:55,307,989...55,425,579
Ensembl chr 5:55,307,989...55,425,579
G
MTSS1
MTSS I-BAR domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTSS1 mRNA
CTD
PMID:21641980
NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,784...124,728,473
G
MTX3
metaxin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTX3 mRNA
CTD
PMID:21641980
NCBI chr 5:79,976,716...79,991,262
Ensembl chr 5:79,976,716...79,991,262
G
MUC20
mucin 20, cell surface associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUC20 mRNA
CTD
PMID:21641980
NCBI chr 3:195,720,978...195,733,551
Ensembl chr 3:195,720,884...195,741,123
G
MUSTN1
musculoskeletal, embryonic nuclear protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUSTN1 mRNA
CTD
PMID:21641980
NCBI chr 3:52,833,121...52,835,019
Ensembl chr 3:52,833,114...52,835,019
G
MVD
mevalonate diphosphate decarboxylase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MVD mRNA
CTD
PMID:21641980
NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
G
MXD4
MAX dimerization protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MXD4 mRNA
CTD
PMID:21641980
NCBI chr 4:2,247,432...2,262,109
Ensembl chr 4:2,247,432...2,262,109
G
MYB
MYB proto-oncogene, transcription factor
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYB mRNA
CTD
PMID:26378955
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYC
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MYC mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MYC mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYH14
myosin heavy chain 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MYH14 mRNA
CTD
PMID:21641980
NCBI chr19:50,203,622...50,310,540
Ensembl chr19:50,188,186...50,310,542
G
MYLK
myosin light chain kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYLK mRNA
CTD
PMID:26378955
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
N4BP2
NEDD4 binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of N4BP2 mRNA
CTD
PMID:21641980
NCBI chr 4:40,056,850...40,190,470
Ensembl chr 4:40,056,797...40,158,252
G
N4BP2L1
NEDD4 binding protein 2 like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of N4BP2L1 mRNA
CTD
PMID:21641980
NCBI chr13:32,400,723...32,429,615
Ensembl chr13:32,400,723...32,428,311
G
NAA50
N-alpha-acetyltransferase 50, NatE catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAA50 mRNA
CTD
PMID:21641980
NCBI chr 3:113,716,458...113,746,249
Ensembl chr 3:113,716,458...113,746,300
G
NABP1
nucleic acid binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NABP1 mRNA
CTD
PMID:21641980
NCBI chr 2:191,678,136...191,686,943
Ensembl chr 2:191,678,068...191,741,097
G
NAIP
NLR family apoptosis inhibitory protein
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NAIP mRNA
CTD
PMID:26378955
NCBI chr 5:70,968,166...71,025,339
Ensembl chr 5:70,968,166...71,025,339
G
NAV1
neuron navigator 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV1 mRNA
CTD
PMID:21641980
NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,539,127...201,826,969
G
NAV2
neuron navigator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV2 mRNA
CTD
PMID:21641980
NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601
G
NBEAL1
neurobeachin like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NBEAL1 mRNA
CTD
PMID:21641980
NCBI chr 2:203,014,608...203,225,194
Ensembl chr 2:203,014,608...203,226,378
G
NCAPG2
non-SMC condensin II complex subunit G2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCAPG2 mRNA
CTD
PMID:21641980
NCBI chr 7:158,631,169...158,704,804
Ensembl chr 7:158,631,169...158,704,804
G
NCF1
neutrophil cytosolic factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NCF1 mRNA
CTD
PMID:26378955
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
G
NCKAP1
NCK associated protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NCKAP1 mRNA
CTD
PMID:21641980
NCBI chr 2:182,909,115...183,038,457
Ensembl chr 2:182,909,115...183,038,858
G
NCL
nucleolin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCL mRNA
CTD
PMID:21641980
NCBI chr 2:231,453,531...231,464,484
Ensembl chr 2:231,453,531...231,483,641
G
NCOA2
nuclear receptor coactivator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCOA2 mRNA
CTD
PMID:21641980
NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
G
NDC1
NDC1 transmembrane nucleoporin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDC1 mRNA
CTD
PMID:21641980
NCBI chr 1:53,765,478...53,838,296
Ensembl chr 1:53,765,478...53,838,463
G
NDRG1
N-myc downstream regulated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDRG1 mRNA
CTD
PMID:21641980
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NDRG2
NDRG family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDRG2 mRNA
CTD
PMID:21641980
NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872
G
NDUFA10
NADH:ubiquinone oxidoreductase subunit A10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFA10 mRNA
CTD
PMID:21641980
NCBI chr 2:239,892,442...240,025,342
Ensembl chr 2:239,892,450...240,025,743
G
NDUFAB1
NADH:ubiquinone oxidoreductase subunit AB1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFAB1 mRNA
CTD
PMID:21641980
NCBI chr16:23,581,014...23,596,316
Ensembl chr16:23,581,014...23,596,316
G
NEAT1
nuclear paraspeckle assembly transcript 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NEAT1 mRNA
CTD
PMID:21641980
NCBI chr11:65,422,798...65,445,540
Ensembl chr11:65,422,774...65,445,540
G
NECTIN2
nectin cell adhesion molecule 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NECTIN2 mRNA
CTD
PMID:21641980
NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,223
G
NECTIN3
nectin cell adhesion molecule 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NECTIN3 mRNA
CTD
PMID:21641980
NCBI chr 3:111,071,816...111,194,170
Ensembl chr 3:111,070,071...111,275,563
G
NEK2
NIMA related kinase 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NEK2 mRNA
CTD
PMID:26378955
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
G
NEK3
NIMA related kinase 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NEK3 mRNA
CTD
PMID:26378955
NCBI chr13:52,132,647...52,159,860
Ensembl chr13:52,132,639...52,159,597
G
NEMF
nuclear export mediator factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NEMF mRNA
CTD
PMID:21641980
NCBI chr14:49,782,083...49,852,788
Ensembl chr14:49,782,083...49,852,821
G
NFAT5
nuclear factor of activated T cells 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFAT5 mRNA
CTD
PMID:21641980
NCBI chr16:69,565,966...69,704,654
Ensembl chr16:69,565,094...69,704,666
G
NFATC3
nuclear factor of activated T cells 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFATC3 mRNA
CTD
PMID:21641980
NCBI chr16:68,085,370...68,229,259
Ensembl chr16:68,084,751...68,229,259
G
NFE2L2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFE2L2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NFE2L2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFE2L2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFIX
nuclear factor I X
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFIX mRNA
CTD
PMID:21641980
NCBI chr19:12,995,475...13,098,796
Ensembl chr19:12,995,475...13,098,796
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFKB1 mRNA Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKB1 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of NFKB1 mRNA]
CTD
PMID:21641980 PMID:26378955 PMID:31163222 PMID:32402895
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKB2
nuclear factor kappa B subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB2 mRNA
CTD
PMID:21641980
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIA mRNA
CTD
PMID:21641980
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIE
NFKB inhibitor epsilon
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIE mRNA
CTD
PMID:21641980
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
G
NFKBIZ
NFKB inhibitor zeta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIZ mRNA
CTD
PMID:21641980
NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022
G
NFX1
nuclear transcription factor, X-box binding 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFX1 mRNA
CTD
PMID:26378955
NCBI chr 9:33,290,516...33,371,157
Ensembl chr 9:33,290,512...33,371,157
G
NINJ1
ninjurin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NINJ1 mRNA
CTD
PMID:21641980
NCBI chr 9:93,121,496...93,134,251
Ensembl chr 9:93,121,496...93,134,251
G
NKD1
NKD inhibitor of WNT signaling pathway 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NKD1 mRNA
CTD
PMID:26378955
NCBI chr16:50,548,396...50,649,249
Ensembl chr16:50,548,396...50,649,249
G
NKTR
natural killer cell triggering receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NKTR mRNA
CTD
PMID:21641980
NCBI chr 3:42,600,612...42,648,735
Ensembl chr 3:42,600,655...42,648,735
G
NLK
nemo like kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NLK mRNA
CTD
PMID:26378955
NCBI chr17:28,042,677...28,206,074
Ensembl chr17:28,041,737...28,196,381
G
NLN
neurolysin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLN mRNA
CTD
PMID:26378955
NCBI chr 5:65,722,205...65,829,283
Ensembl chr 5:65,722,205...65,871,725
G
NLRC4
NLR family CARD domain containing 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLRC4 mRNA
CTD
PMID:26378955
NCBI chr 2:32,224,449...32,265,743
Ensembl chr 2:32,224,453...32,265,732
G
NLRP10
NLR family pyrin domain containing 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NLRP10 mRNA
CTD
PMID:21641980
NCBI chr11:7,957,537...7,965,447
Ensembl chr11:7,957,537...7,965,447
G
NLRP3
NLR family pyrin domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NLRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLRP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NNMT
nicotinamide N-methyltransferase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NNMT mRNA
CTD
PMID:26378955
NCBI chr11:114,257,806...114,313,536
Ensembl chr11:114,257,787...114,313,536
G
NPAS2
neuronal PAS domain protein 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NPAS2 mRNA
CTD
PMID:26378955
NCBI chr 2:100,818,723...100,996,829
Ensembl chr 2:100,820,139...100,996,829
G
NPTX1
neuronal pentraxin 1
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NPTX1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NPTX1 mRNA
CTD
PMID:26378955
NCBI chr17:80,466,834...80,476,607
Ensembl chr17:80,466,834...80,477,843
G
NPY
neuropeptide Y
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NPY mRNA
CTD
PMID:21641980
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NQO1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NQO1 mRNA
CTD
PMID:26378955
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1D2
nuclear receptor subfamily 1 group D member 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR1D2 mRNA
CTD
PMID:26378955
NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617
G
NR2C2
nuclear receptor subfamily 2 group C member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NR2C2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of NR2C2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:14,947,583...15,049,273
Ensembl chr 3:14,947,583...15,053,600
G
NR2F2
nuclear receptor subfamily 2 group F member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR2F2 mRNA
CTD
PMID:26378955
NCBI chr15:96,326,046...96,340,263
Ensembl chr15:96,325,938...96,340,263
G
NR3C1
nuclear receptor subfamily 3 group C member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NR3C1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR3C1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR5A2
nuclear receptor subfamily 5 group A member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NR5A2 mRNA
CTD
PMID:26378955
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
NRIP1
nuclear receptor interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRIP1 mRNA
CTD
PMID:21641980
NCBI chr21:14,961,235...15,065,936
Ensembl chr21:14,961,235...15,065,936
G
NRP1
neuropilin 1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NRP1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
G
NRP2
neuropilin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA
CTD
PMID:26378955
NCBI chr 2:205,682,501...205,798,131
Ensembl chr 2:205,681,990...205,798,133
G
NRXN3
neurexin 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRXN3 mRNA
CTD
PMID:26378955
NCBI chr14:78,170,373...79,868,291
Ensembl chr14:78,170,373...79,868,291
G
NSD1
nuclear receptor binding SET domain protein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NSD1 mRNA
CTD
PMID:26378955
NCBI chr 5:177,131,798...177,300,213
Ensembl chr 5:177,131,830...177,300,213
G
NUAK2
NUAK family kinase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUAK2 mRNA
CTD
PMID:26378955
NCBI chr 1:205,302,063...205,321,745
Ensembl chr 1:205,302,063...205,321,745
G
NUDT11
nudix hydrolase 11
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUDT11 mRNA
CTD
PMID:26378955
NCBI chr X:51,490,011...51,496,592
Ensembl chr X:51,490,011...51,496,592
G
NUDT5
nudix hydrolase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NUDT5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NUDT5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:12,165,330...12,195,891
Ensembl chr10:12,165,330...12,195,891
G
NUPR1
nuclear protein 1, transcriptional regulator
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NUPR1 mRNA
CTD
PMID:21641980
NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
G
OAS1
2'-5'-oligoadenylate synthetase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS1 mRNA
CTD
PMID:26378955
NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219
G
OAS2
2'-5'-oligoadenylate synthetase 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:112,978,519...113,011,723
Ensembl chr12:112,978,395...113,011,723
G
OAS3
2'-5'-oligoadenylate synthetase 3
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460
G
OASL
2'-5'-oligoadenylate synthetase like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OASL1 mRNA
CTD
PMID:21641980
NCBI chr12:121,017,761...121,039,246
Ensembl chr12:121,017,763...121,039,246
G
OASL2P
2'-5' oligoadenylate synthetase like 2, pseudogene
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OASL2 mRNA
CTD
PMID:26378955
NCBI chr12:121,053,732...121,059,670
Ensembl chr12:121,053,732...121,059,670
G
OCSTAMP
osteoclast stimulatory transmembrane protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OCSTAMP mRNA
CTD
PMID:21641980
NCBI chr20:46,540,946...46,550,654
Ensembl chr20:46,540,946...46,550,654
G
ODC1
ornithine decarboxylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ODC1 mRNA
CTD
PMID:21641980
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
G
OGFRL1
opioid growth factor receptor like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of OGFRL1 mRNA
CTD
PMID:21641980
NCBI chr 6:71,288,811...71,309,059
Ensembl chr 6:71,288,811...71,309,059
G
OIT3
oncoprotein induced transcript 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OIT3 mRNA
CTD
PMID:21641980
NCBI chr10:72,893,739...72,933,036
Ensembl chr10:72,893,584...72,933,036
G
ORC3
origin recognition complex subunit 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ORC3 mRNA
CTD
PMID:21641980
NCBI chr 6:87,590,135...87,677,823
Ensembl chr 6:87,590,067...87,667,453
G
OSGIN2
oxidative stress induced growth inhibitor family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OSGIN2 mRNA
CTD
PMID:21641980
NCBI chr 8:89,901,868...89,927,888
Ensembl chr 8:89,901,849...89,927,888
G
OTUD4
OTU deubiquitinase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of OTUD4 mRNA
CTD
PMID:26378955
NCBI chr 4:145,133,650...145,180,589
Ensembl chr 4:145,110,838...145,180,589
G
OVOL2
ovo like zinc finger 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OVOL2 mRNA
CTD
PMID:26378955
NCBI chr20:18,024,152...18,059,188
Ensembl chr20:17,956,979...18,059,188
G
PACRG
parkin coregulated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PACRG mRNA
CTD
PMID:21641980
NCBI chr 6:162,727,132...163,315,500
Ensembl chr 6:162,727,132...163,315,500
G
PADI2
peptidyl arginine deiminase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PADI2 mRNA
CTD
PMID:21641980
NCBI chr 1:17,066,761...17,119,451
Ensembl chr 1:17,066,761...17,119,451
G
PAFAH1B1
platelet activating factor acetylhydrolase 1b regulatory subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:21641980
NCBI chr17:2,593,183...2,685,615
Ensembl chr17:2,593,183...2,685,615
G
PALD1
phosphatase domain containing paladin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALD1 mRNA
CTD
PMID:21641980
NCBI chr10:70,458,485...70,568,450
Ensembl chr10:70,478,767...70,668,754
G
PALS2
protein associated with LIN7 2, MAGUK p55 family member
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALS2 mRNA
CTD
PMID:21641980
NCBI chr 7:24,573,452...24,694,193
Ensembl chr 7:24,573,268...24,694,193
G
PANK1
pantothenate kinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PANK1 mRNA
CTD
PMID:21641980
NCBI chr10:89,579,495...89,645,242
Ensembl chr10:89,579,497...89,645,242
G
PAPPA
pappalysin 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PAPPA mRNA
CTD
PMID:26378955
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions
ISO
Succimer inhibits the reaction [sodium arsenite results in increased expression of PARP1 protein]
CTD
PMID:31163222
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PARP12
poly(ADP-ribose) polymerase family member 12
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PARP12 mRNA
CTD
PMID:26378955
NCBI chr 7:140,023,749...140,062,951
Ensembl chr 7:140,023,749...140,062,951
G
PARP3
poly(ADP-ribose) polymerase family member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PARP3 mRNA
CTD
PMID:21641980
NCBI chr 3:51,942,363...51,948,867
Ensembl chr 3:51,942,345...51,948,867
G
PATZ1
POZ/BTB and AT hook containing zinc finger 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PATZ1 mRNA
CTD
PMID:26378955
NCBI chr22:31,325,804...31,346,346
Ensembl chr22:31,325,804...31,346,346
G
PCBP2
poly(rC) binding protein 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCBP2 mRNA
CTD
PMID:26378955
NCBI chr12:53,452,102...53,481,162
Ensembl chr12:53,452,102...53,481,162
G
PCGF2
polycomb group ring finger 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF2 mRNA
CTD
PMID:26378955
NCBI chr17:38,733,898...38,749,792
Ensembl chr17:38,733,898...38,749,817
G
PCGF5
polycomb group ring finger 5
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF5 mRNA
CTD
PMID:26378955
NCBI chr10:91,156,219...91,284,337
Ensembl chr10:91,163,012...91,284,337
G
PCM1
pericentriolar material 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCM1 mRNA
CTD
PMID:21641980
NCBI chr 8:17,922,988...18,029,948
Ensembl chr 8:17,922,842...18,029,948
G
PCMTD1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCMTD1 mRNA
CTD
PMID:21641980
NCBI chr 8:51,817,575...51,899,186
Ensembl chr 8:51,817,575...51,899,186
G
PDCD1
programmed cell death 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDCD1 mRNA
CTD
PMID:21641980
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
PDCD4
programmed cell death 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDCD4 mRNA
CTD
PMID:21641980
NCBI chr10:110,871,928...110,900,006
Ensembl chr10:110,871,795...110,900,006
G
PDCD6
programmed cell death 6
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDCD6 mRNA
CTD
PMID:26378955
NCBI chr 5:271,646...314,974
Ensembl chr 5:271,621...314,974
G
PDCD6IP
programmed cell death 6 interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDCD6IP mRNA
CTD
PMID:21641980
NCBI chr 3:33,798,630...33,869,703
Ensembl chr 3:33,798,571...33,869,707
G
PDE1A
phosphodiesterase 1A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE1A mRNA
CTD
PMID:26378955
NCBI chr 2:182,140,041...182,716,797
Ensembl chr 2:182,139,968...182,523,359
G
PDE4B
phosphodiesterase 4B
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDE4B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE4B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PDE4DIP
phosphodiesterase 4D interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDE4DIP mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDE4DIP mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:148,808,434...149,033,016
Ensembl chr 1:148,808,140...149,048,286
G
PDE7A
phosphodiesterase 7A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE7A mRNA
CTD
PMID:26378955
NCBI chr 8:65,714,334...65,842,064
Ensembl chr 8:65,714,334...65,842,322
G
PDE8B
phosphodiesterase 8B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE8B mRNA
CTD
PMID:26378955
NCBI chr 5:77,086,715...77,428,256
Ensembl chr 5:77,210,449...77,428,256 Ensembl chr 5:77,210,449...77,428,256
G
PDLIM5
PDZ and LIM domain 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDLIM5 mRNA
CTD
PMID:26378955
NCBI chr 4:94,451,942...94,668,223
Ensembl chr 4:94,451,857...94,668,227
G
PDLIM7
PDZ and LIM domain 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDLIM7 mRNA
CTD
PMID:26378955
NCBI chr 5:177,483,394...177,497,604
Ensembl chr 5:177,483,394...177,497,606
G
PDPN
podoplanin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDPN mRNA
CTD
PMID:21641980
NCBI chr 1:13,583,757...13,617,957
Ensembl chr 1:13,583,465...13,617,957
G
PDSS1
decaprenyl diphosphate synthase subunit 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDSS1 mRNA
CTD
PMID:26378955
NCBI chr10:26,697,701...26,746,798
Ensembl chr10:26,697,701...26,746,798
G
PF4
platelet factor 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PF4 mRNA
CTD
PMID:26378955
NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
G
PGGT1B
protein geranylgeranyltransferase type I subunit beta
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PGGT1B mRNA
CTD
PMID:26378955
NCBI chr 5:115,204,012...115,262,877
Ensembl chr 5:115,204,012...115,262,877
G
PGM2L1
phosphoglucomutase 2 like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PGM2L1 mRNA
CTD
PMID:21641980
NCBI chr11:74,330,316...74,398,433
Ensembl chr11:74,330,316...74,398,433
G
PGM5
phosphoglucomutase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PGM5 mRNA
CTD
PMID:21641980
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
G
PHB2
prohibitin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHB2 mRNA
CTD
PMID:21641980
NCBI chr12:6,965,327...6,970,753
Ensembl chr12:6,965,327...6,970,780
G
PHC3
polyhomeotic homolog 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHC3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PHC3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:170,087,584...170,181,733
Ensembl chr 3:170,086,732...170,181,749
G
PHF20L1
PHD finger protein 20 like 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF20L1 mRNA
CTD
PMID:26378955
NCBI chr 8:132,775,388...132,848,807
Ensembl chr 8:132,775,358...132,848,807
G
PHF3
PHD finger protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:63,635,802...63,726,011
Ensembl chr 6:63,635,802...63,779,336
G
PHF6
PHD finger protein 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PHF6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:134,373,312...134,428,790
Ensembl chr X:134,373,288...134,428,791
G
PHIP
pleckstrin homology domain interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHIP mRNA
CTD
PMID:21641980
NCBI chr 6:78,934,419...79,078,254
Ensembl chr 6:78,934,419...79,078,287
G
PHLDA1
pleckstrin homology like domain family A member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PHLDA1 mRNA
CTD
PMID:21641980
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
G
PIAS2
protein inhibitor of activated STAT 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIAS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PIAS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:46,803,218...46,920,145
Ensembl chr18:46,803,218...46,920,160
G
PIEZO2
piezo type mechanosensitive ion channel component 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIEZO2 mRNA
CTD
PMID:21641980
NCBI chr18:10,670,247...11,149,569
Ensembl chr18:10,666,483...11,149,569
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIK3CA mRNA
CTD
PMID:21641980
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:21641980
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PILRA
paired immunoglobin like type 2 receptor alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PILRA mRNA
CTD
PMID:21641980
NCBI chr 7:100,371,291...100,400,096
Ensembl chr 7:100,367,530...100,400,096
G
PIM1
Pim-1 proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIM1 mRNA
CTD
PMID:21641980
NCBI chr 6:37,170,152...37,175,428
Ensembl chr 6:37,170,152...37,175,428
G
PINK1
PTEN induced kinase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PINK1 mRNA
CTD
PMID:26378955
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
G
PIP4K2A
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIP4K2A mRNA
CTD
PMID:21641980
NCBI chr10:22,534,854...22,714,578
Ensembl chr10:22,534,854...22,714,578
G
PIP5K1B
phosphatidylinositol-4-phosphate 5-kinase type 1 beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIP5K1B mRNA
CTD
PMID:21641980
NCBI chr 9:68,705,240...69,009,176
Ensembl chr 9:68,705,240...69,009,176
G
PIR
pirin
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PIR mRNA
CTD
PMID:26378955
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PITPNM1
phosphatidylinositol transfer protein membrane associated 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PITPNM1 mRNA
CTD
PMID:26378955
NCBI chr11:67,491,768...67,506,266
Ensembl chr11:67,491,768...67,506,263
G
PJA2
praja ring finger ubiquitin ligase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PJA2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PJA2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:109,334,722...109,409,974
Ensembl chr 5:109,334,713...109,409,974
G
PKD2
polycystin 2, transient receptor potential cation channel
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PKD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKD2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:88,007,635...88,077,777
Ensembl chr 4:88,007,635...88,077,777
G
PKLR
pyruvate kinase L/R
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKLR mRNA
CTD
PMID:26378955
NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438
G
PLAGL2
PLAG1 like zinc finger 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAGL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAGL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:32,192,504...32,207,743
Ensembl chr20:32,192,504...32,207,743
G
PLAU
plasminogen activator, urokinase
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAU mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAU mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PLAUR
plasminogen activator, urokinase receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAUR mRNA
CTD
PMID:21641980
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLCB4
phospholipase C beta 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLCB4 mRNA
CTD
PMID:21641980
NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
G
PLD3
phospholipase D family member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLD3 mRNA
CTD
PMID:21641980
NCBI chr19:40,348,695...40,378,485
Ensembl chr19:40,348,456...40,389,472
G
PLK2
polo like kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLK2 mRNA
CTD
PMID:21641980
NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
G
PLK4
polo like kinase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLK4 mRNA
CTD
PMID:21641980
NCBI chr 4:127,880,893...127,899,224
Ensembl chr 4:127,880,893...127,899,224
G
PLPP3
phospholipid phosphatase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLPP3 mRNA
CTD
PMID:21641980
NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301
G
PLSCR2
phospholipid scramblase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLSCR2 mRNA
CTD
PMID:26378955
NCBI chr 3:146,391,420...146,495,991
Ensembl chr 3:146,391,421...146,495,991
G
PLXDC1
plexin domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLXDC1 mRNA
CTD
PMID:21641980
NCBI chr17:39,063,313...39,152,967
Ensembl chr17:39,063,313...39,154,394
G
PMEPA1
prostate transmembrane protein, androgen induced 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PMEPA1 mRNA
CTD
PMID:21641980
NCBI chr20:57,648,396...57,711,472
Ensembl chr20:57,648,392...57,711,536
G
PMS1
PMS1 homolog 1, mismatch repair system component
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PMS1 mRNA
CTD
PMID:21641980
NCBI chr 2:189,784,450...189,877,629
Ensembl chr 2:189,784,085...189,877,629
G
PNISR
PNN interacting serine and arginine rich protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNISR mRNA
CTD
PMID:21641980
NCBI chr 6:99,398,050...99,425,308
Ensembl chr 6:99,397,629...99,425,331
G
PNN
pinin, desmosome associated protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNN mRNA
CTD
PMID:21641980
NCBI chr14:39,175,254...39,183,220
Ensembl chr14:39,175,183...39,183,220
G
PNPLA6
patatin like phospholipase domain containing 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PNPLA6 mRNA
CTD
PMID:26378955
NCBI chr19:7,534,164...7,561,767
Ensembl chr19:7,534,004...7,561,764
G
POGLUT3
protein O-glucosyltransferase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of POGLUT3 mRNA
CTD
PMID:21641980
NCBI chr11:108,472,116...108,498,384
Ensembl chr11:108,472,112...108,498,405
G
POLA1
DNA polymerase alpha 1, catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of POLA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of POLA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:24,693,918...24,996,986
Ensembl chr X:24,693,873...24,996,986
G
POLR1A
RNA polymerase I subunit A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of POLR1A mRNA
CTD
PMID:26378955
NCBI chr 2:86,020,216...86,105,886
Ensembl chr 2:86,020,216...86,106,155
G
POU2F2
POU class 2 homeobox 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of POU2F2 mRNA
CTD
PMID:21641980
NCBI chr19:42,086,110...42,197,936
Ensembl chr19:42,086,110...42,196,585
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA
CTD
PMID:26378955
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPFIA3
PTPRF interacting protein alpha 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIA3 mRNA
CTD
PMID:21641980
NCBI chr19:49,119,544...49,151,026
Ensembl chr19:49,119,544...49,151,026
G
PPFIBP2
PPFIA binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIBP2 mRNA
CTD
PMID:21641980
NCBI chr11:7,513,999...7,667,304
Ensembl chr11:7,513,298...7,657,127
G
PPWD1
peptidylprolyl isomerase domain and WD repeat containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PPWD1 mRNA
CTD
PMID:21641980
NCBI chr 5:65,563,296...65,587,549
Ensembl chr 5:65,563,236...65,587,549
G
PRAM1
PML-RARA regulated adaptor molecule 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRAM1 mRNA
CTD
PMID:21641980
NCBI chr19:8,490,056...8,502,640
Ensembl chr19:8,490,056...8,502,640
G
PRDM1
PR/SET domain 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRDM1 mRNA
CTD
PMID:26378955
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
PRDM2
PR/SET domain 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRDM2 mRNA
CTD
PMID:26378955
NCBI chr 1:13,700,188...13,825,079
Ensembl chr 1:13,700,188...13,825,079
G
PRIM2
DNA primase subunit 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRIM2 mRNA
CTD
PMID:26378955
NCBI chr 6:57,221,540...57,646,850
Ensembl chr 6:57,314,805...57,646,850
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKAA2 mRNA
CTD
PMID:26378955
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
G
PRKAR2B
protein kinase cAMP-dependent type II regulatory subunit beta
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PRKAR2B mRNA
CTD
PMID:26378955
NCBI chr 7:107,044,705...107,161,811
Ensembl chr 7:107,044,705...107,161,811
G
PRKCB
protein kinase C beta
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKCB mRNA
CTD
PMID:26378955
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
G
PROCR
protein C receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PROCR mRNA
CTD
PMID:21641980
NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240
G
PRP4K
pre-mRNA processing factor kinase PRP4K
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF4B mRNA
CTD
PMID:21641980
NCBI chr 6:4,021,300...4,064,983
Ensembl chr 6:4,021,267...4,064,983
G
PRPF38B
pre-mRNA processing factor 38B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF38B mRNA
CTD
PMID:21641980
NCBI chr 1:108,692,310...108,702,928
Ensembl chr 1:108,692,310...108,702,928
G
PRPF39
pre-mRNA processing factor 39
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF39 mRNA
CTD
PMID:21641980
NCBI chr14:45,084,116...45,116,282
Ensembl chr14:45,084,107...45,116,282
G
PRPF40A
pre-mRNA processing factor 40 homolog A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF40A mRNA
CTD
PMID:21641980
NCBI chr 2:152,651,732...152,718,019
Ensembl chr 2:152,651,593...152,718,012
G
PRRC1
proline rich coiled-coil 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRRC1 mRNA
CTD
PMID:21641980
NCBI chr 5:127,517,640...127,555,085
Ensembl chr 5:127,517,617...127,555,085
G
PRRG4
proline rich and Gla domain 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRRG4 mRNA
CTD
PMID:21641980
NCBI chr11:32,829,789...32,858,120
Ensembl chr11:32,829,927...32,858,120
G
PRRT1
proline rich transmembrane protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRRT1 mRNA
CTD
PMID:21641980
NCBI chr 6:32,148,363...32,153,083
Ensembl chr 6:32,148,359...32,153,083
G
PRSS50
serine protease 50
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRSS50 mRNA
CTD
PMID:21641980
NCBI chr 3:46,712,117...46,717,869
Ensembl chr 3:46,712,117...46,717,869
G
PSMA1
proteasome 20S subunit alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PSMA1 mRNA
CTD
PMID:21641980
NCBI chr11:14,504,876...14,643,662
Ensembl chr11:14,504,874...14,643,635
G
PTCH2
patched 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTCH2 mRNA
CTD
PMID:21641980
NCBI chr 1:44,819,845...44,843,253
Ensembl chr 1:44,819,844...44,843,253
G
PTGIR
prostaglandin I2 receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTGIR mRNA
CTD
PMID:21641980
NCBI chr19:46,610,687...46,625,089
Ensembl chr19:46,620,468...46,625,089
G
PTGS1
prostaglandin-endoperoxide synthase 1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTGS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of PTGS1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTGS1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTGS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTGS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTPN11 mRNA
CTD
PMID:26378955
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
G
PTPN14
protein tyrosine phosphatase non-receptor type 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTPN14 mRNA
CTD
PMID:21641980
NCBI chr 1:214,348,700...214,551,602
Ensembl chr 1:214,348,700...214,552,449
G
PTPN2
protein tyrosine phosphatase non-receptor type 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTPN2 mRNA
CTD
PMID:21641980
NCBI chr18:12,785,478...12,884,237
Ensembl chr18:12,785,478...12,929,643
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTPN22 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTPN22 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
PTPRC
protein tyrosine phosphatase receptor type C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTPRC mRNA
CTD
PMID:21641980
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,757,476
G
PUS3
pseudouridine synthase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PUS3 mRNA
CTD
PMID:21641980
NCBI chr11:125,893,485...125,903,206
Ensembl chr11:125,893,485...125,903,221
G
PXK
PX domain containing serine/threonine kinase like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PXK mRNA
CTD
PMID:21641980
NCBI chr 3:58,332,892...58,426,127
Ensembl chr 3:58,332,880...58,426,127
G
PXMP4
peroxisomal membrane protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PXMP4 mRNA
CTD
PMID:21641980
NCBI chr20:33,702,758...33,720,310
Ensembl chr20:33,702,758...33,720,319
G
QPCT
glutaminyl-peptide cyclotransferase
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of QPCT mRNA
CTD
PMID:26378955
NCBI chr 2:37,344,630...37,373,322
Ensembl chr 2:37,342,827...37,373,322
G
QSER1
glutamine and serine rich 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of QSER1 mRNA
CTD
PMID:21641980
NCBI chr11:32,892,811...32,980,270
Ensembl chr11:32,892,811...32,993,316
G
RAB14
RAB14, member RAS oncogene family
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAB14 mRNA
CTD
PMID:21641980
NCBI chr 9:121,178,133...121,201,869
Ensembl chr 9:121,178,133...121,223,014
G
RAB6A
RAB6A, member RAS oncogene family
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RAB6A mRNA
CTD
PMID:26378955
NCBI chr11:73,675,638...73,761,074
Ensembl chr11:73,675,638...73,761,137
G
RAD18
RAD18 E3 ubiquitin protein ligase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAD18 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RAD18 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:8,877,075...8,963,472
Ensembl chr 3:8,775,402...8,963,773
G
RAD54L
RAD54 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAD54L mRNA
CTD
PMID:21641980
NCBI chr 1:46,247,688...46,278,473
Ensembl chr 1:46,246,461...46,278,480
G
RASA2
RAS p21 protein activator 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RASA2 mRNA
CTD
PMID:26378955
NCBI chr 3:141,487,027...141,615,344
Ensembl chr 3:141,487,027...141,615,344
G
RASGRP3
RAS guanyl releasing protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASGRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASGRP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:33,436,348...33,564,731
Ensembl chr 2:33,436,324...33,564,750
G
RASSF1
Ras association domain family member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASSF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:50,329,788...50,340,836
Ensembl chr 3:50,329,782...50,340,980
G
RASSF2
Ras association domain family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF2 mRNA
CTD
PMID:21641980
NCBI chr20:4,780,023...4,823,608
Ensembl chr20:4,780,023...4,823,608
G
RASSF4
Ras association domain family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF4 mRNA
CTD
PMID:21641980
NCBI chr10:44,959,802...44,995,891
Ensembl chr10:44,959,407...44,995,891
G
RASSF8
Ras association domain family member 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF8 mRNA
CTD
PMID:21641980
NCBI chr12:25,958,232...26,079,889
Ensembl chr12:25,958,232...26,079,892
G
RBBP4
RB binding protein 4, chromatin remodeling factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBBP4 mRNA
CTD
PMID:21641980
NCBI chr 1:32,651,208...32,686,211
Ensembl chr 1:32,651,142...32,686,211
G
RBBP6
RB binding protein 6, ubiquitin ligase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RBBP6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RBBP6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:24,539,566...24,572,863
Ensembl chr16:24,537,693...24,572,863
G
RBBP8
RB binding protein 8, endonuclease
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBBP8 mRNA
CTD
PMID:21641980
NCBI chr18:22,914,139...23,026,486
Ensembl chr18:22,798,261...23,026,488
G
RBFOX1
RNA binding fox-1 homolog 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBFOX1 mRNA
CTD
PMID:21641980
NCBI chr16:5,239,721...7,713,340
Ensembl chr16:5,239,802...7,713,340
G
RBL1
RB transcriptional corepressor like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA
CTD
PMID:21641980
NCBI chr20:36,996,349...37,095,997
Ensembl chr20:36,996,349...37,095,997
G
RBM25
RNA binding motif protein 25
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM25 mRNA
CTD
PMID:21641980
NCBI chr14:73,058,534...73,123,899
Ensembl chr14:73,058,532...73,123,899
G
RBM26
RNA binding motif protein 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM26 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM26 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:79,311,827...79,406,255
Ensembl chr13:79,311,824...79,406,477
G
RBM3
RNA binding motif protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM3 mRNA
CTD
PMID:21641980
NCBI chr X:48,574,484...48,581,162
Ensembl chr X:48,574,449...48,581,162
G
RBM39
RNA binding motif protein 39
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM39 mRNA
CTD
PMID:21641980
NCBI chr20:35,701,347...35,742,260
Ensembl chr20:35,701,347...35,742,312
G
RBM5
RNA binding motif protein 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:50,088,919...50,119,021
Ensembl chr 3:50,088,919...50,119,021
G
RC3H2
ring finger and CCCH-type domains 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RC3H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RC3H2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RC3H2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:122,844,556...122,905,359
Ensembl chr 9:122,844,556...122,905,359
G
RCAN1
regulator of calcineurin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RCAN1 mRNA
CTD
PMID:21641980
NCBI chr21:34,516,442...34,615,113
Ensembl chr21:34,513,142...34,615,113
G
RCN2
reticulocalbin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RCN2 mRNA
CTD
PMID:26378955
NCBI chr15:76,931,749...76,954,393
Ensembl chr15:76,931,738...76,954,393
G
REEP3
receptor accessory protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of REEP3 mRNA
CTD
PMID:21641980
NCBI chr10:63,521,401...63,625,128
Ensembl chr10:63,521,401...63,625,128
G
RELB
RELB proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RELB mRNA
CTD
PMID:21641980
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
G
REST
RE1 silencing transcription factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REST mRNA
CTD
PMID:26378955
NCBI chr 4:56,907,900...56,935,844
Ensembl chr 4:56,907,876...56,966,808
G
REV3L
REV3 like, DNA directed polymerase zeta catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of REV3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REV3L mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:111,299,033...111,483,711
Ensembl chr 6:111,299,028...111,483,715
G
RFTN2
raftlin family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RFTN2 mRNA
CTD
PMID:21641980
NCBI chr 2:197,568,224...197,675,587
Ensembl chr 2:197,568,224...197,676,045
G
RFX7
regulatory factor X7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RFX7 mRNA
CTD
PMID:21641980
NCBI chr15:56,087,280...56,245,082
Ensembl chr15:56,087,280...56,245,082
G
RGS16
regulator of G protein signaling 16
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS16 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RGS16 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389
G
RGS18
regulator of G protein signaling 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS18 mRNA
CTD
PMID:21641980
NCBI chr 1:192,158,462...192,185,815
Ensembl chr 1:192,158,462...192,185,815
G
RHEB
Ras homolog, mTORC1 binding
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RHEB mRNA
CTD
PMID:26378955
NCBI chr 7:151,466,012...151,519,895
Ensembl chr 7:151,466,012...151,520,120
G
RHOC
ras homolog family member C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOC mRNA
CTD
PMID:21641980
NCBI chr 1:112,701,131...112,707,408
Ensembl chr 1:112,701,127...112,707,434
G
RHOF
ras homolog family member F, filopodia associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RHOF mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOF mRNA
CTD
PMID:21641980
NCBI chr12:121,777,754...121,793,688
Ensembl chr12:121,777,754...121,803,403
G
RHOQ
ras homolog family member Q
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RHOQ mRNA
CTD
PMID:21641980
NCBI chr 2:46,542,490...46,584,688
Ensembl chr 2:46,541,806...46,584,688
G
RHOV
ras homolog family member V
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RHOV mRNA
CTD
PMID:26378955
NCBI chr15:40,872,214...40,874,234
Ensembl chr15:40,872,214...40,874,234
G
RIF1
replication timing regulatory factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RIF1 mRNA
CTD
PMID:21641980
NCBI chr 2:151,409,902...151,534,435
Ensembl chr 2:151,409,883...151,508,013
G
RIGI
RNA sensor RIG-I
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIGI mRNA [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RIGI mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIGI mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348
G
RILPL2
Rab interacting lysosomal protein like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RILPL2 mRNA
CTD
PMID:21641980
NCBI chr12:123,409,306...123,436,684
Ensembl chr12:123,415,039...123,436,684
G
RIMKLB
ribosomal modification protein rimK like family member B
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RIMKLB mRNA
CTD
PMID:26378955
NCBI chr12:8,668,638...8,783,091
Ensembl chr12:8,681,600...8,783,095
G
RIMS2
regulating synaptic membrane exocytosis 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIMS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:103,500,610...104,256,094
Ensembl chr 8:103,500,610...104,254,430
G
RIN1
Ras and Rab interactor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RIN1 mRNA
CTD
PMID:21641980
NCBI chr11:66,330,241...66,336,774
Ensembl chr11:66,330,241...66,336,840
G
RMND1
required for meiotic nuclear division 1 homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RMND1 mRNA
CTD
PMID:21641980
NCBI chr 6:151,404,762...151,452,126
Ensembl chr 6:151,398,898...151,452,158
G
RMND5A
required for meiotic nuclear division 5 homolog A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RMND5A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RMND5A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:86,720,291...86,778,041
Ensembl chr 2:86,720,291...86,778,041
G
RNASE1
ribonuclease A family member 1, pancreatic
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNASE1 mRNA
CTD
PMID:26378955
NCBI chr14:20,801,228...20,802,844
Ensembl chr14:20,801,228...20,802,855
G
RNASE4
ribonuclease A family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RNASE4 mRNA
CTD
PMID:21641980
NCBI chr14:20,684,560...20,701,216
Ensembl chr14:20,684,560...20,701,216
G
RNF122
ring finger protein 122
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF122 mRNA
CTD
PMID:26378955
NCBI chr 8:33,547,754...33,567,128
Ensembl chr 8:33,547,754...33,567,128
G
RNF144B
ring finger protein 144B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RNF144B mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RNF144B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:18,387,350...18,468,870
Ensembl chr 6:18,387,350...18,468,870
G
RNF183
ring finger protein 183
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF183 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF183 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:113,297,093...113,303,376
Ensembl chr 9:113,297,093...113,303,376
G
RNF19B
ring finger protein 19B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF19B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF19B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809
G
RNF213
ring finger protein 213
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF213 mRNA
CTD
PMID:26378955
NCBI chr17:80,260,852...80,398,794
Ensembl chr17:80,260,852...80,398,794
G
RNF24
ring finger protein 24
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF24 mRNA
CTD
PMID:26378955
NCBI chr20:3,927,311...4,015,558
Ensembl chr20:3,927,309...4,015,558
G
RNF38
ring finger protein 38
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF38 mRNA
CTD
PMID:26378955
NCBI chr 9:36,336,400...36,487,669
Ensembl chr 9:36,336,396...36,487,548
G
RNF39
ring finger protein 39
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF39 mRNA
CTD
PMID:26378955
NCBI chr 6:30,070,270...30,075,769
Ensembl chr 6:30,070,266...30,075,849
G
RNF44
ring finger protein 44
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF44 mRNA
CTD
PMID:26378955
NCBI chr 5:176,526,712...176,543,513
Ensembl chr 5:176,526,712...176,538,025
G
RNF6
ring finger protein 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF6 mRNA
CTD
PMID:26378955
NCBI chr13:26,132,115...26,223,085
Ensembl chr13:26,132,115...26,222,314
G
RO60
Ro60, Y RNA binding protein
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RO60 mRNA
CTD
PMID:26378955
NCBI chr 1:193,059,612...193,091,777
Ensembl chr 1:193,059,454...193,091,777
G
ROCK1
Rho associated coiled-coil containing protein kinase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ROCK1 mRNA
CTD
PMID:26378955
NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813
G
RP2
RP2 activator of ARL3 GTPase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RP2 mRNA
CTD
PMID:21641980
NCBI chr X:46,837,043...46,882,358
Ensembl chr X:46,837,043...46,882,358
G
RPL30
ribosomal protein L30
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL30 mRNA
CTD
PMID:21641980
NCBI chr 8:98,041,721...98,045,545
Ensembl chr 8:98,024,851...98,046,469
G
RPL37
ribosomal protein L37
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RPL37 mRNA
CTD
PMID:26378955
NCBI chr 5:40,825,262...40,835,222
Ensembl chr 5:40,825,262...40,835,222
G
RPL37A
ribosomal protein L37a
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RPL37A mRNA
CTD
PMID:26378955
NCBI chr 2:216,498,844...216,504,086
Ensembl chr 2:216,498,825...216,579,180
G
RPL5
ribosomal protein L5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL5 mRNA
CTD
PMID:21641980
NCBI chr 1:92,831,986...92,841,924
Ensembl chr 1:92,832,013...92,841,924
G
RPS17
ribosomal protein S17
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS17 mRNA
CTD
PMID:21641980
NCBI chr15:82,536,750...82,540,457
Ensembl chr15:82,536,750...82,540,459
G
RPS24
ribosomal protein S24
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS24 mRNA
CTD
PMID:21641980
NCBI chr10:78,033,863...78,056,806
Ensembl chr10:78,033,760...78,056,813
G
RPS27L
ribosomal protein S27 like
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RPS27L mRNA
CTD
PMID:26378955
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
G
RPS6KA2
ribosomal protein S6 kinase A2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RPS6KA2 mRNA
CTD
PMID:21641980
NCBI chr 6:166,409,364...166,862,773
Ensembl chr 6:166,409,364...166,906,451
G
RPS6KA5
ribosomal protein S6 kinase A5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA
CTD
PMID:21641980
NCBI chr14:90,847,861...91,060,641
Ensembl chr14:90,847,861...91,060,641
G
RPS6KB1
ribosomal protein S6 kinase B1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KB1 mRNA
CTD
PMID:21641980
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
RRM2B
ribonucleotide reductase regulatory TP53 inducible subunit M2B
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RRM2B mRNA
CTD
PMID:26378955
NCBI chr 8:102,204,501...102,238,961
Ensembl chr 8:102,204,502...102,238,961
G
RSAD2
radical S-adenosyl methionine domain containing 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RSAD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RSAD2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239
G
RSC1A1
regulator of solute carriers 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RSC1A1 mRNA
CTD
PMID:21641980
NCBI chr 1:15,659,713...15,662,033
Ensembl chr 1:15,659,713...15,662,033
G
RSF1
remodeling and spacing factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RSF1 mRNA
CTD
PMID:26378955
NCBI chr11:77,660,009...77,872,232
Ensembl chr11:77,660,009...77,820,869
G
RSPO3
R-spondin 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RSPO3 mRNA
CTD
PMID:26378955
NCBI chr 6:127,118,671...127,199,481
Ensembl chr 6:127,118,671...127,199,481
G
RSRC2
arginine and serine rich coiled-coil 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RSRC2 mRNA
CTD
PMID:21641980
NCBI chr12:122,503,454...122,526,936
Ensembl chr12:122,503,454...122,527,000
G
RTEL1
regulator of telomere elongation helicase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RTEL1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RTEL1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:63,657,810...63,696,253
Ensembl chr20:63,657,810...63,696,253
G
RTN1
reticulon 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RTN1 mRNA
CTD
PMID:26378955
NCBI chr14:59,595,976...59,870,776
Ensembl chr14:59,595,976...59,870,776
G
RTN4
reticulon 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RTN4 mRNA
CTD
PMID:21641980
NCBI chr 2:54,972,189...55,137,831
Ensembl chr 2:54,972,187...55,112,621
G
RTP4
receptor transporter protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RTP4 mRNA
CTD
PMID:21641980
NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076
G
RUFY3
RUN and FYVE domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUFY3 mRNA
CTD
PMID:21641980
NCBI chr 4:70,703,767...70,808,619
Ensembl chr 4:70,704,204...70,808,619
G
RUNX2
RUNX family transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUNX2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RUNX2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
G
S100A10
S100 calcium binding protein A10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of S100A10 mRNA
CTD
PMID:21641980
NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
G
S100A8
S100 calcium binding protein A8
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of S100A8 mRNA
CTD
PMID:26378955
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of S100A9 mRNA
CTD
PMID:26378955
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
SAA3P
serum amyloid A3, pseudogene
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAA3 mRNA
CTD
PMID:21641980
NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132 Ensembl chr11:18,112,472...18,116,132
G
SACM1L
SAC1 like phosphatidylinositide phosphatase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACM1L mRNA
CTD
PMID:21641980
NCBI chr 3:45,689,396...45,745,409
Ensembl chr 3:45,689,056...45,745,412
G
SACS
sacsin molecular chaperone
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACS mRNA
CTD
PMID:21641980
NCBI chr13:23,328,830...23,433,702
Ensembl chr13:23,288,689...23,433,763
G
SAMD9L
sterile alpha motif domain containing 9 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAMD9L mRNA
CTD
PMID:21641980
NCBI chr 7:93,130,056...93,148,385
Ensembl chr 7:93,130,056...93,148,385
G
SAMHD1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SAMHD1 mRNA
CTD
PMID:26378955
NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
G
SAP18
Sin3A associated protein 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SAP18 mRNA
CTD
PMID:21641980
NCBI chr13:21,140,119...21,149,097
Ensembl chr13:21,140,119...21,149,097
G
SAP30L
SAP30 like
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SAP30L mRNA
CTD
PMID:26378955
NCBI chr 5:154,445,997...154,461,053
Ensembl chr 5:154,445,997...154,461,053
G
SAPCD1
suppressor APC domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAPCD1 mRNA
CTD
PMID:21641980
NCBI chr 6:31,762,656...31,764,850
Ensembl chr 6:31,762,656...31,764,850
G
SASH3
SAM and SH3 domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SASH3 mRNA
CTD
PMID:21641980
NCBI chr X:129,779,949...129,795,201
Ensembl chr X:129,779,949...129,795,201
G
SC5D
sterol-C5-desaturase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SC5D mRNA
CTD
PMID:21641980
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
G
SCAPER
S-phase cyclin A associated protein in the ER
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SCAPER mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SCAPER mRNA
CTD
PMID:26378955
NCBI chr15:76,347,904...76,905,340
Ensembl chr15:76,347,904...76,905,444
G
SCD
stearoyl-CoA desaturase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SCD2 mRNA
CTD
PMID:21641980
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SCIN
scinderin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SCIN mRNA
CTD
PMID:21641980
NCBI chr 7:12,570,720...12,660,182
Ensembl chr 7:12,570,577...12,660,182
G
SCYL3
SCY1 like pseudokinase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SCYL3 mRNA
CTD
PMID:21641980
NCBI chr 1:169,849,631...169,894,268
Ensembl chr 1:169,849,631...169,894,267
G
SDC3
syndecan 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SDC3 mRNA
CTD
PMID:21641980
NCBI chr 1:30,869,466...30,909,735
Ensembl chr 1:30,869,466...30,908,758
G
SDC4
syndecan 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SDC4 mRNA
CTD
PMID:21641980
NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,424
G
SELENBP1
selenium binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENBP1 mRNA
CTD
PMID:21641980
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SELENOW
selenoprotein W
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENOW mRNA
CTD
PMID:21641980
NCBI chr19:47,778,703...47,784,682
Ensembl chr19:47,778,677...47,784,686
G
SEMA3E
semaphorin 3E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA3E mRNA
CTD
PMID:21641980
NCBI chr 7:83,363,238...83,649,139
Ensembl chr 7:83,363,238...83,649,139
G
SEMA4A
semaphorin 4A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA4A mRNA
CTD
PMID:21641980
NCBI chr 1:156,147,373...156,177,744
Ensembl chr 1:156,147,366...156,177,752
G
SEMA4C
semaphorin 4C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4C mRNA
CTD
PMID:21641980
NCBI chr 2:96,859,718...96,870,830
Ensembl chr 2:96,859,718...96,870,757
G
SEMA4G
semaphorin 4G
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4G mRNA
CTD
PMID:21641980
NCBI chr10:100,969,504...100,985,616
Ensembl chr10:100,969,504...100,985,871
G
SEMA5A
semaphorin 5A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA5A mRNA
CTD
PMID:21641980
NCBI chr 5:9,035,033...9,546,075
Ensembl chr 5:9,035,033...9,546,075
G
SEMA7A
semaphorin 7A (JohnMiltonHagen blood group)
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA7A mRNA
CTD
PMID:21641980
NCBI chr15:74,409,289...74,433,958
Ensembl chr15:74,409,289...74,433,958
G
SENP7
SUMO specific peptidase 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SENP7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SENP7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:101,324,205...101,513,212
Ensembl chr 3:101,324,205...101,513,241
G
SERBP1
SERPINE1 mRNA binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERBP1 mRNA
CTD
PMID:21641980
NCBI chr 1:67,407,810...67,430,402
Ensembl chr 1:67,407,810...67,430,415
G
SERINC2
serine incorporator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERINC2 mRNA
CTD
PMID:21641980
NCBI chr 1:31,409,777...31,434,678
Ensembl chr 1:31,409,565...31,434,680
G
SERINC3
serine incorporator 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERINC3 mRNA
CTD
PMID:21641980
NCBI chr20:44,496,221...44,522,070
Ensembl chr20:44,496,221...44,522,085
G
SERPINA1
serpin family A member 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINA1 mRNA
CTD
PMID:26378955
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SERPINA7
serpin family A member 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINA7 mRNA
CTD
PMID:26378955
NCBI chr X:106,032,435...106,038,727
Ensembl chr X:106,032,435...106,038,727
G
SERPINB12
serpin family B member 12
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINB12 mRNA
CTD
PMID:26378955
NCBI chr18:63,519,110...63,569,329
Ensembl chr18:63,542,369...63,569,329
G
SERPINB5
serpin family B member 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB5 mRNA
CTD
PMID:26378955
NCBI chr18:63,476,958...63,505,085
Ensembl chr18:63,476,958...63,505,085
G
SERPINB8
serpin family B member 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERPINB8 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINB8 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:63,970,081...64,019,779
Ensembl chr18:63,970,029...64,019,779
G
SERPINB9
serpin family B member 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:2,887,270...2,903,309
Ensembl chr 6:2,887,270...2,903,309
G
SERPIND1
serpin family D member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPIND1 mRNA
CTD
PMID:26378955
NCBI chr22:20,774,113...20,787,720
Ensembl chr22:20,774,113...20,787,720
G
SERPINE1
serpin family E member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINE1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINE1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINI1
serpin family I member 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINI1 mRNA
CTD
PMID:26378955
NCBI chr 3:167,735,721...167,825,569
Ensembl chr 3:167,735,243...167,825,569
G
SESN1
sestrin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SESN1 mRNA
CTD
PMID:21641980
NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846
G
SETD4
SET domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SETD4 mRNA
CTD
PMID:21641980
NCBI chr21:36,034,541...36,060,526
Ensembl chr21:36,034,541...36,079,389
G
SFI1
SFI1 centrin binding protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFI1 mRNA
CTD
PMID:21641980
NCBI chr22:31,496,139...31,618,588
Ensembl chr22:31,488,688...31,618,588
G
SFPQ
splicing factor proline and glutamine rich
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFPQ mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SFPQ mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:35,176,380...35,193,145
Ensembl chr 1:35,176,378...35,193,446
G
SH3GLB1
SH3 domain containing GRB2 like, endophilin B1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SH3GLB1 mRNA
CTD
PMID:21641980
NCBI chr 1:86,704,576...86,748,184
Ensembl chr 1:86,704,570...86,748,184
G
SIK3
SIK family kinase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SIK3 mRNA
CTD
PMID:21641980
NCBI chr11:116,843,402...117,098,428
Ensembl chr11:116,843,402...117,098,437
G
SKIL
SKI like proto-oncogene
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SKIL mRNA
CTD
PMID:21641980
NCBI chr 3:170,357,715...170,396,849
Ensembl chr 3:170,357,342...170,396,835
G
SLC11A1
solute carrier family 11 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC11A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC11A1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
SLC11A2
solute carrier family 11 member 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC11A2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC11A2 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC12A3
solute carrier family 12 member 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC12A3 mRNA
CTD
PMID:26378955
NCBI chr16:56,865,207...56,915,850
Ensembl chr16:56,865,207...56,915,850
G
SLC15A3
solute carrier family 15 member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC15A3 mRNA
CTD
PMID:21641980
NCBI chr11:60,937,084...60,952,176
Ensembl chr11:60,937,060...60,952,653
G
SLC16A12
solute carrier family 16 member 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A12 mRNA
CTD
PMID:23086747
NCBI chr10:89,430,299...89,556,704
Ensembl chr10:89,430,299...89,556,641
G
SLC16A4
solute carrier family 16 member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A4 mRNA
CTD
PMID:21641980
NCBI chr 1:110,362,857...110,391,026
Ensembl chr 1:110,362,851...110,391,082
G
SLC1A4
solute carrier family 1 member 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC1A4 mRNA
CTD
PMID:26378955
NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
G
SLC20A2
solute carrier family 20 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC20A2 mRNA
CTD
PMID:21641980
NCBI chr 8:42,416,475...42,541,954
Ensembl chr 8:42,416,475...42,541,926
G
SLC22A4
solute carrier family 22 member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC22A4 mRNA
CTD
PMID:21641980
NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,294,394...132,344,190
G
SLC25A23
solute carrier family 25 member 23
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC25A23 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC25A23 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr19:6,436,081...6,459,792
Ensembl chr19:6,436,079...6,465,203
G
SLC25A26
solute carrier family 25 member 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC25A26 mRNA
CTD
PMID:23086747
NCBI chr 3:66,133,610...66,378,927
Ensembl chr 3:66,133,610...66,388,116
G
SLC28A2
solute carrier family 28 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC28A2 mRNA
CTD
PMID:21641980
NCBI chr15:45,252,234...45,277,846
Ensembl chr15:45,252,234...45,277,846
G
SLC31A2
solute carrier family 31 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC31A2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC31A2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:113,151,007...113,164,140
Ensembl chr 9:113,150,976...113,164,140
G
SLC38A2
solute carrier family 38 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC38A2 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr12:46,358,188...46,372,773
Ensembl chr12:46,358,188...46,372,773
G
SLC40A1
solute carrier family 40 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC40A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC40A1 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,590...189,583,758
G
SLC44A1
solute carrier family 44 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC44A1 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 9:105,244,651...105,438,504
Ensembl chr 9:105,244,622...105,439,171
G
SLC48A1
solute carrier family 48 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC48A1 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr12:47,753,934...47,782,751
Ensembl chr12:47,753,916...47,782,751
G
SLC4A7
solute carrier family 4 member 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC4A7 mRNA
CTD
PMID:21641980
NCBI chr 3:27,372,723...27,484,384
Ensembl chr 3:27,372,723...27,484,420
G
SLC5A3
solute carrier family 5 member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC5A3 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr21:34,073,578...34,106,260
Ensembl chr21:34,073,578...34,106,260
G
SLC6A12
solute carrier family 6 member 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A12 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr12:183,848...214,157
Ensembl chr12:190,077...214,570
G
SLC6A13
solute carrier family 6 member 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A13 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr12:220,622...262,836
Ensembl chr12:220,621...262,873
G
SLC7A11
solute carrier family 7 member 11
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC7A11 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC7A11 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC8A1
solute carrier family 8 member A1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC8A1 mRNA
CTD
PMID:26378955
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
G
SLC9B2
solute carrier family 9 member B2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC9B2 mRNA
CTD
PMID:21641980
NCBI chr 4:103,018,029...103,077,319
Ensembl chr 4:103,019,868...103,085,829
G
SLCO4A1
solute carrier organic anion transporter family member 4A1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLCO4A1 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr20:62,642,503...62,690,740
Ensembl chr20:62,642,503...62,685,785
G
SLF1
SMC5-SMC6 complex localization factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLF1 mRNA
CTD
PMID:21641980
NCBI chr 5:94,618,231...94,697,621
Ensembl chr 5:94,618,669...94,739,436
G
SLFN11
schlafen family member 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLFN9 mRNA
CTD
PMID:21641980
NCBI chr17:35,350,305...35,373,621
Ensembl chr17:35,350,305...35,373,701
G
SLPI
secretory leukocyte peptidase inhibitor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLPI mRNA
CTD
PMID:21641980
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SLTM
SAFB like transcription modulator
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLTM mRNA
CTD
PMID:21641980
NCBI chr15:58,879,050...58,933,679
Ensembl chr15:58,879,050...58,933,679
G
SMAD6
SMAD family member 6
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMAD6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:66,702,236...66,782,849
Ensembl chr15:66,702,236...66,782,849
G
SMAD7
SMAD family member 7
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD7 mRNA
CTD
PMID:26378955
NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,950,965
G
SMAD9
SMAD family member 9
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD9 mRNA
CTD
PMID:26378955
NCBI chr13:36,844,831...36,920,854
Ensembl chr13:36,844,831...36,920,887
G
SMC2
structural maintenance of chromosomes 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC2 mRNA
CTD
PMID:21641980
NCBI chr 9:104,088,263...104,141,419
Ensembl chr 9:104,094,260...104,141,419
G
SMC6
structural maintenance of chromosomes 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC6 mRNA
CTD
PMID:21641980
NCBI chr 2:17,663,812...17,753,810
Ensembl chr 2:17,663,812...17,800,242
G
SMG1
SMG1 nonsense mediated mRNA decay associated PI3K related kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMG1 mRNA
CTD
PMID:26378955
NCBI chr16:18,804,860...18,926,408
Ensembl chr16:18,804,860...18,926,408
G
SMOC1
SPARC related modular calcium binding 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMOC1 mRNA
CTD
PMID:26378955
NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366
G
SMPD4
sphingomyelin phosphodiesterase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMPD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMPD4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:130,151,392...130,181,757
Ensembl chr 2:130,151,392...130,182,750
G
SMYD4
SET and MYND domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SMYD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SMYD4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:1,779,485...1,829,902
Ensembl chr17:1,779,485...1,830,634
G
SNAI2
snail family transcriptional repressor 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SNAI2 mRNA
CTD
PMID:26378955
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
G
SNAP23
synaptosome associated protein 23
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SNAP23 mRNA
CTD
PMID:26378955
NCBI chr15:42,491,129...42,533,058
Ensembl chr15:42,491,233...42,545,356
G
SNORD123
small nucleolar RNA, C/D box 123
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SNORD123 mRNA
CTD
PMID:21641980
NCBI chr 5:9,548,827...9,548,914
Ensembl chr 5:9,548,836...9,548,905
G
SNTA1
syntrophin alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SNTA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SNTA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:33,407,957...33,443,763
Ensembl chr20:33,407,957...33,443,763
G
SNX24
sorting nexin 24
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SNX24 mRNA
CTD
PMID:21641980
NCBI chr 5:122,845,613...123,029,318
Ensembl chr 5:122,843,439...123,029,354
G
SOAT1
sterol O-acyltransferase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SOAT1 mRNA
CTD
PMID:21641980
NCBI chr 1:179,293,797...179,358,680
Ensembl chr 1:179,293,714...179,358,680
G
SOCS3
suppressor of cytokine signaling 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SOCS3 mRNA
CTD
PMID:21641980
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
G
SOD2
superoxide dismutase 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SOD2 mRNA
CTD
PMID:26378955
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SORBS2
sorbin and SH3 domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SORBS2 mRNA
CTD
PMID:26378955
NCBI chr 4:185,585,523...185,956,372
Ensembl chr 4:185,585,444...185,956,652
G
SORD
sorbitol dehydrogenase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SORD mRNA
CTD
PMID:26378955
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
G
SORL1
sortilin related receptor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SORL1 mRNA
CTD
PMID:26378955
NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
G
SPAG9
sperm associated antigen 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPAG9 mRNA
CTD
PMID:21641980
NCBI chr17:50,962,174...51,120,868
Ensembl chr17:50,962,174...51,120,868
G
SPATA13
spermatogenesis associated 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPATA13 mRNA
CTD
PMID:21641980
NCBI chr13:23,979,802...24,307,069
Ensembl chr13:23,979,805...24,307,074 Ensembl chr13:23,979,805...24,307,074
G
SPDL1
spindle apparatus coiled-coil protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPDL1 mRNA
CTD
PMID:21641980
NCBI chr 5:169,583,773...169,604,778
Ensembl chr 5:169,583,636...169,604,778
G
SPP1
secreted phosphoprotein 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPP1 mRNA
CTD
PMID:26378955
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPRY2
sprouty RTK signaling antagonist 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPRY2 mRNA
CTD
PMID:26378955
NCBI chr13:80,335,976...80,341,126
Ensembl chr13:80,335,976...80,341,126
G
SQOR
sulfide quinone oxidoreductase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQOR mRNA
CTD
PMID:21641980
NCBI chr15:45,631,148...45,691,281
Ensembl chr15:45,631,148...45,691,281
G
SQSTM1
sequestosome 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQSTM1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SQSTM1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRC mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SRC mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
G
SREK1
splicing regulatory glutamic acid and lysine rich protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SREK1 mRNA
CTD
PMID:21641980
NCBI chr 5:66,144,300...66,183,615
Ensembl chr 5:66,139,971...66,183,615
G
SRPK2
SRSF protein kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRPK2 mRNA
CTD
PMID:21641980
NCBI chr 7:105,114,740...105,399,357
Ensembl chr 7:105,110,704...105,399,308
G
SRSF10
serine and arginine rich splicing factor 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRSF10 mRNA
CTD
PMID:21641980
NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
G
SRSF3
serine and arginine rich splicing factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFRS3 mRNA
CTD
PMID:21641980
NCBI chr 6:36,594,362...36,605,600
Ensembl chr 6:36,594,353...36,605,600
G
SRSF7
serine and arginine rich splicing factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRSF7 mRNA
CTD
PMID:21641980
NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494
G
SRXN1
sulfiredoxin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRXN1 mRNA
CTD
PMID:21641980
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
SSB
small RNA binding exonuclease protection factor La
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SSB mRNA
CTD
PMID:21641980
NCBI chr 2:169,798,871...169,812,064
Ensembl chr 2:169,791,933...169,812,064
G
SSR1
signal sequence receptor subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SSR1 mRNA
CTD
PMID:21641980
NCBI chr 6:7,281,143...7,313,199
Ensembl chr 6:7,268,306...7,347,446
G
ST18
ST18 C2H2C-type zinc finger transcription factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST18 mRNA
CTD
PMID:26378955
NCBI chr 8:52,110,838...52,409,879
Ensembl chr 8:52,110,838...52,460,959
G
ST3GAL1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST3GAL1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:133,454,848...133,571,887
Ensembl chr 8:133,454,848...133,571,926
G
ST3GAL6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL6 mRNA
CTD
PMID:21641980
NCBI chr 3:98,732,262...98,795,852
Ensembl chr 3:98,732,236...98,821,201
G
ST6GAL1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ST6GAL1 mRNA
CTD
PMID:21641980
NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,553
G
ST8SIA4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ST8SIA4 mRNA
CTD
PMID:21641980
NCBI chr 5:100,806,933...100,903,282
Ensembl chr 5:100,806,933...100,903,282
G
STAC2
SH3 and cysteine rich domain 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAC2 mRNA
CTD
PMID:26378955
NCBI chr17:39,210,541...39,225,945
Ensembl chr17:39,210,541...39,225,945
G
STARD4
StAR related lipid transfer domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STARD4 mRNA
CTD
PMID:21641980
NCBI chr 5:111,496,033...111,512,535
Ensembl chr 5:111,496,033...111,512,590
G
STARD9
StAR related lipid transfer domain containing 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STARD9 mRNA
CTD
PMID:21641980
NCBI chr15:42,575,606...42,720,998
Ensembl chr15:42,575,606...42,720,998
G
STAT2
signal transducer and activator of transcription 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAT2 mRNA
CTD
PMID:26378955
NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203
G
STC2
stanniocalcin 2
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STC2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STC2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447
G
STEAP4
STEAP4 metalloreductase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STEAP4 mRNA
CTD
PMID:26378955
NCBI chr 7:88,270,892...88,306,894
Ensembl chr 7:88,270,892...88,306,894
G
STK26
serine/threonine kinase 26
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STK26 mRNA
CTD
PMID:26378955
NCBI chr X:132,023,302...132,075,943
Ensembl chr X:132,023,302...132,075,943
G
STRN3
striatin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STRN3 mRNA
CTD
PMID:21641980
NCBI chr14:30,893,804...31,026,379
Ensembl chr14:30,893,799...31,026,401
G
STX11
syntaxin 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of STX11 mRNA
CTD
PMID:21641980
NCBI chr 6:144,139,963...144,191,939
Ensembl chr 6:144,150,487...144,191,939
G
STXBP4
syntaxin binding protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP4 mRNA
CTD
PMID:21641980
NCBI chr17:54,968,765...55,213,273
Ensembl chr17:54,968,727...55,173,632
G
STXBP5
syntaxin binding protein 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP5 mRNA
CTD
PMID:21641980
NCBI chr 6:147,204,417...147,390,473
Ensembl chr 6:147,204,180...147,391,010
G
SULF2
sulfatase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SULF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SULF2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:47,657,406...47,786,627
Ensembl chr20:47,656,197...47,786,616
G
SUV39H2
SUV39H2 histone lysine methyltransferase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUV39H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SUV39H2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:14,878,866...14,904,315
Ensembl chr10:14,878,820...14,904,315
G
SUZ12
SUZ12 polycomb repressive complex 2 subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUZ12 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SUZ12 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:31,937,007...32,001,038
Ensembl chr17:31,937,007...32,001,038
G
SYN1
synapsin I
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SYN1 mRNA
CTD
PMID:21641980
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,857
G
SYNCRIP
synaptotagmin binding cytoplasmic RNA interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SYNCRIP mRNA
CTD
PMID:21641980
NCBI chr 6:85,607,784...85,643,870
Ensembl chr 6:85,607,779...85,644,063
G
SYTL4
synaptotagmin like 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SYTL4 mRNA
CTD
PMID:26378955
NCBI chr X:100,674,491...100,732,121
Ensembl chr X:100,671,783...100,732,123
G
TAF15
TATA-box binding protein associated factor 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF15 mRNA
CTD
PMID:21641980
NCBI chr17:35,809,484...35,847,242
Ensembl chr17:35,809,482...35,864,615
G
TAF1D
TATA-box binding protein associated factor, RNA polymerase I subunit D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF1D mRNA
CTD
PMID:21641980
NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391
G
TAFA3
TAFA chemokine like family member 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TAFA3 mRNA
CTD
PMID:26378955
NCBI chr 1:112,718,905...112,727,235
Ensembl chr 1:112,718,905...112,727,235
G
TANK
TRAF family member associated NFKB activator
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TANK mRNA
CTD
PMID:26378955
NCBI chr 2:161,136,963...161,236,230
Ensembl chr 2:161,136,908...161,236,230
G
TAP1
transporter 1, ATP binding cassette subfamily B member
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TAP1 mRNA
CTD
PMID:21641980
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TARDBP
TAR DNA binding protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TARDBP mRNA
CTD
PMID:21641980
NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
G
TATDN3
TatD DNase domain containing 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TATDN3 mRNA
CTD
PMID:26378955
NCBI chr 1:212,791,894...212,816,830
Ensembl chr 1:212,791,828...212,816,830
G
TBC1D4
TBC1 domain family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D4 mRNA
CTD
PMID:21641980
NCBI chr13:75,283,503...75,482,169
Ensembl chr13:75,283,503...75,482,169
G
TBC1D5
TBC1 domain family member 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D5 mRNA
CTD
PMID:21641980
NCBI chr 3:17,157,162...17,742,631
Ensembl chr 3:17,157,162...18,444,817
G
TBC1D8B
TBC1 domain family member 8B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D8B mRNA
CTD
PMID:21641980
NCBI chr X:106,802,673...106,876,150
Ensembl chr X:106,802,673...106,876,150
G
TBXAS1
thromboxane A synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TBXAS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TBXAS1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TCAM1P
testicular cell adhesion molecule 1, pseudogene
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TCAM1 mRNA
CTD
PMID:21641980
NCBI chr17:63,857,016...63,864,379
Ensembl chr17:63,849,292...63,864,379 Ensembl chr17:63,849,292...63,864,379
G
TCF12
transcription factor 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TCF12 mRNA
CTD
PMID:21641980
NCBI chr15:56,918,090...57,291,310
Ensembl chr15:56,918,623...57,299,281
G
TCF4
transcription factor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TCF4 mRNA
CTD
PMID:21641980
NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
G
TCN2
transcobalamin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TCN2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TCN2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr22:30,607,174...30,627,271
Ensembl chr22:30,607,003...30,627,271
G
TDO2
tryptophan 2,3-dioxygenase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TDO2 mRNA
CTD
PMID:26378955
NCBI chr 4:155,903,696...155,920,406
Ensembl chr 4:155,854,738...155,920,406
G
TERT
telomerase reverse transcriptase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TERT mRNA
CTD
PMID:26378955
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TET2
tet methylcytosine dioxygenase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TET2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of TET2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:105,145,875...105,279,803
Ensembl chr 4:105,145,875...105,279,816
G
TF
transferrin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRF mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
G
TFDP2
transcription factor Dp-2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA
CTD
PMID:21641980
NCBI chr 3:141,944,428...142,149,544
Ensembl chr 3:141,944,428...142,149,544
G
TFEC
transcription factor EC
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TFEC mRNA
CTD
PMID:21641980
NCBI chr 7:115,935,152...116,159,896
Ensembl chr 7:115,935,148...116,159,896
G
TFRC
transferrin receptor
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of TFRC mRNA; [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFRC mRNA
CTD
PMID:21641980 PMID:23086747 PMID:25522732
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
G
TGFB1
transforming growth factor beta 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFB1 mRNA
CTD
PMID:26378955
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFBR1
transforming growth factor beta receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGFBR1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFBR1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
TGFBR2
transforming growth factor beta receptor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGFBR2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFBR2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249
G
TGM2
transglutaminase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGM2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGM2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578
G
TGM5
transglutaminase 5
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGM5 mRNA
CTD
PMID:26378955
NCBI chr15:43,232,590...43,266,928
Ensembl chr15:43,232,590...43,266,928
G
THAP2
THAP domain containing 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of THAP2 mRNA
CTD
PMID:26378955
NCBI chr12:71,664,301...71,680,644
Ensembl chr12:71,664,301...71,680,644
G
THBS1
thrombospondin 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of THBS1 mRNA
CTD
PMID:26378955
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
THOC1
THO complex subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of THOC1 mRNA
CTD
PMID:21641980
NCBI chr18:214,520...268,047
Ensembl chr18:214,520...268,050
G
THOC2
THO complex subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of THOC2 mRNA
CTD
PMID:21641980
NCBI chr X:123,600,569...123,733,052
Ensembl chr X:123,600,561...123,733,056
G
TIAL1
TIA1 cytotoxic granule associated RNA binding protein like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIAL1 mRNA
CTD
PMID:21641980
NCBI chr10:119,573,465...119,596,964
Ensembl chr10:119,571,802...119,597,029
G
TIFA
TRAF interacting protein with forkhead associated domain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIFA mRNA
CTD
PMID:21641980
NCBI chr 4:112,274,537...112,285,904
Ensembl chr 4:112,272,968...112,285,955
G
TIFAB
TIFA inhibitor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIFAB mRNA
CTD
PMID:21641980
NCBI chr 5:135,444,226...135,452,351
Ensembl chr 5:135,444,226...135,452,351
G
TIMM9
translocase of inner mitochondrial membrane 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIMM9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIMM9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:58,408,494...58,427,531
Ensembl chr14:58,408,495...58,427,531
G
TIMP3
TIMP metallopeptidase inhibitor 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIMP3 mRNA
CTD
PMID:26378955
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
G
TIPARP
TCDD inducible poly(ADP-ribose) polymerase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIPARP mRNA
CTD
PMID:26378955
NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
G
TLCD2
TLC domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TLCD2 mRNA
CTD
PMID:21641980
NCBI chr17:1,702,816...1,710,377
Ensembl chr17:1,702,816...1,710,377
G
TLR4
toll like receptor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TLR4 mRNA
CTD
PMID:21641980
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR7
toll like receptor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TLR7 mRNA
CTD
PMID:21641980
NCBI chr X:12,867,072...12,890,361
Ensembl chr X:12,867,072...12,890,361
G
TM9SF3
transmembrane 9 superfamily member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TM9SF3 mRNA
CTD
PMID:21641980
NCBI chr10:96,518,110...96,587,012
Ensembl chr10:96,518,110...96,587,452
G
TMED10
transmembrane p24 trafficking protein 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMED10 mRNA
CTD
PMID:21641980
NCBI chr14:75,131,469...75,176,612
Ensembl chr14:75,131,469...75,176,612
G
TMEM140
transmembrane protein 140
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM140 mRNA
CTD
PMID:21641980
NCBI chr 7:135,148,072...135,166,215
Ensembl chr 7:135,148,072...135,166,215
G
TMEM170B
transmembrane protein 170B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM170B mRNA
CTD
PMID:21641980
NCBI chr 6:11,537,749...11,583,524
Ensembl chr 6:11,537,749...11,583,524
G
TMEM171
transmembrane protein 171
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM171 mRNA
CTD
PMID:21641980
NCBI chr 5:73,120,575...73,131,809
Ensembl chr 5:73,120,569...73,131,809
G
TMEM202
transmembrane protein 202
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM202 mRNA
CTD
PMID:21641980
NCBI chr15:72,398,305...72,408,367
Ensembl chr15:72,398,302...72,408,367
G
TMEM38B
transmembrane protein 38B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM38B mRNA
CTD
PMID:21641980
NCBI chr 9:105,694,541...105,776,629
Ensembl chr 9:105,694,541...105,776,629
G
TMEM41B
transmembrane protein 41B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM41B mRNA
CTD
PMID:21641980
NCBI chr11:9,280,654...9,314,593
Ensembl chr11:9,280,654...9,314,636
G
TMEM51
transmembrane protein 51
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM51 mRNA
CTD
PMID:21641980
NCBI chr 1:15,152,566...15,220,478
Ensembl chr 1:15,152,532...15,220,478
G
TMEM86A
transmembrane protein 86A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM86A mRNA
CTD
PMID:21641980
NCBI chr11:18,698,779...18,704,785
Ensembl chr11:18,693,122...18,704,785
G
TMPO
thymopoietin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMPO mRNA
CTD
PMID:21641980
NCBI chr12:98,515,573...98,550,351
Ensembl chr12:98,515,579...98,550,351
G
TMPRSS4
transmembrane serine protease 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TMPRSS4 mRNA
CTD
PMID:26378955
NCBI chr11:118,077,078...118,125,505
Ensembl chr11:118,077,012...118,125,510
G
TNF
tumor necrosis factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNF mRNA Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNF protein]; Succimer inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased secretion of TNF protein]
CTD
PMID:21641980 PMID:26378955 PMID:31163222 PMID:32402895
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP2
TNF alpha induced protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFAIP2 mRNA
CTD
PMID:21641980
NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439
G
TNFAIP3
TNF alpha induced protein 3
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP3 mRNA
CTD
PMID:26378955
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFAIP8
TNF alpha induced protein 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP8 mRNA
CTD
PMID:26378955
NCBI chr 5:119,268,759...119,399,688
Ensembl chr 5:119,268,692...119,399,688
G
TNFRSF12A
TNF receptor superfamily member 12A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TNFRSF12A mRNA
CTD
PMID:26378955
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF1B
TNF receptor superfamily member 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFRSF1B mRNA
CTD
PMID:21641980
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TNFSF10
TNF superfamily member 10
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF10 mRNA
CTD
PMID:26378955
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TNFSF12
TNF superfamily member 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFSF12 mRNA
CTD
PMID:21641980
NCBI chr17:7,549,058...7,557,881
Ensembl chr17:7,548,508...7,557,890
G
TNFSF13B
TNF superfamily member 13b
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF13B mRNA
CTD
PMID:26378955
NCBI chr13:108,269,629...108,308,484
Ensembl chr13:108,251,240...108,308,484
G
TNIP1
TNFAIP3 interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNIP1 mRNA
CTD
PMID:21641980
NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577
G
TNKS2
tankyrase 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNKS2 mRNA
CTD
PMID:26378955
NCBI chr10:91,798,426...91,865,475
Ensembl chr10:91,798,426...91,865,475
G
TNNC1
troponin C1, slow skeletal and cardiac type
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNNC1 mRNA
CTD
PMID:26378955
NCBI chr 3:52,451,100...52,454,041
Ensembl chr 3:52,451,100...52,454,041
G
TNRC6B
trinucleotide repeat containing adaptor 6B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TNRC6B mRNA
CTD
PMID:21641980
NCBI chr22:40,044,834...40,335,808
Ensembl chr22:40,044,817...40,335,808
G
TOP2A
DNA topoisomerase II alpha
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TOP2A mRNA
CTD
PMID:26378955
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TOPBP1
DNA topoisomerase II binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TOPBP1 mRNA
CTD
PMID:21641980
NCBI chr 3:133,600,238...133,661,941
Ensembl chr 3:133,598,175...133,662,380
G
TOX2
TOX high mobility group box family member 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TOX2 mRNA
CTD
PMID:26378955
NCBI chr20:43,914,852...44,069,616
Ensembl chr20:43,914,852...44,069,616
G
TP53
tumor protein p53
multiple interactions
ISO
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of TP53 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased phosphorylation of TP53 protein]
CTD
PMID:31163222 PMID:32402895
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TP53INP1
tumor protein p53 inducible nuclear protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRP53INP1 mRNA
CTD
PMID:21641980
NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,378
G
TPBG
trophoblast glycoprotein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TPBG mRNA
CTD
PMID:21641980
NCBI chr 6:82,362,983...82,367,420
Ensembl chr 6:82,363,206...82,367,420
G
TPD52L1
TPD52 like 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TPD52L1 mRNA
CTD
PMID:26378955
NCBI chr 6:125,153,773...125,264,407
Ensembl chr 6:125,119,049...125,264,407
G
TRAF1
TNF receptor associated factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF1 mRNA
CTD
PMID:21641980
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
G
TRAF3IP1
TRAF3 interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRAF3IP1 mRNA
CTD
PMID:21641980
NCBI chr 2:238,320,518...238,400,900
Ensembl chr 2:238,320,441...238,400,897
G
TRAF5
TNF receptor associated factor 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRAF5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:211,326,635...211,374,946
Ensembl chr 1:211,326,615...211,374,946
G
TREX1
three prime repair exonuclease 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TREX1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TREX1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:48,465,830...48,467,645
Ensembl chr 3:48,465,811...48,467,645
G
TRIM16
tripartite motif containing 16
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM16 mRNA
CTD
PMID:26378955
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
G
TRIM2
tripartite motif containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM2 mRNA
CTD
PMID:26378955
NCBI chr 4:153,152,163...153,339,317
Ensembl chr 4:153,152,163...153,339,319
G
TRIM22
tripartite motif containing 22
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM22 mRNA [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRIM30A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089
G
TRIM29
tripartite motif containing 29
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM29 mRNA
CTD
PMID:26378955
NCBI chr11:120,111,286...120,138,113
Ensembl chr11:120,111,286...120,185,529
G
TRIM37
tripartite motif containing 37
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM37 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM37 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:58,967,201...59,106,880
Ensembl chr17:58,982,638...59,106,921
G
TRIM4
tripartite motif containing 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM4 mRNA
CTD
PMID:26378955
NCBI chr 7:99,890,403...99,919,530
Ensembl chr 7:99,876,958...99,919,531
G
TRIM44
tripartite motif containing 44
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM44 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:35,662,775...35,818,007
Ensembl chr11:35,662,775...35,818,007
G
TRIM5
tripartite motif containing 5
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM5 mRNA
CTD
PMID:26378955
NCBI chr11:5,588,635...5,685,074
Ensembl chr11:5,663,195...5,938,619
G
TRIM59
tripartite motif containing 59
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM59 mRNA
CTD
PMID:26378955
NCBI chr 3:160,435,503...160,449,786
Ensembl chr 3:160,432,445...160,485,773
G
TRIM6
tripartite motif containing 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM6 mRNA
CTD
PMID:26378955
NCBI chr11:5,596,111...5,612,952
Ensembl chr11:5,596,109...5,612,958
G
TRIP11
thyroid hormone receptor interactor 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIP11 mRNA
CTD
PMID:21641980
NCBI chr14:91,965,991...92,040,059
Ensembl chr14:91,965,991...92,040,896
G
TRMT6
tRNA methyltransferase 6 non-catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRMT6 mRNA
CTD
PMID:21641980
NCBI chr20:5,937,228...5,950,533
Ensembl chr20:5,937,228...5,950,558
G
TRPC2
transient receptor potential cation channel subfamily C member 2 (pseudogene)
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRPC2 mRNA
CTD
PMID:21641980
NCBI chr11:3,626,460...3,637,559
Ensembl chr11:3,616,679...3,637,549 Ensembl chr11:3,616,679...3,637,549
G
TRPC5
transient receptor potential cation channel subfamily C member 5
increases activity
EXP
Succimer results in increased activity of TRPC5 protein
CTD
PMID:21984481
NCBI chr X:111,768,011...112,082,776
Ensembl chr X:111,768,011...112,082,776
G
TRPM7
transient receptor potential cation channel subfamily M member 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRPM7 mRNA
CTD
PMID:26378955
NCBI chr15:50,557,158...50,686,797
Ensembl chr15:50,552,473...50,686,797
G
TRPS1
transcriptional repressor GATA binding 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRPS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRPS1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:115,408,496...115,668,975
Ensembl chr 8:115,408,496...115,809,673
G
TSC22D1
TSC22 domain family member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TSC22D1 mRNA
CTD
PMID:21641980
NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147
G
TSC22D3
TSC22 domain family member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:21641980
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
G
TSHZ3
teashirt zinc finger homeobox 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TSHZ3 mRNA
CTD
PMID:26378955
NCBI chr19:31,149,876...31,350,877
Ensembl chr19:31,149,979...31,349,436
G
TSPAN14
tetraspanin 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSPAN14 mRNA
CTD
PMID:21641980
NCBI chr10:80,454,310...80,522,631
Ensembl chr10:80,454,265...80,533,124
G
TSPOAP1
TSPO associated protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TSPOAP1 mRNA
CTD
PMID:21641980
NCBI chr17:58,301,231...58,328,795
Ensembl chr17:58,301,228...58,328,795
G
TTC14
tetratricopeptide repeat domain 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC14 mRNA
CTD
PMID:21641980
NCBI chr 3:180,602,163...180,618,329
Ensembl chr 3:180,602,163...180,617,828
G
TTC3
tetratricopeptide repeat domain 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TTC3 mRNA
CTD
PMID:26378955
NCBI chr21:37,073,254...37,203,118
Ensembl chr21:37,073,226...37,203,112
G
TTC7A
tetratricopeptide repeat domain 7A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC7 mRNA
CTD
PMID:21641980
NCBI chr 2:46,915,866...47,076,123
Ensembl chr 2:46,915,869...47,076,137
G
TTLL11
tubulin tyrosine ligase like 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTLL11 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TTLL11 mRNA
CTD
PMID:21641980
NCBI chr 9:121,815,674...122,093,308
Ensembl chr 9:121,815,674...122,093,606
G
TUG1
taurine up-regulated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TUG1 mRNA
CTD
PMID:21641980
NCBI chr22:30,969,265...30,979,395
Ensembl chr22:30,969,245...30,979,395
G
TXN
thioredoxin
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXN1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TXN mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNDC15
thioredoxin domain containing 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXNDC15 mRNA
CTD
PMID:21641980
NCBI chr 5:134,873,770...134,901,635
Ensembl chr 5:134,874,371...134,901,635
G
UBA3
ubiquitin like modifier activating enzyme 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBA3 mRNA
CTD
PMID:21641980
NCBI chr 3:69,054,730...69,080,373
Ensembl chr 3:69,054,730...69,080,408
G
UBA7
ubiquitin like modifier activating enzyme 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UBA7 mRNA
CTD
PMID:21641980
NCBI chr 3:49,805,209...49,813,953
Ensembl chr 3:49,805,209...49,813,953
G
UBAP2L
ubiquitin associated protein 2 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBAP2L mRNA
CTD
PMID:21641980
NCBI chr 1:154,220,172...154,271,510
Ensembl chr 1:154,220,179...154,271,510
G
UBE2I
ubiquitin conjugating enzyme E2 I
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UBE2I mRNA
CTD
PMID:26378955
NCBI chr16:1,309,152...1,327,017
Ensembl chr16:1,291,444...1,327,018
G
UBE2L6
ubiquitin conjugating enzyme E2 L6
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UBE2L6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UBE2L6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
G
UBR3
ubiquitin protein ligase E3 component n-recognin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBR3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UBR3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:169,827,454...170,084,131
Ensembl chr 2:169,827,454...170,084,131
G
UBXN2B
UBX domain protein 2B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBXN2B mRNA
CTD
PMID:21641980
NCBI chr 8:58,411,361...58,451,501
Ensembl chr 8:58,411,359...58,451,501
G
UCP2
uncoupling protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UCP2 mRNA
CTD
PMID:21641980
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
G
UNC13A
unc-13 homolog A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UNC13A mRNA
CTD
PMID:26378955
NCBI chr19:17,601,336...17,688,354
Ensembl chr19:17,601,336...17,688,365
G
UNG
uracil DNA glycosylase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UNG mRNA
CTD
PMID:21641980
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
G
UPF2
UPF2 regulator of nonsense mediated mRNA decay
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UPF2 mRNA
CTD
PMID:21641980
NCBI chr10:11,920,022...12,043,170
Ensembl chr10:11,920,022...12,043,170
G
UPP1
uridine phosphorylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA
CTD
PMID:21641980
NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736
G
USP1
ubiquitin specific peptidase 1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:62,436,395...62,451,804
Ensembl chr 1:62,436,297...62,451,804
G
USP16
ubiquitin specific peptidase 16
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP16 mRNA
CTD
PMID:26378955
NCBI chr21:29,024,668...29,054,488
Ensembl chr21:29,024,629...29,054,488
G
USP18
ubiquitin specific peptidase 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of USP18 mRNA
CTD
PMID:21641980
NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,149,843...18,177,397
G
USP2
ubiquitin specific peptidase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:119,355,215...119,381,690
Ensembl chr11:119,355,215...119,381,711
G
USP34
ubiquitin specific peptidase 34
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP34 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP34 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:61,187,463...61,471,087
Ensembl chr 2:61,187,463...61,471,087
G
USP37
ubiquitin specific peptidase 37
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP37 mRNA
CTD
PMID:26378955
NCBI chr 2:218,450,251...218,568,351
Ensembl chr 2:218,450,251...218,568,351
G
USP47
ubiquitin specific peptidase 47
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP47 mRNA
CTD
PMID:26378955
NCBI chr11:11,841,972...11,961,887
Ensembl chr11:11,841,423...11,961,887
G
USP9X
ubiquitin specific peptidase 9 X-linked
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP9X mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of USP9X mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:41,085,445...41,236,579
Ensembl chr X:41,085,445...41,236,579
G
UTRN
utrophin
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTRN mRNA
CTD
PMID:26378955
NCBI chr 6:144,285,335...144,853,034
Ensembl chr 6:144,285,335...144,853,034
G
UTY
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTY mRNA
CTD
PMID:26378955
NCBI chr Y:13,233,895...13,480,670
Ensembl chr Y:13,234,577...13,480,673
G
VAV3
vav guanine nucleotide exchange factor 3
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VAV3 mRNA
CTD
PMID:26378955
NCBI chr 1:107,571,161...107,965,180
Ensembl chr 1:107,571,161...107,965,180
G
VCPIP1
valosin containing protein interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VCPIP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VCPIP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:66,628,487...66,667,231
Ensembl chr 8:66,628,487...66,667,231
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VEGFA mRNA
CTD
PMID:26378955
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFC
vascular endothelial growth factor C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of VEGFC mRNA
CTD
PMID:21641980
NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922
G
VLDLR
very low density lipoprotein receptor
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VLDLR mRNA
CTD
PMID:26378955
NCBI chr 9:2,621,787...2,660,056
Ensembl chr 9:2,621,182...2,660,056
G
VPS18
VPS18 core subunit of CORVET and HOPS complexes
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS18 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VPS18 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:40,894,450...40,903,975
Ensembl chr15:40,894,450...40,903,975
G
VPS41
VPS41 subunit of HOPS complex
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS41 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VPS41 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:38,722,974...38,909,191
Ensembl chr 7:38,722,974...38,932,394
G
VPS50
VPS50 subunit of EARP/GARPII complex
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS50 mRNA
CTD
PMID:21641980
NCBI chr 7:93,232,366...93,361,123
Ensembl chr 7:93,232,340...93,361,123
G
VTN
vitronectin
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VTN mRNA
CTD
PMID:26378955
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
G
VWF
von Willebrand factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VWF mRNA
CTD
PMID:26378955
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
WBP4
WW domain binding protein 4
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of WBP4 mRNA
CTD
PMID:26378955
NCBI chr13:41,061,509...41,084,006
Ensembl chr13:41,061,509...41,084,006
G
WDHD1
WD repeat and HMG-box DNA binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDHD1 mRNA
CTD
PMID:21641980
NCBI chr14:54,938,949...55,027,099
Ensembl chr14:54,938,949...55,027,105
G
WDPCP
WD repeat containing planar cell polarity effector
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDPCP mRNA
CTD
PMID:21641980
NCBI chr 2:63,119,559...63,840,826
Ensembl chr 2:63,119,559...63,827,843
G
WDR12
WD repeat domain 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDR12 mRNA
CTD
PMID:21641980
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WDR26
WD repeat domain 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDR26 mRNA
CTD
PMID:21641980
NCBI chr 1:224,385,146...224,434,797
Ensembl chr 1:224,385,146...224,437,033
G
WIPF1
WAS/WASL interacting protein family member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WIPF1 mRNA
CTD
PMID:21641980
NCBI chr 2:174,559,574...174,682,913
Ensembl chr 2:174,559,572...174,682,916
G
WWOX
WW domain containing oxidoreductase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of WWOX mRNA
CTD
PMID:21641980
NCBI chr16:78,099,654...79,212,667
Ensembl chr16:78,099,400...79,212,667
G
WWP1
WW domain containing E3 ubiquitin protein ligase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WWP1 mRNA
CTD
PMID:21641980
NCBI chr 8:86,342,547...86,468,503
Ensembl chr 8:86,342,547...86,478,420
G
XAF1
XIAP associated factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of XAF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of XAF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
G
XRN2
5'-3' exoribonuclease 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of XRN2 mRNA
CTD
PMID:26378955
NCBI chr20:21,303,331...21,389,825
Ensembl chr20:21,303,331...21,389,825
G
XYLT2
xylosyltransferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of XYLT2 mRNA
CTD
PMID:21641980
NCBI chr17:50,346,126...50,361,185
Ensembl chr17:50,346,126...50,363,138
G
ZBP1
Z-DNA binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZBP1 mRNA
CTD
PMID:21641980
NCBI chr20:57,603,852...57,620,426
Ensembl chr20:57,603,846...57,620,576
G
ZBTB20
zinc finger and BTB domain containing 20
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZBTB20 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:114,314,500...115,147,288
Ensembl chr 3:114,314,500...115,147,292
G
ZBTB32
zinc finger and BTB domain containing 32
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZBTB32 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZBTB32 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:35,704,558...35,717,038
Ensembl chr19:35,704,558...35,717,038
G
ZBTB4
zinc finger and BTB domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:7,459,378...7,484,249
Ensembl chr17:7,459,366...7,484,263
G
ZBTB43
zinc finger and BTB domain containing 43
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZBTB43 mRNA
CTD
PMID:26378955
NCBI chr 9:126,804,072...126,838,210
Ensembl chr 9:126,805,006...126,838,210
G
ZBTB7A
zinc finger and BTB domain containing 7A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB7A mRNA
CTD
PMID:26378955
NCBI chr19:4,043,303...4,066,899
Ensembl chr19:4,043,303...4,066,899
G
ZBTB8A
zinc finger and BTB domain containing 8A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB8A mRNA
CTD
PMID:26378955
NCBI chr 1:32,539,427...32,605,941
Ensembl chr 1:32,539,427...32,605,941
G
ZC3H11A
zinc finger CCCH-type containing 11A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZC3H11A mRNA
CTD
PMID:26378955
NCBI chr 1:203,795,623...203,854,124
Ensembl chr 1:203,795,623...203,854,999
G
ZC3H12A
zinc finger CCCH-type containing 12A
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377
G
ZC3H12C
zinc finger CCCH-type containing 12C
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12C mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:110,093,392...110,171,841
Ensembl chr11:110,093,392...110,171,841
G
ZC3H13
zinc finger CCCH-type containing 13
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZC3H13 mRNA
CTD
PMID:26378955
NCBI chr13:45,954,465...46,052,746
Ensembl chr13:45,954,465...46,052,759
G
ZC3H15
zinc finger CCCH-type containing 15
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZC3H15 mRNA
CTD
PMID:26378955
NCBI chr 2:186,486,260...186,509,361
Ensembl chr 2:186,486,253...186,509,361
G
ZCCHC2
zinc finger CCHC-type containing 2
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZCCHC2 mRNA
CTD
PMID:26378955
NCBI chr18:62,523,025...62,586,729
Ensembl chr18:62,523,025...62,587,709
G
ZCCHC7
zinc finger CCHC-type containing 7
multiple interactions
EXP ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZCCHC7 mRNA
CTD
PMID:26378955
NCBI chr 9:37,120,167...37,358,149
Ensembl chr 9:37,120,574...37,358,149
G
ZDHHC14
zinc finger DHHC-type palmitoyltransferase 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZDHHC14 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZDHHC14 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:157,381,190...157,678,157
Ensembl chr 6:157,381,133...157,678,157
G
ZDHHC2
zinc finger DHHC-type palmitoyltransferase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZDHHC2 mRNA
CTD
PMID:26378955
NCBI chr 8:17,156,482...17,224,799
Ensembl chr 8:17,156,482...17,224,799
G
ZDHHC21
zinc finger DHHC-type palmitoyltransferase 21
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZDHHC21 mRNA
CTD
PMID:26378955
NCBI chr 9:14,588,797...14,693,432
Ensembl chr 9:14,611,071...14,693,432
G
ZEB2
zinc finger E-box binding homeobox 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZEB2 mRNA
CTD
PMID:26378955
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
G
ZFC3H1
zinc finger C3H1-type containing
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFC3H1 mRNA
CTD
PMID:26378955
NCBI chr12:71,609,599...71,663,848
Ensembl chr12:71,609,599...71,667,725
G
ZFHX4
zinc finger homeobox 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFHX4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFHX4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:76,681,247...76,867,281
Ensembl chr 8:76,681,239...76,867,281
G
ZFP36
ZFP36 ring finger protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP36 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:39,406,847...39,409,407
Ensembl chr19:39,406,847...39,409,407
G
ZFP36L1
ZFP36 ring finger protein like 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36L1 mRNA
CTD
PMID:26378955
NCBI chr14:68,787,655...68,796,243
Ensembl chr14:68,787,660...68,796,253
G
ZFP91
ZFP91 zinc finger protein, atypical E3 ubiquitin ligase
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP91 mRNA
CTD
PMID:26378955
NCBI chr11:58,579,063...58,621,550
Ensembl chr11:58,579,063...58,621,550
G
ZFR
zinc finger RNA binding protein
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFR mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFR mRNA
CTD
PMID:26378955
NCBI chr 5:32,354,350...32,444,740
Ensembl chr 5:32,354,350...32,444,740
G
ZFYVE16
zinc finger FYVE-type containing 16
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFYVE16 mRNA
CTD
PMID:26378955
NCBI chr 5:80,407,610...80,483,379
Ensembl chr 5:80,408,013...80,483,379
G
ZFYVE21
zinc finger FYVE-type containing 21
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFYVE21 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFYVE21 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:103,715,810...103,733,664
Ensembl chr14:103,715,730...103,733,668
G
ZIK1
zinc finger protein interacting with K protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZIK1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZIK1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:57,584,145...57,593,890
Ensembl chr19:57,578,456...57,593,890
G
ZKSCAN1
zinc finger with KRAB and SCAN domains 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZKSCAN1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZKSCAN1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:100,015,596...100,045,374
Ensembl chr 7:100,015,572...100,041,689
G
ZMYM3
zinc finger MYM-type containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYM3 mRNA
CTD
PMID:26378955
NCBI chr X:71,239,624...71,255,290
Ensembl chr X:71,239,624...71,255,146
G
ZMYND15
zinc finger MYND-type containing 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZMYND15 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZMYND15 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:4,739,833...4,746,119
Ensembl chr17:4,739,833...4,746,119
G
ZMYND19
zinc finger MYND-type containing 19
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZMYND19 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYND19 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:137,582,081...137,590,512
Ensembl chr 9:137,582,081...137,590,512
G
ZMYND8
zinc finger MYND-type containing 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYND8 mRNA
CTD
PMID:26378955
NCBI chr20:47,209,214...47,356,699
Ensembl chr20:47,209,214...47,356,889
G
ZNF117
zinc finger protein 117
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF117 mRNA
CTD
PMID:26378955
NCBI chr 7:64,971,772...64,991,036
Ensembl chr 7:64,970,663...65,006,687
G
ZNF146
zinc finger protein 146
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF146 mRNA
CTD
PMID:26378955
NCBI chr19:36,214,723...36,238,768
Ensembl chr19:36,214,602...36,238,771
G
ZNF148
zinc finger protein 148
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP148 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP148 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:125,225,669...125,375,354
Ensembl chr 3:125,225,669...125,375,325
G
ZNF165
zinc finger protein 165
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF165 mRNA
CTD
PMID:26378955
NCBI chr 6:28,080,282...28,089,563
Ensembl chr 6:28,080,568...28,089,563
G
ZNF185
zinc finger protein 185 with LIM domain
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP185 mRNA
CTD
PMID:26378955
NCBI chr X:152,898,067...152,973,481
Ensembl chr X:152,898,067...152,973,481
G
ZNF207
zinc finger protein 207
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP207 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP207 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:32,350,157...32,381,885
Ensembl chr17:32,350,132...32,381,885
G
ZNF253
zinc finger protein 253
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF253 mRNA
CTD
PMID:26378955
NCBI chr19:19,865,830...19,894,674
Ensembl chr19:19,865,882...19,894,674
G
ZNF267
zinc finger protein 267
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP267 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP267 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:31,873,807...31,917,357
Ensembl chr16:31,873,807...31,917,357
G
ZNF280D
zinc finger protein 280D
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP280D mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF280D mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:56,630,176...56,733,509
Ensembl chr15:56,630,176...56,734,086
G
ZNF292
zinc finger protein 292
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP292 mRNA
CTD
PMID:26378955
NCBI chr 6:87,155,565...87,265,943
Ensembl chr 6:87,151,803...87,265,943
G
ZNF296
zinc finger protein 296
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP296 mRNA
CTD
PMID:26378955
NCBI chr19:45,071,500...45,076,478
Ensembl chr19:45,071,500...45,076,478
G
ZNF329
zinc finger protein 329
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP329 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZFP329 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:58,126,248...58,155,104
Ensembl chr19:58,126,248...58,155,110
G
ZNF367
zinc finger protein 367
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP367 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP367 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:96,385,941...96,418,370
Ensembl chr 9:96,385,941...96,418,370
G
ZNF394
zinc finger protein 394
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZKSCAN14 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZKSCAN14 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:99,486,519...99,500,281
Ensembl chr 7:99,473,877...99,504,857
G
ZNF420
zinc finger protein 420
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF420 mRNA
CTD
PMID:26378955
NCBI chr19:37,007,902...37,130,368
Ensembl chr19:37,007,857...37,130,368
G
ZNF43
zinc finger protein 43
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP729A mRNA
CTD
PMID:26378955
NCBI chr19:21,804,946...21,852,065
Ensembl chr19:21,804,946...21,852,125
G
ZNF430
zinc finger protein 430
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF430 mRNA
CTD
PMID:26378955
NCBI chr19:21,020,657...21,060,050
Ensembl chr19:21,020,634...21,060,050
G
ZNF444
zinc finger protein 444
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP444 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP444 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:56,132,553...56,160,893
Ensembl chr19:56,132,599...56,160,893
G
ZNF445
zinc finger protein 445
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP445 mRNA
CTD
PMID:26378955
NCBI chr 3:44,431,705...44,477,670
Ensembl chr 3:44,431,705...44,477,670
G
ZNF503
zinc finger protein 503
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP503 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP503 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:75,279,725...75,401,916
Ensembl chr10:75,397,830...75,401,764
G
ZNF518A
zinc finger protein 518A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF518A mRNA
CTD
PMID:26378955
NCBI chr10:96,129,715...96,205,291
Ensembl chr10:96,129,715...96,205,288
G
ZNF519
zinc finger protein 519
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF519 mRNA
CTD
PMID:26378955
NCBI chr18:14,071,121...14,132,435
Ensembl chr18:14,057,457...14,132,490
G
ZNF562
zinc finger protein 562
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP266 mRNA
CTD
PMID:21641980
NCBI chr19:9,641,807...9,675,100
Ensembl chr19:9,641,807...9,675,100
G
ZNF567
zinc finger protein 567
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF567 mRNA
CTD
PMID:26378955
NCBI chr19:36,666,934...36,727,506
Ensembl chr19:36,687,612...36,727,701
G
ZNF572
zinc finger protein 572
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF572 mRNA
CTD
PMID:26378955
NCBI chr 8:124,973,295...124,979,389
Ensembl chr 8:124,973,295...124,979,389
G
ZNF596
zinc finger protein 596
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF596 mRNA
CTD
PMID:26378955
NCBI chr 8:232,137...247,340
Ensembl chr 8:232,137...264,703
G
ZNF605
zinc finger protein 605
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF605 mRNA
CTD
PMID:26378955
NCBI chr12:132,918,306...132,956,306
Ensembl chr12:132,918,306...132,956,306
G
ZNF638
zinc finger protein 638
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP638 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP638 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:71,331,782...71,435,061
Ensembl chr 2:71,276,561...71,435,069
G
ZNF644
zinc finger protein 644
multiple interactions
ISO EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP644 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF644 mRNA
CTD
PMID:26378955
NCBI chr 1:90,915,304...91,022,035
Ensembl chr 1:90,915,298...91,022,272
G
ZNF682
zinc finger protein 682
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF682 mRNA
CTD
PMID:26378955
NCBI chr19:19,995,131...20,039,505
Ensembl chr19:19,997,058...20,039,505
G
ZNF765
zinc finger protein 765
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF765 mRNA
CTD
PMID:26378955
NCBI chr19:53,395,149...53,427,321
Ensembl chr19:53,389,793...53,430,413
G
ZNF799
zinc finger protein 799
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP799 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP799 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:12,390,016...12,415,084
Ensembl chr19:12,390,016...12,401,271
G
ZNF800
zinc finger protein 800
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP800 mRNA
CTD
PMID:26378955
NCBI chr 7:127,342,859...127,392,708
Ensembl chr 7:127,346,790...127,431,924
G
ZNF804A
zinc finger protein 804A
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF804A mRNA
CTD
PMID:26378955
NCBI chr 2:184,598,529...184,939,492
Ensembl chr 2:184,598,529...184,939,492
G
ZNF831
zinc finger protein 831
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF831 mRNA
CTD
PMID:26378955
NCBI chr20:59,123,388...59,259,113
Ensembl chr20:59,123,381...59,259,113
G
ZNF836
zinc finger protein 836
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF836 mRNA
CTD
PMID:26378955
NCBI chr19:52,154,107...52,171,621
Ensembl chr19:52,153,864...52,171,643
G
ZNF93
zinc finger protein 93
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF93 mRNA
CTD
PMID:26378955
NCBI chr19:19,900,946...19,935,575
Ensembl chr19:19,900,913...19,963,464
G
ZNRF1
zinc and ring finger 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZNRF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNRF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:74,999,024...75,110,994
Ensembl chr16:74,999,024...75,110,994
G
ZNRF2
zinc and ring finger 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZNRF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNRF2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:30,284,597...30,367,689
Ensembl chr 7:30,284,597...30,367,689
G
ZRANB1
zinc finger RANBP2-type containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZRANB1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZRANB1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:124,916,894...124,988,189
Ensembl chr10:124,942,123...124,988,189
G
ZUP1
zinc finger containing ubiquitin peptidase 1
multiple interactions
EXP
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZUP1 mRNA
CTD
PMID:26378955
NCBI chr 6:116,635,618...116,668,766
Ensembl chr 6:116,635,618...116,668,794
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all